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SUMMARY
Two distinct mechanisms of catecholamine release from the adrenal
medulla were investigated.
One was whether the two catecholamines, noradrenaline and
adrenaline, could be released selectively by different reflex or pharm¬
acological stimuli to the adrenal gland.
The other \iias whether a humoral mechanism involving the anterior
pituitary - adrenocortical axis participated in the regulation of adrenal
catecholamine secretion.
We have studied these phenomena in anaesthetised cats and dogs
in which we independently elicited the baroreceptor and chemoreceptor
reflexes^and in isolated Locke - perfused adrenal glands subjected to
pharmacological stimulation by specific muscarinic and nicotinic agonists.
Techniques were established
a) For constant pressure perfusion of the carotid bifurcation using a
servo control amplifier system.
b) For chemoreceptor stimulation by using the reducing agent, sodium
dithionite, to lower the oxygen tension of the blood.
c) Isolated adrenal gland perfusion with automated sample collection and
differential catecholamine assay.
In Dogs no evidence for selective release was found.
1) The incremental releases mediated by the baroreceptor and chemoreceptor
reflexes and by splanchnic nerve stimulation contained the same proportion
i
of noradrenaline to adrenaline (i.e. 1:4) which was equal to that found
in the resting output.
2) This proportion of noradrenaline to adrenaline was also found in the
increments released in response to specific nicotinic and muscarinic
i
stimulation using hppTMA and acetyl-^-Methyl Choline respectively.
In Cats we did find evidence of selective catecholamine release
with both reflex and pharmacological stimulation.
1) Baroreceptor stimulation released an increment containing predominantly
noradrenaline (75?^ noradrenaline).
2) Chemoreceptor stimulation released an increment containing predominantly
adrenaline (16% noradrenaline)
3) Both of the mean percentages were significantly different (P<0.01)
i
from one another and from that in the resting output which contained k6%
noradrenaline.
k) Nicotinic (hppTMA.) stimulation released an increment which contained
significantly (P<0.01) more noradrenaline (57/^ noradrenaline) than that
released by muscarinic (methacholine) stimulation (3^/o noradrenaline).
However, at none of the doses, tested was there any evidence that either
drug released solely one catecholamine.
These results suggest that with respect to the above reflexes
and drugs, there is a species difference between the dog and the cat
regarding the selective release of adrenal catecholamines.
Our evidence for the participation of a. humoral component, via
the anterior pituitary - adrenocortical axis, in the control of adrenal
catecholamine output in the dog is as follows
1) We found that the release of catecholamines provoked by chemoreceptor
stimulation outlasts the stimulus and usually continues to rise after its
cessation.
2) This delayed component of the adrenal catecholamine discharge in
response to chemoreceptor stimulation was seen in a denervated gland.
Denervation abolished the immediate catecholamine release in response to
chemoreceptor stimulation and the baroreceptor reflex.
3) Oheraoreceptor stimulation has been shown by other workers to release
corticotrophin from the pituitary gland.
4) We found that intravenous Synacthen releases catecholamines from both
intact and denervated adrenal glands.
5) The delayed release of catecholamines in response to both Synacthen
and chemoreceptor stimulation is inhibited by cycloheximide, which has
been shown by other workers to block steroid secretion. There was no
evidence that cycloheximide had any effect on neuronally mediated adrenal
medullary release.
6) Hydrocortisone, in the order of concentration found in adrenal venous
blood after stress, was shown to increase the catecholamine output from
the isolated Locke perfused adrenal gland in a dose dependent manner.
I have included in the appendices some of the other work which
we did concurrently with the above studies.
We present evidence, from experiments done in man, that
increased concentrations of arterial plasma noradrenaline contribute to
the hypoxic potentiation of the respiratory response to moderate exercise.
Techniques are discussed for the estimation of catecholamines and their
ortho-methylated metabolites in peripheral plasma and urine.
Our technique for measuring venous capacitance in the lower
i
half of the body is described and evidence is presented which suggests
that there is an interaction between portal and systemic capacitance
which could have unexpected effects on venous return.
Part of our work has been published previously



















Evidence for the participation of the Anterior
Pituitary-Adrenocortical Axis in the Regulation
of Adrenomedullary Secretion. 66
Review of Techniques Available for Catecholamine
Assay. ' 77
Whole Animal Experiments:
A- Selective Catecholamine Release. 83
(includes Servo-control system, 89
taaroreceptor tests, chemoreceptor tests, 92
adrenal venous effluent collection). 9^
B - Endocrine Mechanism of Adrenal Medullary
Release. 102
Some Comments on our Whole Animal Experimental
Techniques. 106
A: Choice of Anaesthesia. 106
B: Carotid .Bifurcation Perfusion System. 108
C: Adrenal Venous Blood Collection Technique. 108
D: Use of Dithionite in Chemoreceptor
Stimulation. 109





Outline of our Technique. 126
Details of our Catecholamine Assay. 129
Notes on the Assay Technique. ' 133
Isolated .Adrenal Gland Perfusion Experiments 1.52
Automated gland Assay. 158
Some Comments on the Isolated Adrenal
Gland Perfusion System. 165
Investigation of Selective Adrenal Cate¬
cholamine Release:
- Dog Whole Animal Experiments. 167
- Dog Isolated Gland Experiments. 171
- Cat Whole Animal Experiments.' 17^
- Cat Isolated Gland Experiments. 177
- Effects of Nicotinic and Muscarinic
Antagonists in Cats. 181
DISCUSSION
Humoral Control of Adrenal Catecholamine
Output. 188
- Whole Animal Experiments. 190
- Action of Corticosteroids on Isolated
Perfused Canine A.drenal Glands. 207
- Observations on Adrenal Blood Flow in our
Whole Animal Experiments. 210
- Adrenal Blood Flow, Corticosteroid Concern-
tration & Catecholamine Output. 215
Selective Release Experiments. 22-1
- The Dog. 225
- The Cat. 227









A Role of Circulating Noradrenaline.
Further Studies on Peripheral Plasma
Catecholamine Assay.
Urinary Catecholamine Assay.
Measurement of Total Abdominal- Venous






















We investigated two separate aspects of catecholamine release
from the adrenal medulla.
Firstly, whether the two catecholamines, noradrenaline and
adrenaline, could he released independently by different reflex stimuli
to the gland.
Secondly, whether a humoral mechanism involving the anterior
pituitary-adrenocortical axis participated in the regulation of cate¬
cholamine secretion.
Most authorities now accept that noradrenaline and adrenaline
are stored within the adrenal medulla in clusters of cells containing one
or other catecholamine but there is controversy over whether the two
catecholamines are under independent secretory control.
We describe this phenomenon as selective release and define it
as the ability of different reflex stimuli to release from the adrenal
medulla, mixtures of catecholamines containing significantly different
ratios of noradrenaline to adrenaline in the increment secreted in excess
of the resting output. We distinguish selective release from preferential
release. A reflex may preferentially release more adrenaline than nor¬
adrenaline because this is the proportion in which the two catecholamines
are stored in a releasable form within the gland. Selective release is
only demonstrated when two distinct reflexes result in incremental
releases of equivalent magnitude which contain significantly different
proportions of the two hormones.
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Since 19^9j differential assays have been used to measure the
noradrenaline and adrenaline secreted in response to various reflex stimuli.
Some workers are adamant that selective release does not occur while others
present evidence in favour of the independent release of noradrenaline and
adrenaline by a number of different stimuli. Hie majority of these experi¬
ments have been done using dogs or cats and on detailed examination of the
literature, we found convincing evidence of selective release only in those
experiments done on cats. Those workers who used dogs either did not find
selective release or their results did not justify their conclusion.
To our knowledge, the responses to the same pair of reflex
stimuli had not been compared satisfactorily by using similar techniques in
both dogs and cats. We decided to see if the explanation to the contro¬
versy regarding selective release from the adrenal medulla was that it was
due to a species difference between dogs and cats.
The baroreceptor reflex is invoked by a fall in blood pressure
in the carotid and aortic arch stretch receptors while the arterial chemo-
receptor reflex will result from a fall in the oxygen tension of the blood
perfusing the carotid and aortic bodies. Both these reflexes have been
shown to induce adrenal medullary secretion and there is some evidence,
from Scandinavian and Russian work, that in cats the baroreceptor reflex
selectively releases noradrenaline while chemoreceptor stimulation releases
a mixture containing a much greater proportion ox adrenaline.
We designed a system which enabled us to alter independently
baiorecejjtor tone or stimulate the chemoreceptors in the region of the
carotid bifurcation. By giving short discrete stimuli of one or two
minutes duration and sampling the effluent blood from the adrenal gland,
we compared the noradrenaline to adrenaline ratios in the incremental
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releases invoked, by the two reflexes,. The intensities of the reflex
stimuli were adjusted with the objective of obtaining releases of equal
magnitude.
It is well known that the mammalian adrenal gland consists of
an outer cortex and an inner medulla which are enclosed within the capsule
of the gland, The cortex, synthesising steroid hormones, is under humoral
control while the medulla has a preganglionic sympathetic innervation and
produces noradrenaline and its methylated derivative, adrenaline.
These two tissues of the adrenal gland have quite different
embryological origins and classical physiological teaching considers that
the control and activity of the two parts are completely independent.
However, the internal circulation of the gland is complex and consists of
a portal system whereby the cortical effluent blood perfuses the sinusoids
of the medulla. There are also through channels, the arteriae rnedullae,
which pass through the outer cortex and carry blood direct from the capsular
plexus to parts of the medulla and the central collecting vein.
Only in mammals is there such a close association between the
steroid hormone and catecholamine synthesising tissues. Shepherd and West
(195*1) observed that the ratio of cortical to medullary tissue in the glands
of various species directly correlated with the proportion of adrenaline to
noradrenaline in the medulla. The cortex, therefore appeared to influence
the degree of methylation of noradrenaline to adrenaline. More recently
it has been suggested, with much supporting evidence that the continued
synthesis of the enzyme which methyiakes noradrenaline to adrenaline (that
is phenylethanolamine-W-methyl transferase - PNMT) requires the high concen¬
trations of glucocorticoid hormones that are delivered to the medullary
sinusoids via the portal system from the cortex.
However, we wondered whether this was the full explanation of
this complex and intimate relationship between the cortex and medulla.
Other vertebrates such as the frog can synthesise adrenaline without the
presence of high concentrations of steroids and non-steroid dependent iso¬
enzymes of PNMT have been reported in mammalian brain tissue -
We thought that the adrenal cortex might also participate in the
regulation of catecholamine release. This cortical control of medullary
secretion could be mediated through the influence of the concentration of
glucocorticoid hormones in the blood perfusing the adrenal medullary cells.
I shall now review the literature on which the previous para¬
graphs are based. However I will first give a brief historical account of
the work on the arterial chemoreceptors, baroreceptors and the adrenal
medulla. Then I shall go on to discuss the evidence for the storage of
noradrenaline and adrenaline in separate cells as well as the nature of
the innervation of the medulla. The work on the various reflexes inducing
adrenal catecholamine secretion will be described before considering in
detail that done with differential assays which is the basis of the evidenc
for and against selective release.
Finally I shall discuss the research which prompted us to
investigate the influence of the anterior pituitary-adrenocortical axis
on adrenal medullary catecholamine secretion.
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THE ARTERIAL CHEMORECEPTORS
The systemic arterial chemoreceptors are found in the carotid
bodies, lying on each side of the neck immediately rostral to the carotid
bifurcation, and in the aortic bodies which are scattered in the tissue
between the aorta and the pulmonary artery. They are the receptors
in the body which respond to oxygen lack and section of the nerves from the
chemoreceptors completely eliminates the normal response to a fall in
arterial oxygen tension.
A distinction should be made between the arterial chemoreceptors
and the central chemoreceptors. The latter are situated in the floor of
the fourth ventricle and the medulla oblongata and maintain a constant
arterial PCO^ by regulating ventilation. Unless X state otherwise, when
I use the term chemoreceptor, I am referring specifically to the systemic
arterial chemoreceptors.
The existence of the carotid bodies has been known for several
hundred years and as a consequence of their far easier access compared
with the aortic bodies, they have been used for most arterial chemoreceptor
research.
The presence of a ganglion in the region of the carotid bi¬
furcation was first noted by Haller (17^3) and then, according to Sigmund
Mayer, (1865) by Neubauer in 1772. At first it was named the "gangliolura
intercaroticurn" and the earliest good description which made reference to
its rich sympathetic nerve supply, was given by Lushka in 1862. Sigmund
Mayer (1865) confirmed these findings and in the same year Arnold noted the
extraordinary vascularity of the carotid bodies which he renamed the
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"glomeruli arteriosi intercarotici". J.I'. Heymans and C. Heymans (192?)
discovered that there were chemoreceptors in the chest sensitive to a
lack of oxygen and also to an excess of carbon dioxide. In the following
year de Castro (1928) suggested that the carotid bodies in the neck also
had a chemo-sensory function and Heymans and co-workers (1930> 1931°)
were able to prove this experimentally.
The work of Bouckaert and others (1931) established that by
ligating the nerve fibres leaving the carotid sinus in the region between
the carotid body and the sinus, the response to pressure changes was
removed but changes as a result of chemical stimulation remained unaffected.
Comroe and Schmidt (1938) confirmed that the receptors in the carotid region
responsible for the hypernoea induced by cyanide,are entirely within the
carotid body. Thus the receptors of the carotid sinus were shown to be
insensitive to chernoreceptor stimulation and those in the carotid body
appeared insensitive to pressure changes. Electrical recordings from
the carotid sinus nerve which carried the chemoreceptor fibres,showed that
asphyxia or 10% carbon dioxide inspiration increases the frequency of dis¬
charge and thus firmly established that these receptor organs are sensitive
to chemical changes in the blood (Zotterman 1935)-
The peripheral chemoreceptors apparently respond only to three
of the four classically described types of anoxia - anoxic, histotoxic
and stagnant. They do not appear to respond to anaemic anoxia which
explains the absence of hyperventilation in cases of carbon monoxide
poisoning or severe anaemia. For their weight the carotid bodies have
the highest blood flow of any tissue in the body (2 litres/100 g/min. -
Daly et al. 195*+) and a very small arteriovenous oxygen difference.
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Thus it seems that they respond, only to changes in the PO^ of arterial
blood and not oxygen concentration.
A considerable amount of research has been carried out on the
arterial chemoreceptors and that prior to 1958 has been excellently
reviewed in Eeyrnansand Neil's book "Reflexogenic Areas of the Cardio¬
vascular System". Some of the later research is discussed in the
Prolegomenon to "Arterial Chemoreceptors" edited by K.W. Torrance and
recently "The Systemic Arterial Chemoreceptors" edited by M. Purves
has been published. Anichkov and Belen'kii (1963) have catalogued the
/
pharmacology of the arterial chemoreceptors. Thus, I shall only mention
a number of aspects of arterial'chemoreceptor physiology which are relevant
to this thesis.
1. The chemoreceptors appear to be sensitive to the flow through them
in a manner which depends on the PO^ of the perfusing blood. The
explanation of this phenomenon is controversial but a change in flow at a
high PO^ has very little effect compared to the same change at a low PO^.
This property is of importance when one proposes to alter independently
baroreceptor and chemoreceptor activity.
2. Hypercapnia potentiates the response of the chemoreceptors to hypoxia.
Hornbein and co-workers (e.g. Hornbein and Roos 1963) showed that the
response of the chemoreceptors to hypoxia is potentiated by a degree of
hypercapnia which has no effect at a higher P0o. Other workers have
published further evidence of the interaction between hypoxia and hypercapnia
at a level of the arterial chemoreceptors but it must be remembered that
the main component of the xvhole body response to changes in arterial FGO^
is mediated via the central :chemoreceptors.
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3. Chemoreceptor stimulant agents fall into two groups. These are the
metabolic inhibitors such as the cyanide ion and" the nicotinic drugs
(see Anichkov and Belen'kii 1963)•
(a) Cyanide was the first stimulant drug used in chemoreceptor
studies and it was in 1900 that Pagano noted the hyperventilation and
bradycardia in response to intracarotid injections of cyanide and
nicotine. However, although he found that the reflex response did
not occur if the internal, rather than the common carotid was chosen
as the injection site, apparently he was unaware of the existence of
the carotid bodies. '
(b) Acetyl choline and the nicotinic receptor stimulant drugs also
have powerful actions on the chemoreceptors. In fact J.R. Comroe(i960)
attributes all the autonomic effects of smoking to the action of nicotine
on the chemoreceptors which respond to much lower blood concentrations
than are required for significant direct actions on smooth muscle.
4. Hexamethonium abolishes the response of the chemoreceptors to nicotinic
drugs but not to hypoxia or cyanide (Douglas 1952)
5. Recently there has been growing evidence for an efferent modulation
of chemoreceptor activity. Neil and O'Regan (1971 ) reported that efferent
stimulation of the carotid or aortic nerve increased chemoreceptor blood
flow and decreased discharge. Bisco and Purves (19&7) have shown that
passive limb movements increase chemoreceptor activity via a sympathetic
pathway. Joels and White (1968) found that noradrenaline infusions into
the carotid blood led to an increased chemoreceptor discharge which was
related to the arterial oxygen tension. Thus we entertained the idea
that changes in the arterial plasma concentration of noradrenaline could
alter the sensitivity of the chemoreceptors by way of its vasoconstrictor
action.
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Daly and Scott (1963) demonstrated that the primary effects of chemo-
receptor stimulation on the circulation are peripheral vasoconstriction
and bradycardia with a consequent fall in cardiac output.
However the reflex hypernoea invokes the lung stretch reflex
which causes reflex tachycardia and some reflex inhibition of the vaso¬
constrictor discharge (Daly and Robinson 1968). Thus the overall cardio¬
vascular responses in the spontaneously breathing animal are complex
(Korner, Chalmers and White 1967). There is considerable species
variation with regard to whether it is the primary or secondary reflex
which predominates in the resulting effect of chemoreceptor stimulation
on each area of cardiovascular territory.
To my knowledge, although stimulation of the chemoreceptors has
been shown to cause increased adrenal medullary secretion, the possibility
of any interaction with the lung stretch reflex has not been investigated.
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THE ARTERIAL BAHORECEPTORS
The baroreceptors are found in the carotid sinus, aortic arch,
thyrocarotid junction and the cardiopulmonary area and because of its site,
the carotid sinus has been subjected to the most study. They are stretch
receptors which are excited by the expansion of the vessel wall and not by
the pressure rise itself.
The carotid sinus is a small dilatation at the base of the
internal carotid artery. Meyer (1876) noted that this dilatation was
i
associated with a marked thinning of the arterial wall. Schaefer (1877)
showed that the sinus was present in all the corpses he investigated and
established that it was a normal structure (confirmed by Binswanger 1879)•
Work by Hering (192*0 showed that stimulation of the central end
of the nerve to the sinus caused reflex bradycardia and systemic hypotension
and later (1927) he found that sectioning of the nerve, abolished all reflexes
in response to mechanical stimulation of the sinus.
Following the suggestions of Erasucker (1922) and Banielopolu
and co-workers (1927)i it has been confirmed that the vagus, sympathetic
and glossopharyngeal nerves all contributed to the innervation of the sinus.
Gerard and Billingsley (1923) described the innervation of the carotid
sinus and adjacent carotid body and De Castro (1926, 1928) demonstrated the
richness of the sensory innervation to the sinus. Reis and Fuxe (1968)
demonstrated the considerable supply of adrenergic nerve fibres which is
found in some species. Vasoconstrictor drugs can provoke a big discharge
in the afferent fibres from the sinus and this observation has led to much
debate as to whether the sympathetic efferent innervation functions as some
sort of servo control.
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It was shown by Ead, Green and Neil (1932) and a number of
other groups that the baroreceptors respond more to pulsatile pressure
than to a steady pressure even when the mean pressures are identical.
With a normal blood pressure the baroreceptors exert a tonic
inhibitory influence on sympathetic drive to the heart (combined with an
increase in vagal activity), the blood vessels (especially muscle resistance
vessels) and of course the adrenal medulla.
As the carotid sinus pressure falls, so does this inhibitory influence
and it has ceased completely at around 70 mm.Hg, accompanied by a
corresponding increase in sympathetic activity and adrenal medullary
x'




One of the earliest descriptions of the adrenal glands was
made by Eustachius in I563 and later Bartholinus (1611) attributed to
them the secretion of the "black bile or atrabile". They'were named
"suprarenal glands" by Winslow. Although this term is appropriate for
the human adrenal gland, they are separate from the kidneys in species
other than primates and as these do not have an erect posture, the
commoner term, adrenal (near to the kidney]) is more suitable. Three ,
centuries after their description by Eustachius, Addison (1855) described
the symptoms caused by destructive lesions of the adrenal glands and thus
initiated a considerable amount of research on the organs. Brown-Siquard
(1856) performed the first experimental adrenalectomies and in the same
year Vulpian found that watery adrenal extracts from various species
contained a substance which gave a remarkable rose-carmine colour with a
number of reagents (e.g. Ferric chloride, iodine, alkali and sunlight).
Vulpian also detected this substance in the adrenal vein after death and
considered that it was released into the blood stream during life.
However, forty years were to pass before the potent pharmacological properties
of adrenal extracts began to be investigated which followed the discovery
of their pressor,effect by Oliver and Schaefer (189*0* Cybulski (1895) and
Szymonowicz (1896).
In 1897 Abel and Crawford purified and in 1901 Takamine isolated
a substance from the adrenal gland which became known as adrenaline. It
was the first hormone ever to be isolated or synthesised (Stolz 190*0.
Independently, Aldrich (1901) also isolated adrenaline and found its
empirical formula in 1913-
18
Also at the turn of the century, Lewandowsky (1899? 1900) and
Langley (1901) had both noted that there was a great similarity between
the response of various organs to the stimulation of their sympathetic
nerve supply and the injection of adrenal extracts. Thus Elliot (190^),
who was one of the first people to present the idea of neuro-humoral
transmission, suggested that the transmitter substance released at
sympathetic nerve endings was adrenaline. However, doubts were laid on
this theory by the work of Barger and Dale (1910) and Cannon and Uridil
(1921) who showed that the effects produced by sympathetic nerve
stumulation were not identical to those produced by adrenaline. On the
other hand, Loewi (1921) demonstrated the release of a sympathomimetic
substance from frog's heart which was found (Loewi, 1936, 1937) to be
adrenaline. Cannon tried to resolve this apparent anomaly by his theory
of the two sympathins (Cannon and Rosenblueth, 1933) and he considered
that the sympathetic transmitter at the mammalian heart was also adrenaline.
However, Raab (19^3) and Shaw (1938) showed that the sympathomimetic,
substance in mammalian extracts was not identical to adrenaline.
Von Buler confirmed their results and went on to show (19^6)
that a substance extracted from sympathetic nerves as well as from different
organs was pharmacologically identical to a compound which was closely
related to adrenaline. It had. been named, noradrenaline. (The NOR
comes from its old German name Stickenstoff-N-Ohne Radikal). Thus von
Euler (19^8) had identified the sympathetic neurotransmitter and for this
work was later awarded a Nobel Prize. About the time he was doing these
studies, it was shown both pharmacologically (Holtz et al. 19^7) and
chemically (James 19^+8) that the adrenal medulla contains noradrenaline
as well as adrenaline. Tullar (19^9) then demonstrated the presence of
noradrenaline in the commercial adrenaline standards of that time.
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Since this work, the presence of noradrenaline in the adrenal
glands of various species has been established by many investigators,
using a variety of different techniques, and large species differences
in the proportion of the two catecholamines have been noted. The presence
of noradrenaline in adrenal venous blood was demonstrated by Holtz et al (19^7)
BtJlbring and Burn (I9^9a)and Kaindl and von Euler (195"0. Blaschko
09^2) suggested that noradrenaline was the precursor of adrenaline and
its conversion to adrenaline was shown by' a number of groups e.g. (Holtz
and Kroneberg 19^9? Biilring and Burn 09^9b).
t
The chromaffin reaction xvhich is used to identify catecholamine -
containing tissue, although not differentiating between noradrenaline and
adrenaline, was first noted by Henle in 1865. ' He showed that the cells
of-the medulla become brown on treatment with chrome salts. Cells with
this special affinity for chrome salts were named chromophil by Stilling
(1890) and chromaffin by Kohn (1898). Phaeochrome was also suggested
as a name by Poll in 1906. Then there followed numerous studies on the
nature of the chromaffin reaction and the work by Gerard et al in 1930
resulted in it being accepted for a long time that the colour was due to
oxidation products of adrenaline.
However, in 195^ Coupland shewed that the compound produced by
dichroraate is different from that produced by iodate. It appears that
following reaction with formol dichromate, chromium is fixed with the
formation of chromadrenachrome. Er£!nk8 (3957) then demonstrated the
analogous reaction where, following fixation with formal iodate, polymeric
iodoadrenochrorae derivatives are formed. The chromaffin reaction not only
identifies catecholamine containing tissue but many studies have shown
that a good correlation exists between the intensity of the reaction and
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the concentration of catecholamine estimated in the tissue by chemical
assays- A good example is the study of Er&nkiJ and HMisMnen (19&1)
which used photometric measurements of the intensity of the chromaffin
reaction.
The adrenal medulla is made up of irregular strands or masses
of polygonal cells separated by sinusoidal vessels. However, the notable
feature of medullary cells is their cytoplasmic granulation. The
granules are evenly distributed in the cytoplasm and localised in them
are the sympathomimetic amines of the adrenal medulla. This was shown
by Hillarp and Nilsson (1953i 195*0 and Blaschko and Welch (1953)-
Early investigations described two or more different types of medullary
cells (Cramer (1916, 1928), Kolmer (1918), Hion "(1927) and Ma (1929) )•
Hoirever the significance of the different cell types remained obscure and
it was Cramer who concluded that the differences v/ere due to the secretory
stage of the cells rather than to their basic properties. This opinion
was shared by later investigators such as Bennett (19*1-1 ), Bachmann (195*0
and even Hillarp (I9*f6).
After the discovery of the presence of noradrenaline in adrenal
extracts, Binder (1950) and Er&nkiJ (1951) independently proposed that the
presence of two cell types could reflect a difference in the quantitative
nature of their catecholamine content. BMnd'er used classical staining
techniques to show two types of cell in the adrenal medulla of the cat,
dog and mouse. ^ He called them picrinophil (P) and fuchsinoph.il (F)
and thought them to be related to the production of noradrenaline and
adrenaline respectively. Unfortunately, at that time only a little
evidence supported this idea. Then ErMnkb' (1952) using histochemical
methods, demonstrated phosphatase positive and phosphatase negative types
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of cell in the medulla. These cells were indistinguishable with the
chromaffin reaction technique.- Furthermore, following treatment with
formaldehyde and ammoniacal silver nitrate, the phosphatase negative
cells fluoresced under ultra violet light. By microdissection and paper
chromatographic separation, he then demonstrated (195'+) that the nor¬
adrenaline content of the fluorescent cells is far higher than that of
the non-fluorescent, phosphatase positive cells. This work was supported
(1955) hy the correlation found between the number of fluorescent cells
and the noradrenaline content in various species.
Eichter and Blaschko had shown in 193^ that adrenaline is
oxidised by potassium iodate to a coloured compound - (in fact iodoadreno-
chrorne) which is soluble in water. On treatment with this reagent
adrenaline cells remain colourless as the bright red coloured compound is
leached out by the rinsing solutions. However, the corresponding compound
formed from noradrenaline decomposes into a dark insoluble melanin-like
derivative (Bu'lock and Harley-Mason (I95i)^ Thus, the adrenal medulla
appears as dark staining noradrenaline cells against a background of
colourless adrenaline cells. As with the chromaffin reaction, there is a
good correlation between the intensity of the iodate colouration and the
noradrenaline content of the tissue. In combination with the chromaffin
reaction (dichromate), Hillarp and HiJkfelt (195'+) used this technique to
show that there were separate noradrenaline and adrenaline containing cells
in the medulla.
The iodate and fluorescent methods were subsequently compared
and it was confirmed that they both demonstrate the same type of medullary
cell (i.e. that containing mainly noradrenaline-).
As to Binder's original P and F cells, methods that he himself
had proposed in 195^ were used by Er&ikif and Palkama (1959) to show that
the differential staining Binder had obtained was dependent on the
catecholamine concentration rather than the nature of the catecholamine
in tne cells.
With autoradiography using radioactive iodine and improved
fluorescent methods, ErSnkd (1958) obtained further evidence of the
segregation of noradrenaline and adrenaline into separate cells.
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INNERVATIOH OF THE ADRENAL MEDULLA
Since the investigations of the late nineteenth century on
the functional organisation of the autonomic nervous, system, it has
been accepted that the splanchnic nerves are the mediators of adrenal
secretion.
Jacobj (1891) stated that the splanchnic nerves send fibres to
the adrenal gland and Biedl (1897) also suggested that these nerves
regulated the secretion .of the gland. Jacobj (1892) had already
observed that electrical stimulation of the peripheral end of the dog's
greater thoracic splanchnic nerve had identical effects on gut contractions
as did direct stimulation of the gland itself.
More evidence was Dreyer's (1899) demonstration that electrical
stimulation of the splanchnic nerve increased the amount of an active
hypertensive substance in the adrenal venous blood. In J913» Elliot
suggested that the chromaffin cells are directly innervated from the
primary preganglionic nerves without'the intervention of ganglion cells.
This was later confirmed by Hoschi (1926), Hollinshead (1936), Swinyard
(1937) and others.
The general conclusion of nearly all investigators is that the
main innervation comes from the greater thoracic splanchnic nerve but
there is also a minor contribution from the lesser splanchnic nerve and
the lumbar para-vertebral ganglion (Hollingshead, 1936).
Teitelbaum (193'+) suggested the possibility of a vagal contri¬
bution but no further evidence in its favour has been obtained.
It was Langley (1896) who demonstrated that the sympathetic ganglion was
blocked by nicotine and also showed that the normal pressor effect of
splanchnic nerve stimulation was abolished by previous injections of
nicotine. As I will discuss later, although transmission at the
adrenal medulla has classically been considered as nicotinic, FeldbCrg,
Minz and Tsudzimura (193*0 did demonstrate atropine-sensitive responses
after nicotinic blockade.
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RELEASE FROM THE ADRENAL MEDULLA
Within a few years of the discovery of the potent properties
of adrenal gland extracts, Jacobj (1892) and Dreyer (1899) had shown
that electrical stimulation of the splanchnic nerve released a substance
with similar properties into the blood. Soon afterwards the effects
on the gland of stimuli such as muscular exhaustion (Battelli and Boatta
1902), asphyxia (Elliott 1905) and various centrally acting drugs
(Elliott 1912) were described.
During the first half of this century many reflex stimuli and
drugs were found to influence the adrenal medulla but, up to 19^9>nor¬
adrenaline was not considered to be an adrenal catecholamine and thus all
this foundation work on the nature of the releasing stimuli, can only be
interpreted in terms of "total catecholamine release.
I shall now describe some of these stimuli with emphasis on
those relevant to my thesis. However, at this stage, I shall not consider
which, or pin what proportions, the two catecholamines are released
1. Electrical stimulation of the splanchnic nerve.
2. Electrical stimulation of the Central Nervous System.
3. Stimuli related to ,hypoxia:-
(a) Asphyxia
(b) Whole body hypoxia
(c) Whole, body hypercapnia
(d) Selective chemoreceptor stimulation
(e) Local action of hypoxia on the gland
Stimuli related to a fall in blood pressure
(a) Haemorrhagic hypotension
(b) Carotid occlusion
(c) Selective stimulation of the baroreceptor reflex









The observations of Jacobj and Dreyer have been confirmed many
times and the pressor effect of splanchnic stimulation was used by us to
tell when we had located the splanchnic nerve in experiments DNI to DN3.
The following work has been done using differential assays
Dogs . Cats
Rapela and Houssay (1953) Eade and Wood (1958)
Rapela and Covian (195*0
KLepping (1955» 1956)
Cier and Klepping (1957)
Malmejac (See Review 196*0 Calf
Vogt (1965) Silver (i960)
Mirkin (1961)
Lund (1951)
2. CENTRAL NERVOUS SYSTEM - ELECTRICAL STIMULATION
Elliott (1912) suggested that there was a centre participating
in the control of adrenal medullary secretion which was situated in the
brain stem close to the postulated vasomotor centres. This was based on
the observation that the adrenal discharge induced by afferent nerve
stimulation was abolished by section of the spinal cord at the T1 segment
but not prevented by section at the level of the corpora quadrigemina.
On the basis of sectioning and ablation experiments, Cannon and Rapport
(1922) concluded that there was a bulbar centre capable of exciting or
inhibiting reflexly induced adrenal discharge. (N.B. Nowadays, many
authorities consider that the control of the autonomic nervous system is
not localised in discrete centres).
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Other workers began to search for areas in the brain which
on stimulation induced catecholamine secretion and these were found in:-
(a) Bulbar region - Tournade and Malmejac (1932)
Cannon and Rapport (1922)
(b) Fourth ventricle - Cannon and Rapport (1922)
Houssay and Molinelli (1923)
Piqure (puncture of the Fourth Ventricle) - Kahn (1911)
Carrasco - Formiguera (1922)
(c) Hypothalamus - Houssay and Molinelli (1925)
Magoun, Ranson and Hetherington (1937)
Brauner, Brtlcke, Kaindl, .Neumayer (1951)
Brtfcke, Kaindl and Mayer (1952)
Grant, Lindgren, Rosen and Uvnas (1958)
Iremoto (1955)
Redgate and Gellhorn (1953)
Folkow and von Euler (195^)
(d) Mesencephalon - Lindgren (1955)
(e) Medulla oblongata (dorsalateral to the pyramids)
Lindgren, Rosen and Uvnas (1959)
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3. STIMULI BELATED TO HYPOXIA
(a) Asphyxia
at
A dilation of the denervated iris during asphyxia was described
by Budge in 1855 and also observed by Anderson (1903)- Elliott (1912)
suggested that this phenomenon was mediated by the adrenal glands as no
dilatation was observed after adrenalectomy. Between 1910 and 1920
various workers used a number of methods to demonstrate the influence of
asphyxia on the gland.
Asphyxia produced by tracheal closure reduced the intensity of
the chromaffin reaction in the adrenal glands from dogs, rabbits and
monkeys (-for comparison one adrenal had been removed before asphyxia)
(Kahn 1912, Borberg 1913 )•
Asphyxia resulted in a higher concentration of catecholamines
in inferior vena caval blood samples (-taken from above the adrenolumbar
veins - Cannon and Hoskins 1911) and in adrenal vein samples (Gley and
Quinquand (1917)- Anrep (1912) described a vasoconstriction in the
denervated hind limb of dogs subjected to closure of the trachea, which
was abolished by tying off the adrenal glands.
In 1923? Tournade and Chabrol described their classic technique
whereby the adrenolumbar vein of a donor dog is anastamosed to the jugular
vein of another dog (recipient was the assay animal) and showed that
asphyxia in the donor resulted in a rise in blood pressure in the recipient
animal.
Using a similar technique, Houssay and Molinelli (1926) confirmed
the results of the latter pair and other workers,using various internal
and external bioassays;have generally found that asphyxia resulted in cate-
30
cholaraine release from the adrenal gland. However, Stewart and Eogoff
did publish a series of papers between 19'l6 and 1920 in which they describe
testing a variety of preparations but never found any evidence for an
adrenal medullary response to asphyxia. This was the case with internal
tests such as the denervated iris (1916) and blood pressure (1916) and
also external biological assay (rabbit intestine and uterus}- of blood
collected in a vena canal pocket (1917)-
However it is now generally accepted that asphyxia is one of the
stimuli to adrenal catecholamine release and further confirmation came
from the work of:-
Binet and Lanxade (1936), Herman and Jourdan (19^2),
Malmejac & Gross (1952), Sato, Inaba & Takahashi (1932)
Asphyxia is a generalised stimulus involving hypoxia, hypercapnia
and acidaemia and all of these may act on the arterial chemoreceptors, the
central nervous system itself and directly on the gland.
(b) Whole body hypoxia
When this is produced by altering the gas mixture breathed by
the animal, the effect on adrenal discharge is similar, although usually
less intense, to that of asphyxia. Kellaway (1919) used the denervated
iris assay and detected adrenal discharge with oxygen concentrations below
about 12/o. Houssay and Molinelli (1926) found that an oxygen concentration
of less than 11$ was required for a measurable response in their adreno-
lumbar-jugular anastomosis preparations.
(c) Whole body hypercapnia
Houssay and Molinelli (1926) did not obtain any evidence for an
adrenal response to increasing the inspired C0o carbon dioxide concentration
up to 16$. However Itami C1912) observed a vasoconstriction in the
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denervated hind limbs of dogs breathing10-12% carbon dioxide mixture.
Cathcart and Clark (191*0 also detected an adrenal response and Tenney
(1956) using the denervated nictitating membrane assay found that the
carbon dioxide threshold in the cat was 15%-
Not only does hypercapnia directly stimulate the central
chemoreceptors in the medulla oblongata but it also potentiates the
action of hypoxia on the peripheral arterial chemoreceptors. This
interaction between hypoxia and hypercapnia, results in the effect of
hypercapnia being, in part, dependent on the arterial oxygen tension
and thus hypercapnia is a much greater adrenal stimulus under hypoxic
conditions.
(d) Selective stimulation of the Arterial Chemoreceptors
Cyanide was found to be a powerful chemoreceptor stimulant by
Heymans et al (I931a)and von Euler and Liljestrand (1937)- Many workers
have shown that intravenous administration of cyanide induces adrenal
medullary discharge although not all of them were aware of the chemorec-
eptor's peculiar sensitivity to this drug. Its action was considered to
be due to a generalised tissue hypoxia which is the case when larger doses
than those required for chemoreceptor stimulation are used.
An adrenal catecholamine release in response to potassium cyanide
administration was shown by Houssay and Molinelli (1926) using their above
mentioned technique. Molier and Stefanson (1937) showed thai the hypergly-
caemia resulting from hydrocyanic acid administration was abolished by
adrenalectomy. Paulet, Cier and KLepping (1957) used sodium cyanide in case
the potassium ion was having a direct effect on the adrenal. However,
Petropavlovskaya in 1953 bad established that the reflex hyperglycaemia
was not seen after section of the carotid sinus nerves. She used doses of
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around 0.1 rng/kg in non-anaesthesised dogs and decerebrate cats. Later I
shall discuss further work by the Russian group under Anichkov (to which
Petropavlovska belonged) with reference to differential secretion. Other
workers who noted increased adrenal catecholamine release after cyanide
administration were Kudo (1931)5 Suzuki et al (1951)5 Poshalenko (1955)
Malygina (1961), Anichkov et al (i960).
Nicotine has been shown to be a powerful chemoreceptor stimulant
(Heymans and Heymans (1927), Heymans et al (1931a)and this action should
be considered when assessing the effects of intravenous drug administration. t
Much more recently other specific chemoreceptor stimulant drugs
have been used to provoke adrenal discharge such as the work done by A.
Ungar and his former PhD student D.S.McQueen, using Suberyl Choline.
(e) Local action on the Gland
Finally there is the possibility of a local effect of hypoxia on
the gland. A paper by BuLbrLng, Burn and de Elio (19^8) is often quoted as
evidence for the direct action of hypoxia on the adrenal gland. They used
the 'in situ' dog adrenal which was perfused with the animal's own blood
from a closed circuit system containing a Hooker oxygenator. After allowing
the preparation to equilibrate for one hour, the gas mixture aerating the
blood was changed from oxygen with 3% 00^ to nitrogen with 3% 00^. The
oxygen-free aeration was continued for a further hour before returning to
the original mixture. They did find an increased discharge of catecholamines
(output rose to around b ug/min) but this response did not start until
after half an hour of anoxia. On discontinuing the nitrogen aeration,there
was a similar latent period before the catecholamine output began to fall.
Thus there is no evidence here for a local action of anoxia play¬
ing a significant part in the response to asphyxia. Bulbring et al did find
that the administration of 0.5 - 2.0 mg potassium cyanide to the gland gave
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an immediate .response which they attributed to the anoxia resulting from
the cyanide. However, this amount of potassium chloride also causes a
pronounced adrenal release which is due to the action of the potassium
ion (e.g. Vogt 1952, 1965).
The paper of Vogt (1952) is often quoted as evidence that anoxia
has a direct effect on the glands and is only evidence that authors do
not read their references. She was investigating the secretion from the
denervated adrenal medulla and in one experiment took one adrenal sample
before and one after reducing the blood pressure by severe haemorrhage.
i
She interpreted the two-fold increase in catecholamine secretion rate as
being due to the "anoxia" prevailing during haemorrhage. (See p215 for an
alternative explanation). This is the sole piece of evidence in this paper
that hypoxia has a local action on the adrenal gland.
b. STIMULI RELATED TO A FALL IN BLOOD PRESSURE
(a) Haemorrhagic Hypotension
An increased adrenal medullary output in response to blood loss
has been described by many authors e.g. Trendelenburg (1912), Bedford (1917)
Stewart and Rogoff (1918), Tournade and Chabrol (1926), Lund (195*1 ), Cier
and Klepping (1957), Walker et al (1959)-
The response to haemorrhagic hypotension involves the baroreceptor
and chemoreceptor reflexes (see Heymans and Neil 1958p179) as well as
the generalised effects of reduced tissue perfusion and acidaemia.
Others have examined the more discreet stimulus of carotid occlusion.
(b) Carotid Occlusion
The reflex response to carotid occlusion is not solely due to a
withdrawal of baroreceptor tone but also has a variable chemoreceptor comp¬
onent due to the reduction in the perfusion pressure of the carotid body.
The anastomoses between the facial vessels, internal carotid
and vertebral arteries leads to a rapid recovery of sinus pressure.
Various groups have shown that in the dog, although the fall in sinus
pressure which results from unilaterial carotid occlusion may be up to
fifty percent, it has recovered to within 10-35$ °f its initial value
within half a minute. (Schmidt 1932, Euler and Liljestrand (1936),
Ghungcharoen et al 1952 and Wang et al 1952). Even though the degree
of recovery is less when both common carotids are occluded there is still
a good anastamosis in dogs betxveen the internal carotid and maxillary
arteries and the vertebral arteries via the circle of Willis.
However, cats very rarely have a patent internal carotid artery
(Davis and Storey 19^3) and thus there is less recovery of sinus pressure
during carotid occlusion in this species. Chungcharoen et al (1952)
recorded from chemoreceptor and baroreceptor fibres in the 'sinus nerve of
the cat and found that occlusion of the common carotid on that side gave
a great reduction in baroreceptor activity and a small chemoreceptor
discharge. If the external carotid was occluded as well, then all baro¬
receptor activity ceased and there was a heavy chemoreceptor discharge.
Thus there is a chemoreceptor component in the carotid occlusion response
but it must be remembered that the recovery pressure through anastamotic
channels will be far less pulsatile than that before carotid occlusion.
Therefore the recovery will be much more effective at reducing the chemo¬
receptor component by returning carotid body blood flow towards its
original level than in restoring baroreceptor tone. The latter receptor
respond much more to a pulsatile pressure than to the equivalent mean
pressure (Ead, Green and Neil 1952).
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Thus the interpretation of the reflex responses from, carotid
occlusion is variable. It will primarily depend on the initial blood
pressure. If the preparation is in a poor state with a low blood
pressure it will have no baroreceptor tone and any response can only be
due to reduced ■ chemoreceptor perfusion which is likely to be potentiated
by the accompanying hypoxia and acidaemia.
In the dog, with a normal or above normal arterial oxygen and
blood pressure, the response to occlusion of both common carotids will tend to
be small and largely due to the response of the baroreceptors to a great
4
reduction in the pulsatile nature of the sinus pressure. On the other
hand, Brauner, Brttcke and Kaindl (1950) found that, in unanaesthetised
dogs with exteriorised carotids, this stimulus led to a rise in blood
pressure which was 5G%- less when breathing 100% 0o than when on 7% 0^.
In the cat, the reduction in baroreceptor tone will be much
greater but the chemoreceptor component is also increased and very
dependent on the arterial oxygen tension.
1
However, when interpreting the results of carotid occlusion,
not only must one consider systemic blood pressure, ventilatory state
and species but also note whether or not the preparation was vagotomised.
If these nerves are not cut, the aortic baroreceptors will buffer the
(see p.36)
change in systemic blood pressure/and other reflex responses resulting
from carotid occlusion. Finally, the nature of the anaesthesia must be
borne in mind as,in cats, chloralose has been shown greatly to reduce the
cardiovascular responses to baroreceptor impulses without similarly
affecting the chemoreceptor response (Neil, Redwood and Schweitzer 19^9)•
However, we find that a very severe hypoxic chemoreceptor stimulus is
required to invoke a significant neural release from the adrenal medulla
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in both, cats and dogs. On the other hand the fall in sinus pressure one
\ifould expect from carotid occlusion in a cat with a good blood pressure, will
provoke a sizeable catecholamine release. Thus I would predict that the
catecholamine discharge resulting from carotid occlusion in a pentobarbitone
anaesthetised cat would be dominated by the baroreceptor reflex component.
Furthermore, I think that in the chloralose anaesthetised cat
the question of which reflex predominates will depend on the balance
between the dose of anaesthetic and the state of the preparation.
There is some debate as to whether or not carotid occlusion i
has an effect at all on adrenal catecholamine output. Aomura ■ (1930)
found an increased catecholamine secretion on clamping both carotid
arteries as did Hartwick and Hessel (1931) and Von Euler and Liljestrand
(193'+)- As I will discuss in more detail later, the following authors
also detected adrenal discharge with the above. Holtz and Schumann (19^9)
Brauner, Brftche and Kaindl (1950), Brauner, Brllche, Kaindl and Neumayer
(1951)5 Kaindl and Von Euler (1951) and Anichkov et al (i960).
Kaindl and Von Euler (1951) had to cut the vagi in their cars
before an adrenal discharge could be observed. A bigger cardiovascular
response to carotid occlusion is found after vagotomy for two possible
reasons. " Firstly, this removes the buffering effect of the aortic arch
baroreceptors in response to the rise in systemic blood pressure.
Secondly, the inhibitory effect of the lung stretch reflex is abolished.
I have already mentioned how the primary vasoconstrictor response to p 14
chemoreceptor stimulation is inhibited by the ensuing reflex hyperventilation
and it is possible that adrenal catecholamine release is likewise suppressed.
In some of the experiments of Comline and Silver (1966) where they examined
the adrenal response to asphyxia in foetal calves, they noticed a sudden
drop in secretion if the animal recommenced ventilation.
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This may explain why some workers did not detect a significant
response to carotid occlusion as was the case in the experiments done
on cats by Driver and Vogt (1950). These two did occasionally cut the
vagi in the neck but they found that this was without effect on the
adrenal release nor did it enhance the blood pressure response. The
latter is described as "unusual" by Heymans and Neil (1958-P-6V) who
consider that the animals may have been depressed by the sodium pento¬
barbitone anaesthesia.
Cier and Klepping (1957) using dogs also found that carotid
i
occlusion gave only a minimal release. In each experiment they go on
to produce hypotension by cardiac slowing due to vagal stimulation and
thus I cannot tell if the vagi were cut during the carotid occlusion.
(c) Baroreceptor Reflex - Selective Stimulation
Heymans (1929) was the first to demonstrate satisfactorily
that a fall in carotid sinus pressure induced adrenal discharge. The
adrenal venous blood from a dog was assayed by means of the degree of
splenic contraction in a second dog (using the adrenolumbar-jugular
anastomosis). The carotid sinus of the first dog was perfused with
arterial blood from a third dog. A fall in sinus pressure resulted
in splenic contraction (increased catecholamine output) while a rise
in sinus pressure relaxed the splenic vessels (decreased catecholamine
output).
However, unless the blood perfusing the carotid sinus was
hyperoxygenated there would have been a chemoreceptor component while
the sinus pressure was low.
De Schaepdryver (1959) demonstrated that in vagotomised dogs
a rise in pressure (to 190 mm Hg) in the vascularly isolated innervated
sinus preparation reduced the adrenal secretion nearly to zero.
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5- BLOOD GLUCOSE AND INSULIN HYFOGLYCAEHIA
Houssay, Lewis and Molinelli (1924) used an adreno-
lurabar- jugular anastomosis to show that insulin hypoglycaemia produced
a catecholamine discharge in a donor dog which resulted in hyperglycaemia
in the recipient animal.
The observation that insulin hyperglycaemia induces adrenal
medullary secretion has been confirmed by Cannon, Mclver and Bliss (1924),
Abe (1924), Duner (1954), Goldfein et al (1958) and Wurtman et al (1968).
The depletion of catecholamines from the gland in response to
hypoglycaemia is largely prevented by previous denervation (Gohar, 1934,
Hillarp 1946).
Duner (1953). did a very good study on .the influence of hypogly¬
caemia on catecholamine output in cats and found that it decreased
adrenal secretion. Furthermore when the head of a recipient animal was
perfused via its carotid arteries by blood from a donor, a rise in the
donor's blood glucose depressed the adrenal discharge in the recipient.
6. OTHER REFLEX STIMULI
Adrenal catecholamine discharge has been shown to result from
the following stimuli:-
(a) Muscular contractions
Small active movements were shown to increase adrenal secretion
by Cannon, Linton and Linton (1924). Houssay and Molinelli (1925) and
Cannon and Britton (192?).
(b) Centripetal stimulation of an afferent nerve such as the sciatic
or brachial plexus or any other painful stimulus e.g.,Cannon, Carrasco and
Formiguera (1922), Houssay and Molinelli (1925).
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(c) Exercise
Battelli and Boatta (1902) found that exercise depleted dog
adrenals while Stewart and Rogoff (1922) found a small depletion with
severe exercise in cats. I have reviewed elsewhere the evidence for
adrenal involvement during exercise in man. (Synapse 1973)*
(d) Emotional stimulation, cold and heat have also been shown to




Since Elliott (1912) observed that morphine and ether, chloro-
lose and urethane anaesthesia reduced the catecholamine content of cat
adrenal glands, the catecholamine releasing actions of anaesthetics have
been the subject of much investigation e.g. Elmes and Jefferson (19^2)
and Vogt (195^)»
(b) Chemoreceptor stimulation
A number of drugs release adrenal catecholamines by virtue of
their chemoreceptor stimulant action. These have been reviewed by
Anichkov and Belen'kii (1963) and include cyanide, nicotine and suberyl
choline.
(c) Local action
I have considered the action of nicotinic and muscarinic drugs
in my section on selective release. A number of other drugs such as
bradykinin, histamine (see discussion), angiotensin and tyramine have
been shown,in pharmacological doses,to release catecholamines from
isolated adrenal glands (Vogt 1965 and Vane 1969)*
However, we have never come across a study similar to that
of our own work on the release of adrenal catecholamines by steroid
hormones. Established experts in the field such as M. Vogt have told
us that they too do not know of any such investigation.
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SELECTIVE RELEASE
As mentioned previously, noradrenaline v/as not considered to be
an adrenal catecholamine until 19^9 and thus the foundation work on the
nature of the releasing stimuli was only in terms of adrenaline. This
v/as the case when W.B. Cannon began to formulate his ideas on the emergency
function of the adrenal medulla (e.g. Cannon 191*0 and put forward the
concept of the sympathetic nervous system as the "flight and fight"
mechanism. A single adrenal hormone fitted in well with his view that
the sympathetic exerted a diffuse and general influence over the structures
which it innervated. He contrasted the sympatho-adrenal system with the
parasympathetic which, unlike the former system, dealt with organs separately
and not as a group. Cannon talked in terms of the sympatho-adrenal
activity evoking widespread changes, such as dilating pupils, accelerating
the pulse and constricting splanchnic blood vessels while a reduction in
activity permitted these v/idely scattered organs to resume their former
state. "Because of their double innervation the organs under tonic control
of the autonomic system can be made to alter the degree of their functional
use either as an integrated group, through the sympatho-adrenal system
or as separate structures through the direct effects of para-sympathetic
impulses". (Cannon 1930's).
Cannon's flight and fight concept profoundly influenced this
area of biological thought up to the present day and is still seen in many
textbooks as v/ell as being heard at Fnysiological Society Meetings.
Although it is a useful generalisation it has hampered the understanding
of the ability of the sympathetic nervous system to respond selectively.
However, there is good evidence to show that in a number of reflex responses
the sympathetic drive to one organ increases while .that to another is
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decreasing and thus is not acting as the diffuse and unselective system
which Cannon proposed. For example, the primary chemoreceptor reflex
involves peripheral systemic vasoconstriction while the sympathetic drive
to the heart is withdrawn. However, the increased ventilation invokes
the lung stretch reflex which reduces vasoconstrictor tone while at the
same time increasing sympathetic drive to the heart, (Daly & Robinson 1968).
Our interest was whether the nervous system could selectively
control adrenaline and noradrenaline secretion from the adrenal medulla
or were the two catecholamines always released in the same proportions
i
without independent innervation of the two types of chromaffin cell.
However, when one considers catecholamine release into the blood it must
always be remembered that a considerable proportion of the circulating
noradrenaline comes from the adrenergic neurones and not the adrenal gland.
Thus the proportion of circulating noradrenaline to adrenaline can be
altered by independent changes in adrenergic neurone activity and
discharge from the adrenal medulla. (See Appendix I for work on one poss¬
ible role of noradrenaline as a circulating hormone.) This factor has
i
not been considered in many studies which investigate the influence of
variousmanoeuVres on urinary catecholamine excretion. When a change is
found in the proportion of noradrenaline to adrenaline excreted, it is
often taken as evidence of differential release from the adrenal medulla..
Instead, it is merely further proof that sympathetic adrenergic neurone
activity and adrenal medullary secretion do not always change in parallel.
With regard to the adrenal medulla, once it was established that nor¬
adrenaline was released as well as adrenaline, the possibility of independent
secretion of the two hormones began to be considered. Most of this
research was concentrated at a few centres.
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Houssay's group in Buenos Aires had already done much work in
the dog on the types of stimuli acting on the adrenal medulla and thus
began to assay noradrenaline as well as adrenaline in their experiments.
In France, Malmejac and his associates also used dogs and published a
considerable number of abstracts in "Comptes Rendus de la Societe
Biologique".
However, the Scandinavian physiologists did their experiments
on cats and U.S. von Euler was their main spokesman. He does not appear
to have a very high opinion of the French workers. In his book
"Noradrenaline" (1956) he refers to only one of their publications and
then only with regard to their results on resting secretion. He argued
in favour of the view that various physiological stimuli could independently
release noradrenaline or adrenaline from the adrenal medulla. On the
other hand, Malmejac did not believe that independent release occurred.
They both put forward their views in a number of papers and
reviews and each tended to play down the publications of the other groups.
They presented opposing papers at the XXI International Congress
of Physiological Sciences in Buenos Aires 1959 and certainly do not appear
to have been great friends. However, although Malmejac wrote a
Physiological Review in 196^ his work does appear to have been largely
ignored. Although this will, in part_.be due to von Euler's prestige,
Malmejac's case has not been helped by his own habit of publishing work
in the form of numerous small and repetitive abstracts in French, in a
relatively inaccessible journal.
Over the past twenty years various authors have argued for and
against independent adrenal catecholamine release but in all that I have
read, no one has made more than a passing reference to the possibility
of a species difference between the Dog and the Cat. Nearly all the
work pertinent to selective release has been performed in these two species
Although many writers have discussed a good part of the work in order to
support one idea or the other, as far as I know no one has tried to
explain the controversy by examining the published data to see if
selective release occurs in one species but not in the other. Further¬
more, no one laboratory has tried the same set of reflex stimuli in both
dogs and cats.
On examining the literature I found that in the dog, the data
suggests that whatever the nature of the stimulus to the adrenal gland,
noradrenaline and adrenaline are released in about the proportion of 1 to A
Any claims for independent secretion of one catecholamine (always
adrenaline) are usually based on comparisons with the catecholamine
proportion in very low control outputs and one finds the 1 to A ratio
holds for the composition of the releases. Most published data gives
the proportion of noradrenaline in the releases as between 15-20% except
for Malmejac's group which find it to be around 5/° - a figure they obtain
with both biological and chemical assays.
On the other hand the results obtained from Cats appear to shov/
that the adrenal medulla has the capacity to release independently nor¬
adrenaline and adrenaline. This evidence comes from work with hypo¬
thalamic stimulation (von Euler), changes in blood glucose (Duner),
chemoreceptor reflexes (Anichkov), etc. as well as more recent work by
Fuerstein and Gutrnan.
I shall now examine the research in more detail.
Papers discussed with reference to Selective Release
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1. Eapela and Houssay (1952)
2. Malraejac (196^ Review)
3. Cier and KLepping (1957)
k. Lund (1951)
5- De Schaepdryver (1959)
6. Mirkin (1961)
7. Goldfien and Ganong (1958)
8. Wurtraan et al (1968)
Cats
1. Holtz and Schumann (l9*+8)
2. Brauner, Briicke and Kaindl (1950)
3- Kaindl and Von Euler (1951)
*f. Britcke, Kaindl and Mayer (1952)
5« Von Euler and Folkow (1953)
6. Folkow and Von Euler (195*0
7. Buner (1953, 195*0
8. Redgate and Gellhorn (1953)
9. Anichkov and Belen'kii (1963)
10. Grant, Lindgren, Rosen, Uvnas (1958)
11. Eade and Wood (1958)
12. Fuerstein and Gutman (1971)
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DOGS
1. Rapela and Houssay (1952)
Most of the Argentinian work was done by B.A. Houssay and C,E.
Rapela who investigated the effect of the following stimuli on the secretion
of adrenaline and noradrenaline by the adrenal gland
1. Electrical stimulation of the greater splanchnic nerve (Rapela and
Houssay 1952, Rapela and Covi^n 195*0.
2. Nicotine - Intravenous administration (Rapela and Houssay 1952).
5. Asphyxia (Rapela and Houssay 1952)
They claim that both electrical stimulation and nicotine
preferentially release adrenaline, while asphyxia does not produce any
change in the proportion of the two catecholamines.
However, after examination of their figures, I feel that their
conclusion is not justified.
I calculated from their data that the percentages of adrenaline
(mean _+ S.E.M.) in the output during the various stimuli are as follows:-
1. Electrical stimulation (with Havard inductorium) = 79»5 +. 3-7%
2. Nicotine (denervated gland) = 83.8 _+ b.6%
3. Asphyxia = 85.6 _+ h.3%
Thus there is no evidence, in this work, for what we define as
selective release. However, I shall now comment on their experiments and
conclusions.
1. Electrical Stimulation
They performed two series of experiments. The first used a
Harvard inductoriurn and gave an output containing 79»5 + 3*7% (n = 17)*
N.B. I did not attempt to calculate increments as the control outputs
were usually < 2% of that during stimulation. The second series used
a Grass model 3C stimulator and gave outputs containing 76 _+ 6, 65 _+ 6
and 73 +, at 10? ^0 and 160 pulses per second respectively. Only the
lowest rate is physiological (see Celander, 195^ p-7&19). The reduction
in adrenaline at the higher rates may be explained by exhaustion of stores
thus the adrenaline proportion will fall due to its slower rate of
synthesis.
2. Nicotine
Denervated glands were used and the doses gave outputs between
10 and over 200 times the controls. Here the adrenaline proportion in
the output was 83.8 _+ k.6%.
3- Asphyxia
This gave a thirty fold release with 85-6 _+ b.J>% adrenaline in
the output.
Thus the three stimuli released the same proportion of nor¬
adrenaline to adrenaline and the reason \irhy Rapela and Houssay considered
that two of the stimuli selectively released adrenaline while the other
did not, was that they compared them with two different types of control
percentage. For the asphyxia experiments they used the control output
from the innervated gland which they found to contain 86.8 +_ 3>7%
adrenaline and thus concluded that there was no pz^eferential secretion
with asphyxia.
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However, when they considered, nicotine and electrical stimulation,
they used the control output from the denervated gland which contained
59-7 +_ 9-0$ (nicotine experiments)and 69-9 _+ h.2.% (electrical stimulation
experiments ).
The only explanation that I can offer for this observed fall in
adrenaline proportion after nerve section is' as follows
At the reduced adrenal outputs which are usually seen after
section and tend to give the low adrenaline percentages, the circulating
noradrenaline in the blood will contribute significantly to the adrenal ,
output. For example, consider a 10 Kg dog (they used animals of about this
weight) with a control output of h ng/Kg.min which contains 75$ adrenaline:-
I
The noradrenaline output from the gland = 10 ng/min
With an arterial blood noradrenaline of 0.5 ng/ml, which is very
likely in the haemorrhagic experimental animal, and an adrenal blood flow.
' ' i
of 8 ml/min:-
The delivery of noradrenaline to the gland = h ng/rain
. , Actual adrenal noradrenaline output = (10 - k) = 6 ng/min
. . Adrenaline proportion of circulating catecholamines
Adrenaline = -22. x —~ - 83$
3o I
Thus circulating noradrenaline could explain the lower adrenaline
i
proportion in the outputs from denervated glands. A drawback to my explanation
is the small difference between the denervated and pre-asphyxia control
outputs. Furthermore, there was no change in output on denervation in six
out of the eleven experiments.
However, their control outputs are very small and even assuming that
their assay (rat uterus and dog blood pressure), was adequate over a two
hundred range in total amount, I do not think it is justified to claim
that the preferential secretion of adrenaline occurs. I may appear to
have laboured the point'but Rapela and Houssay's conclusion is often
quoted in favour of selective release
2. Malmejac (Review 196*0
From the work that he and his group did on dogs, Malmejac
concluded that, whatever the stimulus, adrenaline and noradrenaline were <
released in the same ratio. This multitude of publications is very
adequately reviewed in his 196^ article "Activity of the Adrenal Medulla
and its Regulation" (Physiol. Rev. W,186). I shall not waste space
attempting to discuss them all in detail.
Their more useful work was done on the irrigated "in situ"
adrenal gland which involved perfusing the adrenal region of the aorta
with blood from a donor. Bioassay or later fluorimetry, was used to
assay the catecholamine secretion.
An example of the sort of results they obtained is:-
Catecholamine
Output




Acetyl Choline i.v. 63.3 Wo
Nicotine i.v. 2366 12%
Splanchnic nerve 285^ 2%
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The odd thing about all their results is that they always found
a low noradrenaline percentage no matter which assay they used. (Perhaps
the donor dogs had very high circulating corticotrophin levels-see p.237).
The noradrenaline percentage rose on sectioning the nerve but this
can be explained by the contribution of circulating noradrenaline from
the donor.
3. Cier and Klepping (1937)
Cier and Klepping looked at a number of secretory stimuli.
Their published results are very variable and give no consistent evidence
of selective release with cyanide (Paulet, Cier and Klepping 1957)
various forms of hypotension (Klepping and Cier 1957). No doubt as a
consequence of the larger releases, their assay appears more reliable
when splanchnic stimulation was used and gave on average 2.0-30% nor¬
adrenaline. Increasing the frequency of stimulation (3, 20 and ^0) gave
no convincing shift in ratio (Klepping 1956).
k. Lund (1951)
More reliable work on the influence of splanchnic nerve stim¬
ulation is that of Lund (1951)- He assayed fluorimetricallly the adrenal
venous effluent from chloralose anaesthetised dogs during electrical
stimulation (50/sec ) and haemorrhage. He observed no change in nor¬
adrenaline to adrenaline ratio with either stimulus.
5. De Schaepdryver (1959)
The trihydroxyindole fluorimetric assay was also used by De
Schaepdryver whose work is sometimes quoted in favour of selective release
in the dog. He quotes mean values without giving standard errors or any
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idea of the number of determinations involved. In other publications
he does give this data and, as he did over thirty different procedures
in only ^+8 dogs, it is likely that each procedure was done in only one
or two animals. Thus, as the noradrenaline proportions in the resting
and incremental outputs during carotid occlusion, acetyl choline, nicotine
and insulin administration are between ten and forty percent,there is
no convincing evidence here for selective reflex release. Furthermore,
he himself states that there is no significant change in noradrenaline
to adrenaline ratio on carotid occlusion and his claims for a selective
effect on secretion are with reference to the :action of the drugs
Reserpine, arproniazid and P-286.
6. Mirkin (1961 )
Mirkin (1961) used direct bioassay (Cat blood pressure and chick
rectum) to investigate the content of adrenal venous sample collected
during stimulation of the splanchnics at 1-20 pulses/second. He found
a linear relation between frequency and output up to 10 hertz with no
change in the noradrenaline percentage released. However, he claims that the
.age
noradrenaline percent/fell by 10-20 percent at 20 hertz and cooling
of the nerve increased noradrenaline percentage by a similar amount.
7. Goldfien and Ganong (1958,1960)
Wise, Goldfien and Ganong (19SO ) publish results for output
from the right adrenal gland in response- to haemorrhage:-
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A NA W.%
Resting output 93 + 25 17 + 5 15!%
5 minutes after
haemorrhage 209 +83 10+4 3%
20 minutes after
haemorrhage 276 +98 12+5
(ng/min)
k°/o
Their standard errors for eight experiments are very large but
there is definitely no evidence of selective release of noradrenaline in
response to haemorrhage. Although their results are rather erratic the
work of Goldfien et al (1958) provides further evidence that during insulin
induced hypoglycaemia; noradrenaline and adrenaline are released in a 1 to 4
ratio.
8. Wurtman et al (1968 )
Some recent work done by Wurtman et al (1968) provides good
supporting evidence for our view that catecholamines are always released
from the adrenal medulla of the dog in the proportion of 1 to 4 (nor¬
adrenaline :adrenaline). These are the workers who have investigated the
influence of the pituitary-adrenocortical axis on the methylating enzyme
and thus are experienced at differential assay. They find that the
increase in adrenaline output after insulin is paralleled by a rise in
noradrenaline secretion and the adrenaline proportion in the release is
82 + b%.
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G A T 5
1. Holtz and Schumann (19^8)
They found that in the cat, carotid occlusion produced a
contraction of the spleen and an increase in blood pressure but had
no effect on blood sugar or peristalsis. However, a dose of adrenaline
which gave a comparable degree of splenic contraction also arrested
peristalsis while the corresponding dose of noradrenaline did not affect
gut motility. The splenic response to carotid occlusion was abolished
by adrenalectomy and thus the authors concluded that this reflex stimulus ,
releases noradrenaline from the cat adrenal gland.
A later paper (Holtz, Engelhadt, Greeff and Schumann, 7952)
confirmed their earlier finding that carotid occlusion releases mainly
noradrenaline.
They employed barbituate anaesthesia and it is probable that
in these tests the baroreceptor reflex was the main component of the
adrenal response to carotid occlusion. Using the cat blood pressure
and chicken rectum to assay adrenal blood samples, they detected a
resting output containing 78% noradrenaline (72-86%).
Carotid occlusion gave a two fold increase in output and the
increments contained 68% noradrenaline.
On the other hand, direct stimulation of the splanchnic
nerves gave ten to thirty fold, increases which contained only 10% nor¬
adrenaline .
2. Brauner, BrUcke and Kaindl (1950)
In these experiments the cats were anesthetised with chlor-
alose and they found that the catecholamine release in response to
carotid occlusion was abolished by breathing 100$ 0o. Repeated
carotid occlusion gave rise to effects indicating an increasing
proportion of adrenaline in the output. In a second paper (Brauner,
Britcke, Kaindl and Neumayer, 1950) which is based on a delightful assay
of adrenal venous samples, involving the pilomotor action of cate¬
cholamines on the hairs of the cat's tail (and the isolated rabbit
jejunum), they again state that carotid occlusion released a large
proportion of adrenaline.
3. Kaindl and Von Euler (193^)
Kaindl joined forces with Von Euler and the following year
published a paper criticising the first technique used by his former
' i
colleagues. This was on the grounds that their assay depended on the
animal's own blood pressure and intestinal volume which were both under
the influence of adrenergic innervation. Kaindl and Von Euler worked
on vagotomised cats anaesthetised with chloralose and used the cat
/
blood pressure and chick rectal caecum to assay their samples.
Hie resting secretion was on average 73 &g /kg- min and
contained 77% noradrenaline (60-89$). With carotid occlusion, cate¬
cholamine output rose to a mean of .230 ng /kg. min although there
was only a slight rise when the vagi were intact.
The increments contained 73 +. 3$ noradrenaline and in two
out. of the four experiments, there was a tendency for the noradrenaline
proportion to fall as the experiment progressed.
The important question is whether carotid occlusion was
invoking mainly a baroreceptor or a chemoreceptor reflex. The resting
blood pressure was usually over 150 mmHg. and presumably the preparation
was in a good state with a normoxic arterial P0o. The blood pressure
response to the tests was good (usually over 250 mmHg) except when the
vagi iv'ere intact and thus it appears that the depressant effect of
chloralose anaesthesia (50 mg./kg-} on the baroreceptor reflex (see p.106)
was not sufficient to inhibit markedly the aortic baroreceptor reflex.
Furthermore, resting system bipod pressure was over 150 mmHg and as it
rose during the reflex test to over 250 mmHg, carotid sinus pressure
would have been unlikely to fall much below 80 mmHg. Hence, I expect
that the chemoreceptor component in the adrenal response was small.
h. Britcke, Kaindl and Mayer (1952)
Kaindl then went back to his old friends and investigated the
action of hypothalamic stimulation on secretion from the cat adrenal
medulla. Brttcke, Kaindl and Mayer (1952) found that hypothalamic
stimulation released equal amounts of adrenaline and noradrenaline while
the resting secretion was 90/ noradrenaline. (Biological assay of
adrenal venous samples).
5. Von Euler and Folkow (1955)
Von Euler then worked with Folkow and compared carotid occlusion
with afferent stimulation of the sacral and brachial plexus. Carotid
occlusion again released about 70/ noradrenaline (60-90/) but in every
experiment^ afferent nerve stimulation always released a greater proportion
of adrenaline although the composition of the mixture varied between
experiments from 10 to 75/ noradrenaline. In each out of eleven experi¬
ments, nerve stimulation produced twice the adrenaline output, but a
similar noradrenaline output as carotid occlusion. (Biological assay
of adrenal venous samples).
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6. Folkow and Von Buler (195^)
The following year they (Folkow and Von Euler 195^+) used a
Horsley-Clarke instrument to stimulate in the region of the hypoth¬
alamus. Again using chloralose-anaesthetised cats and the cat blood
pressure/chick rectal caecum differential assay, they found brain
areas which selectively released adrenaline, noradrenaline or a variable
mixture of the two.
They did sixteen successful experiments and although they do
not present full details of their results, this paper is one of the *
most quoted in favour of selective release. (it is written in English.).
At the end of nine experiments, they injected (i.v.) 1-2 mg /kg- of
nicotine which as well as having a direct action on the gland, must have
evoked a maximal chemoreceptor discharge. The proportion of adrenaline
in the adrenal output nearly always increased relative to the preceding
"resting" secretion, but the composition varied from 20-86/ noradrenaline.
7. Duner (1953, 195*0
Duner (1953) did some of the best described work on selective
release from the cat adrenal gland. Using pentobarbitone —anaesthetised
cats and the cat blood pressure/chick rectal caecum assay, he investigated
the influence of hyperglycaemia on adrenal secretion.
In ten cats with a resting secretion of 1t +■ k ng /eg. min
adrenaline and 70 + 12 ng /kg noradrenaline (86/ noradrenaline),
glucose infusions induced varying degrees of hyperglycaemia and selec t-
ively depressed adrenaline secretion.
Thus adrenaline output (plotted as a percentage of the initial
resting output) was linearly related to blood glucose and fell to about
zero at a glucose concentration of 500 mg/l00ml. On the other hand
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noradrenaline did not fall belov; ^0% of its initial output and thus
the noradrenaline proportion in the mixture rose with increasing
glucose concentration.
Cross perfusion and other experiments confirmed that the
blood glucose concentration was acting through a central mechanism.
In eight cats, Duner compared the composition of the resting
secretion (12 _+ 3% adrenaline) with the content of the gland itself
(V? _+ adrenaline) and found no correlation.
In a further paper, Duner (195^) describes six experiments '
J
(again pentobarbitone anaesthesia) in which insulin hypoglycaemia
f
resulted in selective adrenaline release. Adrenaline output would
by
increase/usually about ten fold while noradrenaline output never rose
by more than 25-50%•
Ij: is interesting to note that Hokfelt (1951) showed that, in
rats, large doses of insulin almost completely depleted the adrenal
glands of adrenaline, while noradrenaline content changed much less.
Similar results were obtained by Outschoorn (1952).
Duner is claimed by a number of authors (e.g. Von Euler, 1956)
to have investigated the influence of hypoxia and hypercapnia on cate¬
cholamine release. However, a reference is never given and I have
been unable to find this publication.
8. Redgate and Gellhorn, 1955
Another selective release classic, is the paper by Redgate and
Gellhorn (1953)- Their work is often claimed to show selective release
of adrenaline by asphyxia (chloralose anaesthesia) and adrenaline or nor¬
adrenaline by hypothalamic stimulation (pentobarbitone anaesthesia).
They used the denervated nictitating membrane and the denervated spleen
volume as an 'in vivo' differential assay of circulating catecholamines.
The former preparation assayed adrenaline while the spleen responded to
both catecholamines but unfortunately was relatively less sensitive.
Close examination of their published graphs confirms that if nor¬
adrenaline was also released during asphyxia, it could only have been
1
in smaller quantities to the amounts of adrenaline detected. However,
they were apparently unaware that the release of noradrenaline into the
circulation from adrenergic nerve endings usually predominates over that
from the adrenal medulla. Thus the detection^during hypothalamic
stimulation, of an increase in circulating noradrenaline without a
)
corresponding rise in adrenaline, is more likely to be evidence of
adrenergic neurone activation than selective noradrenaline release from
the adrenal medulla.
9. Anichkov et al i960
In Russia, Anichkov's group carried out a considerable number
of investigations on the reflexes invoked by chemoreceptor stimulation
and this included adrenal catecholamine release (Anichkov and Belen'kii,
1963, p. 3MH).
Experiments were carried out on decerebrate cats and compared
chemoreceptor stimulation resulting from an intracarotid injection of
potassium cyanide with that from carotid occlusion.
'Their assay was rather unusual, consisting of the 'in vivo'
denervated leg (reduction in limb volume determined by plethysmography)
and the denervated, cocaine-sensitised, nictitating membrane. They
used a dose of cyanide which gave a change in limb volume to match that
from carotid occlusion. However, this dose resulted in greater
contraction of the nictating membrane. Thus:-
Limb volume:. Potassium Cyanide = g + q_q6Carotid Occlusion —
„ « r, ±. • • . Potassium Cyanide „N.M. Contraction: 7= rc-r—r—» : = 1.70 + 0.1oCarotid Occlusion —
They claim that noradrenaline produces the greater reduction in limb
volume and adrenaline produces the greater contraction of the nictit¬
ating membrane. Vie must assume that they checked this by injecting
standards into their preparations.
Thus it would appear that chemoreceptor stimulation releases
a mixture with a higher proportion of adrenaline than carotid occlusion.
(Anichkov, Malyghina, Poskalenko and Ryzhenkov, i960).
10. Grant et al 1958
Grant, Lindgren, Rosen and Uvnas (1958) topically stimulated
the area of the hypothalamus in cats which activates the atropine-
sensitive vasodilator fibres to skeletal muscle. They found selective
release of adrenaline from the adrenal medulla during such stimulation.
They investigated fourteen cats under either chloralose/
urethane, urethane or Dial anaesthesia and found that .the adrenaline out¬
put increased,on average,over fourfold, while there was often no nor¬
adrenaline increase at all (in fact, an average increase of 8k%).
Under Dial anaesthesia the selectivity was most marked ,with four to
sixty fold increases in adrenaline and no change or a fall in nor¬
adrenaline output.
'The mean resting output of 250 ng /kg. mill consisted of
between 67 +. ^ to 98 _+ 0.3% noradrenaline depending on the nature
of the anaesthesia. The increment on hypothalamic stimulation was
on average k20 ng /kg. min and contained a mean of 38% noradrenaline.
I will discuss later their results concerning the influence
of anaesthesia on the composition of the resting secretion.
11. Eade and Wood (1958)
This pair of workers examined the composition of the cate¬
cholamine mixture released during splanchnic stimulation (cats anaes¬
thetised with chloralose) using a fluorimetric assay very similar to
ours. Electrical stimulation released between *fO-50% noradrenaline
and there was a tendency for the noradrenaline proportion to fall with
the three successive stimulations:
i.e. k8 + 3% ^2 + y/o and 39 +
As the glands contained 37 + 3% noradrenaline, it appears that
electrical stimulation releases a mixture with a similar composition
to that found in the medulla.
12. Fuerstein and Gutman 1971
Hie most recent evidence in favour of selective catecholamine
release in the cat comes from Israel.
Fuerstein and Gutman (1971) used pentobarbitone anaesthesia
and assayed their adrenal venous plasma samples fluorimetrically.
Hie stimuli employed were haemorrhage, hypoglycaemia and hypo¬
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Thus hypotension, , with its baroreceptor and chemoreceptor
reflex components, released a mixture containing predominantly nor¬
adrenaline (68$) while hypoglycaemia released mainly adrenaline (32$).
Hypothermia appeared to change the proportion of cate¬
cholamines in the resting output.
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SUMMARY OF THE WORK ON CATS
All those workers who have examined the influence of various
reflex stimuli on the release of adrenaline and noradrenaline from the
adrenal medulla of the cat, have found evidence of selective release.
Carotid occlusion and haemorrhage}which probably exert their
main effect on the adrenal medulla via the baroreceptor reflex, give
rise to a secretion containing about 70% noradrenaline (i.e. Kaindl
and Von Euler (1951)? Von Euler and Folkow (1953)? Fuerstein and Gutman
(197'0 with supporting evidence from Anichkov's group). '
There is good evidence that hypoglycaemia releases predomin¬
antly adrenaline (Duner, 195*+? Fuerstein and Gutman, 1971) and from
Duner's work (1953? 195*0 it appears that blood glucose exerts its
reflex effects only on adrenaline secretions.
Asphyxia and cyanide-induced chemoreceptor stimulation seem
to preferentially release adrenaline (Redgate and Gellhorn (1953)?
Anichkov et al (i960)) but this work depended on less reliable assays.
Stimulation in the region of the hypothalamus has been shown
by three groups to release adrenaline selectively (Redgate and Gellhorn,
(1953)? Folkow and Von Euler (195*0 and Grant et al (1958)).
Folkow and Von Euler (195*0 also found stimulation points
in the brain which 'selectively released noradrenaline or varying pro¬
portions of the two catecholamines.
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NICOTINIC ADD MUSCARINIC RECEPTOPS IN THE ADRENAL MEDULLA
The transmission from the preganglionic nerve endings to the
chromaffin cells of the adrenal medulla is classically regarded to be
of the nicotinic (-ganglionic) type. However, in 193^ Feldbe.rg, Minz
and Trudzimura had found evidence of a potential muscarinic component.
By using the pressor effect as an index of catecholamine release, they
observed that a large blocking dose of nicotine did not appreciably
alter the response of the cat adrenal medulla to acetyl choline.
If atropine was given as well as nicotine the response was blocked
but the same dose of atropine alone did not convincingly reduce the
response to splanchnic stimulation and so atropine did not appear to
be acting through a local anaesthetic effect.
However, muscarinic transmission only-appeared important during
nicotinic blockade and these observations were largely forgotten until
the work of Douglas and Poisner (I965K These two were engaged in a
series of experiments with the aim of investigating the part played by
calcium in catecholamine release and were using isolated cat adrenal
glands perfused with Locke solution.
They decided to re-investigate Feldbeirg's observation and not
only did they confirm that nruscarinic stimulation released adrenal cate¬
cholamines but they also showed that the mixture released contained less
than 20% noradrenaline while that in response to nicotine contained over
50% noradrenaline. The mean percentage of the total catecholamine
appearing as noradrenaline was only h% with pilocarpine and '\&% with
muscarine while acetyl choline and nicotine released 58?o and
respectively.
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Rubin and Miele (1968) followed up this work in cats and
using the same technique, found that,although high doses of nicotine
_ IT
(1.2 x 10 M) released approximately equal amounts of the two cate-
-6
cholamines, lower doses (1.2 x 10 M) gave outputs containing about
70% noradrenaline. Doses of acetyl choline which gave outputs of
comparable magnitude to the lower doses of nicotine still released
the catecholamines in equal proportions.
Further evidence comes from the work of Butterworth and Mann
(1957) who investigated the action of serial injections of acetyl
choline in atropinised (6 mg /kg ) chloralose anaesthetised cats which
had had the right adrenal gland removed. These injections, of the
order of 2 mg intravenously, gave very reproducible pressor responses
which slowly declined over the course of the experiment (up to 100 doses).
The pressor effect was abolished by removal of the other gland but was
still seen after splanchnic nerve section and thus was not due to chemo-
receptor stimulation. They found that acetyl choline and other choline
esters depleted the noradrenaline and adrenaline in the glands by the
same factor and so the noradrenaline percentage in the depleted gland was
the same as that in the right (control) gland (mean = 6k% noradrenaline).
Although there was much variation between animals (35~90% noradrenaline),
within each experiment the percentage of noradrenaline in the adrenal
venous effluent (mean = 62% noradrenaline) was always the same as that
in the gland.
Thus it appears that in the atropinised animal, acetyl choline
releases the same proportion of catecholamines as found in the gland
and this figure of 60-65% noradrenaline is compatible with the results
obtained with acetyl choline and the higher doses of nicotine in the
work of Douglas and Poisner (1965) and Rubin and Miele (1968).
On the other hand, Kayaalp and Mclsaac (1968) used dog glands
and reporbed that nicotinic stimulation released a mixture containing
21% noradrenaline. The output in response to methacholine consisted
on average of k0% noradrenaline but due to the scatter in their results,
the difference between the two types of stimulation is not significant.
However, once again there appears to be a species difference
between the dog and the cat with respect to selective activation of
noradrenaline and adrenaline release. In the dog, both nicotinic and
muscarinic stimulation released similar proportions of the two cate¬
cholamines while in the cat,nicotinic drugs had much more of an effect
on noradrenaline release than did muscarinic stimulation.
I must stress that I realise that a difference in distribution
of the two types of receptor cannot explain,by any simple mechanism,
selective reflex release in the whole animal.
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EVIDENCE FOE THE PARTICIPATION OF THE ANTERIOR PITUITABY-
ADRSNOCORTICAL AXIS IN IKE REGULATION OF &DRENOMEDULLARY SECRETION
Influence of the Adrenal Cortex on Medullary Catecholamine Secretion
Although it is generally accepted that the adrenal cortex and
medulla function independently, there is growing evidence that the cortex
does exert a significant influence on the medulla.
First, there is the existence of the complex internal circu¬
lation of the gland with a portal system carrying blood rich in steroid
hormones to the medulla.
Secondly, there is the work.of Shepherd and West (1951) and
Coupland (1953) which drew attention to the correlation between the
cortex to medullary size ratio and the percentage of adrenaline in the
glands of various mammalian species. More recently Pohorecky and
Wurtman (1971) have shown in the rat that the high concentration of
glucocorticoids delivered to the medulla from the cortex is essential
for the maintenance of the enzyme, Phenylethanolamine-N-methyl trans¬
ferase (PNMT) which methylates noradrenaline to adrenaline.
Thirdly, there is a little evidence from studies on adrenal
gland catecholamine content that corticotrophin administration results
in the depletion of adrenaline but not noradrenaline.
Finally, the results published by Wurtman, Casper, Pohorecky
and Eartier (1968) in support of their above mentioned theory also
contain some good evidence that corticotrophin presumably by acting through
glucocorticoid secretion, modulates the release of catecholamines in
response to neural stimuli.
67
Blood Supply to the Adrenal Gland
This is very thoroughly reviewed by R.E. Coupland in his book
"The Natural History of the Chromaffin Cell" (19^5i p.113-119) which is
well worth reading. He not only describes, with an awareness of cortico-
medullary relationships, the details of the anatomy of the vasculature
but also discusses some interesting work on the factors which affect
intra-adrenal blood flow.
R.G. Harrison and M.J. Hoey produced a monograph entitled
"The Adrenal Circulation" (i960) which also contains a good description
of the gland's vasculature.
Multiple small adrenal arteries, derived from the nearby large
arteries - (the balance of which depends on-species), converge on the
gland and in man there are fifty to sixty of these small vessels.
They arborize in the peri-adrenal connective tissues and form a capsular
plexus in the dog or a subcapsular plexus in the cat and rat.
Capillary vessels, supplied by arterioles from the plexus, pass centri-
petally between and around the columns of cortical cells. A few
arterioles pass deep into the cortex before breaking up into capillaries
(arteriae corticis).
The blood supply to the medulla is from two main sources.
These are the capillary channels of the cortical zona reticularis which
become the sinusoids of the medulla. Also the arteriae medullae pass
through the cortex from the "capsular" plexus before breaking up into
capillary channels which form a network around adjacent chromaffin ceils.
Capillary blood vessels derived primarily from the arteriae medullae
anastomose with each other and the branches of the venous tree (Flint
1900). Thus not all the blood flowing through the arteriae medullae
enters the cortico-medullary sinuses as it can also pass directly to the
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central vein through the venae medullae.
The above description is taken from Coupland's book but most
of the points were first noted by Flint (1900) who worked on dog glands.
It is very interesting to note that in ungulates such as the
sheep and the cow, the regions of cells containing solely noradrenaline
are supplied almost entirely by the arteriae medullae. However, the
adrenaline storing cells are arranged in palisade form along vthe cortico-
medullary venous sinuses and have well defined arterial and venous poles.
Symington (1962) has described bundles of smooth muscle flanking '
the orifices of the cortico-medullary venous sinuses. He suggests that
contraction of this muscle will obstruct blood flow from the venous
sinuses without interfering with that from the central vein-.' The
anatomy of the musculature of the adrenal vessels is complex and not
understood but one wonders if it could alter the distribution of flow
between the cortico-medullary sinusoids and the arteriae medullae.
This would change the concentration of glucocorticoids bathing the
medullary cells.
Dependence of Methylation on the Cortex
When Shepherd and West (1951 ) surveyed the percentage of
adrenaline in the adrenal medulla of various mammalian and avian species
they found a good correlation with the ratio of the volume of cortical
to medizllary tissue. In species where this ratio is high such as in
the cavy and rabbit, the medulla contains almost exclusively adrenaline
while in those with a lower ratio;(e.g. cat, dog and man) a greater
percentage of noradrenaline is found.
Moreover, the medulla of foetal mammals contains very little
adrenaline and the adrenal content of this catecholamine rises sharply
after birth in parallel with a period of marked cortical development.
(Cavy and rabbit - Shepherd and West, 1951; Human - West, Shepherd
and Hunter, 1951; Calf - Holton, 1951).
The dependence of methylation on the cortex only appears to
be thq case in mammals. Other vertebrates which have separate steroid
and catecholamine synthesising tissues^have chromaffin glands containing
a large proportion of adrenaline (Shepherd, West and Erspaner (1953)
e.g. 20-67% adrenaline in various speeies of fish).
However, Coupland (1958, 1959) claims to have transplanted
adult rat adrenal medullary tissue to the orbital cavity and found that
these transplants had a normal adrenaline to noradrenaline ratio despite
being deprived of the majority of cortical cells.
This latter work is hard to.reconcile with the studies of
Pohorecky and Wurtman (1971) which have established that in the adrenal
medulla,the maintenance of the mammalian PNMT enzyme depends on the
delivery of a high concentration of sterpids vip. the corticomedullary
portal system. Their evidence is summarised in two reviews (Pharmacol.
Rev. 23 and 24, 1971 and 1972) and I shall now.mention the salient
features.
1. Most of the studies have been done on rats.
2. Hypophysectomy results in a rapid fall in medullary PNMT activity
(half life = 3-5 days)
3- This activity is restored by corticotrophin administration but not
glucocorticoid maintenance therapy.
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k. Enzyme activity only begins to be restored by the administration of
amounts of glucorticoids which give peripheral arterial concentrations
fifty to one hundred times normal.
5. Thus the high concentrations of glucocorticoids found in the adrenal
medulla (one hundred to two hundred times peripheral levels) appear
to be necessary for the maintenance of PNMT and th<= effect is
thought to be related to the synthesis of the enzyme protein.
6. Other classes of steroid hormones do not appear to have a physio¬
logical action on PNMT activity. t
However, it is interesting to note that they base little of
their argument on the actual catecholamine content of these glands.
This is,no doubt, because they found that the changes in cate¬
cholamine content lag behind the changes in enzyme activity. After
hypophysectomy, adrenaline content does decline but with a half life of
30 days (although it may be as high as 80 days) while noradrenaline does
show an increase but not in proportion to the fall in adrenaline.
However, radioactive tracer studies have shown that .the half
life of adrenaline in intact rat's adrenal medulla is 7-1^ days
(Udenfriend and Wyngarden, 1956).
The discrepancy between the half life of adrenaline in intact
and hypophysectomised animals can be explained by postulating that
adrenaline synthesis still continues at a near-normal rate in spite of
the very low PMNT levels found after one to two weeks. However, a
much simpler explanation is that release of adrenaline is considerably
reduced.
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Effects of Corticobrophin Administration
In 1933 Houssay, Biasotti, Mayzocco and Sammartino found that
the catecholamine content of dog adrenal glands fell to seventy per cent
of the control value after two days' treatment with anterior pituitary
extract. However, after seven days' treatment the level had returned
to normal. Seventeen years later, Houssay found a fifty percent
reduction in the catecholamine content of adrenal glands of toads
hypophysectomised three to five xreeks previously (Houssay, Gerschman
and Rapela, 1950)- They also found that the percentage of noradrenaline
tended to rise from a mean of in the controls to 53% in .the hypophy¬
sectomised animals.
About this time Hokfelt (1951) was investigating the effect
of corticotrophin and/or hypophysectomy on the noradrenaline and adrenaline
content of rat adrenal glands:-
(a) After hypophysectomy the noradrenaline content doubled in two
days and it stayed at this level for over ten days while, apart
from an initial fall, adrenaline remained at its control level.
(b) A single injection of corticotrophin given to rats hypophysectomised
two days previously was followed by a progressive fall in nor¬
adrenaline content to ten percent of the hypophysectomised control
value after three hours. Over the same period adrenaline content
rose to about twice its initial value.
(c) Corticotrophin was given to intact and hypophysectomised rats
three times daily for ten days. The intact rats showed depletion
of adrenaline to two thirds of its control value while noradrenaline
was not significantly affected. The adrenaline content of the
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liver increased which presumably indicates adrenal release.
The hypophysectomised rats were restored to a state similar to
intact untreated rats.
Er^nkiJ (1952) also used a biochemical method to assay the
catecholamine content of rat glands exposed to five to ten days treatment
with corticotrophin. He confirmed that there was no significant
alteration in noradrenaline but adrenaline content was again observed to
fall.
Another interesting observation is that of Harrison and
MacKinnon who were investigating the palmar anhidrosis which was seen in
response to intravenous adrenaline. Corticotrophin administration mimicked
the anhidrosis while Cortisol itself did not have any effect. Furthermore,
the responses to stress and to adrenaline are prevented by phenoxy-
benzamine. (See Harrison and MacKinnon 1966).
Luft and Von Euler (1952) are often quoted for having shown
that corticotrophin and cortisone administration reduces noradrenaline
work
excretion in man. This/is based on one patient and their graph does show
a fall in noradrenaline, with no change in adrenaline excretion,during the
period of corticotrophin administration. However, with cortisone, the
claimed fall in noradrenaline excretion is the continuation of a trend
which started well before the period of administration of the latter drug.
However, a considerable amount of histological work has been
done on the influence of corticotrophin or its lack on the adrenal cortex.
Thus it is unlikely that any marked morphological changes in the medulla
resulting from these procedures, have gone unnoticed.
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The work that really gave us an incentive to investigate the
influence of corticotrophin on adrenal medullary secretion was that of
Wurtman, Gasper, Pohorecky and Bartier (1968). There are several
pieces of evidence in this paper which support the idea that the anterior
pituita.ry-adrenocort.ical axis modulates catecholamine secretion.
However, this does not appear to have occurred to the authors who interpret
ir
all the/results in terms of the action of the anterior pituitary-adreno-
cortical axis on methylation and adrenaline output.
They used a reliable fluorimetric technique to assay the adrenal
noradrenaline and adrenaline output in response to insulin hypoglycaemia.
Intact dogs were compared with animals hypophysectomised three to five
months previously. Some of the latter animals had received cortico¬
trophin (kO units/day) during the previqus month.
The dose of insulin was adjusted so that the extent to which
the blood glucose level fell did not differ significantly betv/een the
three groups of animals. The authors seem to be trying to disguise the
point I want to make by quoting the peak response as adrenaline output
and adrenaline percentage of the total output. However, from their
figures I have calculated peak total catecholamine output in response
to hypoglycaemia in the three groups.
Resting. Output Peak Response A%
— A lot NA A Tot
Normal 1.6 7.5+0.01 9.1 7.0 31.9+ 6.1 38.9 82.0 + k.2
Hypophysectomised 2.6 k.2 _+ 0.7 6.8 9.5 15-6 _+ h.9 25-1 62.2 _+ 8.3
Hypophyse c tomised
8c Corticotrophin 3-1 7-2 + 2.9 10.3 32-3 7h.k + 2^.5 107 69.7 + 3-5
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Apart from its effect on methylation, hypophysectomy reduces
both the resting output of total catecholamine and the response to
hypoglycaemia. The corticotrophin more than restored the resting out¬
put and considerably potentiated (by 2-g- - 3 fold) the peak response to
hypoglycaemia.
1The increased resting output and potentiated insulin induced
response cannot be entirely due to increased PNIiT activity as the nor¬
adrenaline output is also increased (-.by over three fold in the peak
response).
PNMT activity
Normal 123-1 _+ 10.4 mpM/gland
Hypophysectomised 28.8 + 3-5 rapM/gland
Hypophysectomised
8c Corticotrophin 190.0 + 24.9 muM/gland
Their PNMT activity results are also worth considering. It
is strange that the activity in the corticotrophin treated group should
be higher than the intact animals when the former animals have a lower
adrenaline percent in the output. (A suggestion of ours is that the secretion
of catecholamines induces PNMT. cvf. the effect of neural stimulation).
Furthermorejafter three to five months;a fall in activity to a quarter
of that in thq intact animal is only associated with a reduction from
8?.%' to 62/a in the proportion of adrenaline secreted.
When they assayed the catecholamine content of the glands
(ug/gland) they found that there was no difference between the nor-
'
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520 h- 100 pg/gland
260 _+ 60 pg/gland
1260 60 (ug/gland
These adrenaline figures do not correlate well with the PNM'T
activities and neither is the absenc.e of change in noradrenaline content
what one would expect from their theory.
There is one further piece of supporting evidence for the
hypothesis that the anterior pituitary-adrenocortical axis participates
in the control of catecholamine release. They publish three graphs
(one typical of each group) showing noradrenaline and adrenaline output
against time. The potentiation of noradrenaline and adrenaline output
by corticotrophin is very clear but in both the hypophysectomised animals
(i.e. the corticotrophin treated one as well) catecholamine output rises
sharply to a peak at about fifty minutes and then falls, although there
is no evidence that the blood glucose has begun to rise. However, in
the intact animal, catecholamine output rapidly rises to near its peak,
within twenty minutes and stays elevated (still gradually rising) for
ninety minutes after the insulin injection.
The differences between the time course of these two responses
cannot be explained by the blood glucose levels which all fall to the
same level and shoitf no tendency to rise again. However, insulin hypo-
glycaemia is known to release corticotrophin from the anterior pituitary
and this could be participating in maintaining the catecholamine release
seen in the intact but not, of course, in either of the hypophysectomised
animals. N.B. The endogenously released corticotrophin xi/ould not
necessarily potentiate the release to the same, extent as the large dose
administered daily.
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Coldfien, Sheref Zileli, Despointes and Bethune (1958)
measured both, canine adrenal catecholamine and 1? - hydroxycorticosteroid
output during insulin hypoglycaemia. These results could have been very
interesting but they are, unfortunately,too scattered and inconsistent
for any useful conclusions to be drawn.
i
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REVIEW OF TECHNIQUES AVAILABLE FOP. CATECHOLAI-SNE ASSAY
There are four basic types of method which have been used for
the determination of catecholamines
1. Biological assays
See reviews of Gaddum (1959) and Callingham (19^7)
2. Chemical techniques
These are dependent on the formation of fluorescent derivatives
(see reviews of Udenfriend (1958i 19^2) and Callingham (1967)
3. Isotope derivative techniques
These depend on enzyme specificity and the formation of radio-
actively labelled derivatives (see Engelman and Portnoy (1970))-
^r. Radioimmunoassay
Not yet developed.
The techniques differ in their sensitivities and whether they
measure total catecholamine (by this term I mean adrenaline plus nor¬
adrenaline) or if they differentiate between adrenaline and noradrenaline.
Other important considerations are reliability, the number of samples
handled in one batch and cost.
After a survey of the literature and discussion with authorities
in the field of catecholamine assay, we decided that a chemical technique
using spectrophotofluoriraetry would be most suitable for our adrenal
effluent assay.
We developed an adequate assay for the fundamental part of our
research and, once familiar with it, examined the modifications necessary
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to assay catecholamines in peripheral plasma and urine.
Before discussing our assay in detail, I shall briefly discuss
the three other approaches to catecholamine assay.
1. Bioassay
Catecholamines were first detected by their pharmacological
properties and these led to biological methods of quantitative assay.
Although bioassay has been largely replaced by the various
biochemical techniques available, when efficiently and carefully exploited
it can be several orders more sensitive than the latter techniques, and
does not require expensive apparatus - (it is commonly used in the
developing countries).
Concerning the assay of catecholamines released from the
adrenal- medulla, there are three approaches
(a) Use of the experimental animal's own tissues to detect changes in
circulating catecholamine levels. The tissues (e.g. nictitating
membrane, perfused hind limb) are usually denervated prior to the
experiment which both abolishes neuronally mediated effects and leads to
the development, of denervation supersensitivity. Reuptake blockers such
as cocaine have also been used to increase sensitivity.
(b) Isolated organ assays
Samples removed from animals (e.g. taken from adrenal vein)
and assayed on standard isolated tissue preparations (e.g. cat blood
pressure and chicken caecum - see Gaddura 1959). These techniques usually
involve an extraction procedure which makes them more specific and can be
extremely sensitive. Harvey and Pennefather (1962) have modified the
rat uterus inhibition technique of Gaddum and Lembeck (19^9) by using
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electrical stimulation to produce the contractions and claim to be able
to detect picogram qualities of adrenaline.
Much of the pioneer work on the urinary excretion of cate¬
cholamines under different conditions, was done with isolated organ
bioassay and it has been applied with varying degrees of success to
peripheral plasma estimations.
(c) Superfusion techniques
Bioassay has recently returned to fashion with the exploitation
of the superfusion technique by Professor J.R. Vane's group. It
involves a cascade of isolated tissue preparations down which the experi¬
mental animals's own blood passes in an extracorporeal circuit (Vane 1966).
This technique combines the degree of sensitivity and
specificity which can be obtained by careful selection of tissue prepar¬
ations with the great advantage of "on line" assay (i.e. the assay result
is obtained during the animal experiment and not days later as happens
when a batch of samples is collected).
The main criticisms of this method are that other biologically
active substances in, the blood could interfere with the isolated tissue
preparations and that it only detects changes in the level of circulating
hormones.
However, we did consider using a superfusion cascade for our
differential estimation of the catecholamines in adrenal venous blood as
it would have had the following advantages
(i) On line assay
(ii) The adrenal blood would have been fed into a flow of artificial
perfusate upstream of a Watson-Marlow pump supplying the cascade of
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isolated organs. Catecholamine secretion would have been
determined with respect to time and would have been independent of changes
in blood flow through the gland.
Ciii) Due to the very high concentrations of catecholamines in adrenal
venous blood we could have used a dilution of the adrenal outflow and
probably been able to disregard any other substances in the blood. •
(iv) Peripheral venous blood would have been alternated with adrenal
effluent so as to provide a reference base line for our isolated tissues.
However, the cascade should be set up in parallel with the
whole animal preparation and we decided that we did not have the man¬
power or financial resources to attempt this approach.
2. Chemical techniques based on fluorescent derivatives - see later.
3- Isotope derivative techniques (Engleman, Poi-tnoy and Lovenberg 1968;
Engelman and Portnoy, 1970).
This method depends on the specificity of catechol-O-methyl
transfercse for noradrenaline and adrenaline. It converts them to
11
normetanephrine and metanephrine by the addition of a C-methyl group
lo¬
using S-adenosyl-L-rnethionine-r-methyl- C as the donor. It is of course
imperative to completely separate the labelled donor from the newly
formed metanephrines and to accomplish this, a rather involved extraction
procedure is used. The metanephrines are absorbed on to a carboxylic
acid ion exchange resin, eluted off and converted to vanillin. This is
extracted into toluene for scintillatian counting. The number of steps
involved and especially the enzymic conversion leads to low and irregular
recoveries. Hov/ever, the disadvantage of this is neatly circumvented by
the addition of tracer amounts ox tritiated noradrenaline and adrenaline
to the plasma samples. The scintillation counter separately counts
Ik 3
C and H giving each sample an internal recovery factor.
The enzymatic double isotope derivative assay is increasingly
used for peripheral plasma total catecholamine assays and especially in
clinical departments which did not previously attempt them. This is
probably because the technical departments detailed to do the assays are
more likely to have access to a scintillation counter than an adequately
sensitive fluorimeter and furthermore, are unlikely to have experience
with the exacting fluor'imetric techniques required for success.
The modification of this technique described for differential
assay of noradrenaline .and adrenaline is in my opinion far less satis¬
factory as it depends on thin layer chromatography to separate the two
catecholamines before enzymatic conversion. It is difficult for even
the most conscientious workers to achieve routinely complete separation
of the two substances by this technique (Personal communications from
Dr. C.KYates and Dr. T.B.B. Crawford). The users of the assay claim to
add traces of both noradrenaline and adrenaline but this will give no
internal control over the differential aspect of the assay as both are
tritium labelled and thus indistinguishable.
My final comment is that a scintillation counter has the
"advantage" of producing a neatly typed-out set of numbers and thus a




The development of an assay with, a similar degree of sensitivity
to those currently available for steroid hormones would greatly benefit
catecholamine research in general and completely transform peripheral
plasma studies. • •
So far attempts to raise antibodies to unmodified catecholamines
have failed but research is in progress (Dr.W.M. Hunter's unit* ) to
find a suitable antigenic derivative. Once this is achieved then a
reliable method of producing this derivative in catecholamine-containing
samples from various sources, will have to be established.




METHODS - WHOLE ANIMAL EXPERIMENTS
A - SELECTIVE CATECHOLAMINE RELEASE
Objective
Our objective was to find out if a discrete reflex stimulus
would selectively release one or other adrenal catecholamine in either
the dog or the cat. In each species, we investigated whether the ratio
of noradrenaline to adrenaline in the increment released by the barore-
ceptor reflex was significantly different from that released during chemo-
receptor stimulation. <
Outline of Technique
The effect of the baroreceptor and chemoreceptor reflexes on
noradrenaline and adrenaline secretion from the adrenal medulla was in¬
vestigated in:-
(a) Dogs anaesthetised with chloralose-urethane
(b) Cats anaesthetised with sodium pentobarbitone
The carotid bifurcations were vascularly isolated and perfused
by a roller pump at constant pressure with the animal's own arterial blood.
A servo amplifier system controlled the speed of the pump and enabled us to
set the carotid sinus pressure at will. (See figure 1 ). p 84
Baroreceptor tests were performed by lowering the carotid sinus
pressure. Chemoreceptor tests were performed by lowering the oxygen
tension of the blood perfusing the carotid bifurcations either by changing
from arterial to venous blood or by infusing the reducing agent, sodium
dithionite, which combines with the oxygen in the blood. The duration
of the periods of reflex stimulation was one minute in the dog and two
minutes in the cat.
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The venous effluent from the left adrenal gland was
collected and the catecholamine extracted before being assayed for














CAROTID BIFURCATION PERFUSION AND ADRENAL VENOUS BLOOD COLLECTION
Surgical Protocol
1. Routine initial surgery performed (i,e. tracheal cannulation and
hind or forelimb vein cannulated for anaesthetic infusion).
2. Carotid bifurcations prepared for vascular isolation and perfusion. p88
3. Vagi cut in the neck (We usually waited half an hour between
sectioning the two nerves).
4-. Venous outflow of the left adrenal gland prepared for collection p94
of blood. The animal was put on artificial ventilation once the
abdomen was opened. t
5. Half an hour alloxred for haemcstasis
6. Heparin administered intravenously (500 i.u„/kg.)
7- Carotid perfusion system set up and carotid bifurcations
vascularly isolated
8. Blood gases and acid-base balance adjusted and anaesthetic state
checked.
9. Collection of adrenal venous blood commenced. The waste blood not
required for catecholamine estimation was collected and periodically
re-injected into the animal
10. Alternate baroreceptor and chemoreceptor tests performed. p97
N.B. E'etails (e.g. manufacturer) of the instruments, reagents and drugs




Premedication - morphine sulphate (1 mg/kg) dissolved in 0.9% saline given
sub-cutaneously half an hour before inducing anaesthesia.
Induction - A mixture of c>C~chloralose (55 mg/kg) and urethane (ethyl
carbamate) (550 mg/kg) given intravenously.
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Maintenance - Constant intravenous infusion of one tenth of the induction
dose per hour - with due regard to the state of the animal's reflexes.
(See p.106 for explanation of our choice of anaesthesia).
The chloralose-urethane mixture was given as a solution in equal
volumes of 0.9$ saline and polyethylene glycol resulting in a final
concentration of 2.9% W/V o(-chloralose and 29°% W/V urethane. The use of
polyethylene glycol enabled us to dissolve the relatively insoluble
anaesthetic mixture in a manageable volume of fluid. There is no
evidence from previous work (e.g. that of Ungar and co-workers) that the
latter reagent has any adverse effects.
Cats
No premedication was used because the anaesthetic was gi\'en by
the intraperitoneal route.
Induction - Sodium pentobarbitone "Nembutal" given intraperitoneally in
a dose of 30 mg/kg.
Maintenance - Constant intravenous infusion of one tenth of the induction
dose per hour (volume increased with saline) with due regard to the state
of the animal's reflexes.
(See p.106 for explanation of our choice of anaesthesia).
Respiration,Blood Gases and Acid-Base Balance
Once the abdomen had been opened,the animals were put on positive
pressure ventilation with a Starling "Ideal" pump using either air or a
gas mixture enriched with oxygen (2,5-100$).
The respiratory rate was set at 25 per minute for both dogs and
cats.
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The stroke volume was adjusted with reference to the arterial
blood gas tensions and ventilatory efforts of the animal. A sample of
arterial blood was taken every ten to twenty minutes and the PaC^,
PaCO^, and pH measured using a Radiometer Blood Gas Microanalysis
system.
The PaCO and pH were kept at the normal levels for the two
species and any base deficit corrected by giving molar sodium bicarbonate
according to the Singer-Hastings nomogram (19^8).
The PaO^ was usually kept well above normal so as to minimise '
any chemoreceptor component during the baroreceptor tests. However, it
had to be lowered when we wanted to use venous blood (without sodium
dithionite infusion) as a hypoxic chemoreceptor stimulant.
Temperature
A rectal probe and thermostat maintained the animal's body
temperature at 37° C with the aid of a heating pad (i.e. small electric
blanket under the animal) and infra red lamps.
Blood Loss
Systemic arterial blood pressure was monitored throughout the
experiment and maintained by the intravenous administration of Dextran
I
(prewarmed to 37°C in a waterfcath). Hie solution usually contained
glucose but, during the period of adrenal venous blood collection, we
used dextran solution without glucose - (Changes in blood glucose are
known to alter adrenal catecholamine output - see Introduction). p 38
Bladder Reflexes
-In our preparations the bladder was drained by catheter or
suprapubic puncture as there is evidence that the stimulus of a full
bladder can modify activity in the central nervous system.(eg.Taylor 1968)
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CAROTID BIFURCATION PERFUSION
A roller pump (Watson-Marlow MKRE) perfused both vascularity,
isolated carotid bifurcations at constant pressure v/ith blood taken
centrally from a common carotid artery. The carotid bifurcations were
vascularly isolated so as to prevent tlie hypoxic blood reaching the
brain and having a central action during chernoreceptor stimulation.
Also it was easier for the pump to deliver the flow required to maintain
any desired pressure. However, the flow through the system had to be
sufficient to allow an efficient change from oxygenated to hypoxic blood.
For chemoreceptor stimulation, a Y-piece (not shown on the
diagram) enabled either the carotid arterial supply to be switched to
venous blood (obtained centrally from external jugular vein) or the
infusion of the reducing agent, sodium dithionite.
A pressure transducer sited down stream of the pump enabled
our servo-system (set on negative feedback) to hold carotid sinus pressure
at any desired level by controlling the speed of the pump. Thus we
could dial any required pressure and performed baroreceptor tests by
lowering the perfusion pressure. There was a gradient doxvn the tubing
from the transducer side arm to the carotid sinus and we ensured that the
cannulas into the carotid bifurcations were of the same length so that
the carotid sinus pressures were equal on the two sides.
Surgery
Sufficient lengths of both common and carotid arteries were
exposed for two-way cannulation.
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The carotid bifurcations were prepared for isolation by
placing ligatures around the:-





The superior thyroid arteries were tied off immediately and
i
the vagi prepared for section. Great care was taken to keep the
dissection as far ai^ay as possible from the carotid body and the sinus
nerve. (The venous drainage of the carotid body is said to be partic¬
ularly vulnerable to damage).
The lingual arteries were left open so as to ensure an adequate
flow of blood through the carotid bifurcations. We assumed that the
anastomosis between the lingual artery and the brain is negligible.
Once the perfusion apparatus had been set up and adjusted, we
tied off the ligatures in order to vascularly isolate the carotid bi¬
furcations. The roller pump slowed due to the reduced requirement for
flow.
Servo-control system
The details can be seen in the circuit diagram (Figure 2) but, p£
in brief, the servo-system is based on two operational amplifiers. The
first is the comparator into which is fed the voltage from the pressure
transducer and also that from an adjustable (clock) potentiometer. The
difference between these two voltages is amplified and fed into the second
amplifier, the integrator, which controls the speed of the Watson-Marlow





a potentiometer which can be bypassed and substituted with another
voltage input). Any change in output from the comparator is inte¬
grated and added to or subtracted from the voltage held by the second
amplifier which drives the pump. The operational amplifiers have a
positive and negative input and hence the output from the comparator
is the difference between the pressure transducer and clock potentio¬
meter voltages. The polarity of any such difference and therefore,
that of any change in the comparator's output■depends on the orientation
of the two input voltages. (See circuit diagram).
Thus the servo-system can be set for either positive or
negative feedback and in these modes it can:-
(a) Maintain a pressure set by the clock potentiometer
(b) Follow an external pressure when the clock potentiometer is bypassed
and replaced by an input from a second pressure transducer.
Examples of the four basic modes of action of the servo-system
are :-
1. Pressure set by clock potentiometer
(a) Negative feedback - Carotid bifurcation perfusion at constant
pressure.
(b) Positive feedback - Venous Capacitance technique at constant
pressure (See Appendix IV ).
2. Following an external pressure.
(a) Negative feedback - Perfusing a region (e.g. hindlimb, carotid
bifurcations) at a pressure equal to Systemic Blood Pressure.
(b) Positive feedback - Maintenance of Portal Venous Pressure at
Central Venous Pressure (See Appendix IV ).
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Baroreceotor tests
These are performed by changing the setting on the clock
potentiometer and thus lowering carotid sinus pressure from, say,
1^f0 mm Hg to 80 mm Hg (See Figure 3)- P93
The animals were usually breathing an oxygen-rich mixture
which gave a high arterial PO. Thus the chemoreceptor component
in response to the fall in carotid body perfusion pressure should
have been minimal, (see p.12)
Chemoreceptor tests
These were performed in one of two ways:-
1. Changing the carotid bifurcation perfusate from arterial to venous
blood taken centrally from the external jugular vein - this was
usually only a mild stimulus.
2. Infusing the reducing agent, sodium dithionite, into the arterial
blood perfusing the carotid bifurcations. A 0.25 M solution of
sodium dithionite was freshly prepared under liquid paraffin and
infused into the carotid perfusate. By altering the rate of
infusion, graded hypoxic stimuli could be given down to a PaO^ of
zero. A blood gas sample told us the degree of hypoxia, hyper-
capnia and acidaemia achieved with each infusion.












ADRENAL VENOUS EFFLUENT COLLECTION
Pop;
The adreno-lumbar vein normally collects its tributaries from
adrenal
the body wall, receives a small branch from the/gland and then runs the
short distance from the gland to join the renal vein or the inferior vena
cava. It is usually impracticable to cannulate this latter short length
of vein and so we used the well established retrograde cannulation
technique.
A ligature is placed around the adrenal vein in the region /
. vena
between the gland and the large collecting vein Qmierior/cava or renal
vein). The tributaries of the adreno-lumbar vein are tied off and a
short length near the gland is prepared for cannulation towards the gland.
Soft and flexible polyethylene tubing was used for the
cannulation and was as wide as possible in order to reduce resistance.
Cannulation was performed after heparinisation and setting up
the carotid perfusion. The end of the cannula was clamped and the out¬
flow to the great vein left untied until just before adrenal collection
was commenced so as to minimise blood loss.
Great care was taken not to damage the gland or its nerve
supply.
Cat
The venous drainage of the adrenal gland in the cat is similar
to that in the dog, although it appeared to be more variable in the
former species.
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We often found that the adreno-lumbar vein was so small that
we could not cannulate it with the narrowest cannula which we considered
reasonable to use. The resistance of a very narrow cannula would have
led to an abnormal back pressure in the gland. (There is evidence
that this can increase catecholamine discharge. Kayaalp and Mclsaac,
1968).
Other workers in the past have used the vena caval or, where
necessary, renal vein pocket technique. This involved ligating the
collecting vein above and below the entrance of the adrenal vein and
I
creating a pocket from which the adrenal venous effluent was sampled.
However, if one ties the adreno-lumbar vein to reduce haemorrhage, ivhich
one must the-preparation is to last for any length of time, the dead
space of the system becomes relatively large. Thus this technique is
only satisfactory for samples collected over large periods of time (e.g.
15 minutes) and would have been unreliable in our situation where stimuli
lasted only 2 minutes. We overcame this disadvantage by the following
technique
A double lumen cannula was made using a "Portex" Y-piece and
two cannulae of different diameters. (Figure k). Sucrose solution
(10%) was perfused down, the inner cannula at a flow of b mis/minute and
continuously washed the blood out of the pocket. The washing action
was made more efficient by positioning the cannula so that the outflow
from the gland was situated between-the ends of the inner and outer
cannulae (see diagram). p9
We checked (by using a finger stall to imitate the caval pocket)
that, at the above flow rate, the pressure gradient along the outer
lumen was less than 10 mm Hg. N.B. Sucrose solution was used because
it did not alter the ionic content of the sample (see section on cate¬
cholamine extraction) and increased the sedimentation rate of the red cells
(thus making centrifugation quicker). p13:
FIGUREk.
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PROTOCOL FOR REFLEX TESTS
Baroreceptor and Chemoreceptor tests.v/ere performed alternately
at ten or twenty minute intervals.
The duration of the periods of reflex stimulation and adrenal
venous blood collection in each species were:-
Bogs - One minute
Cats - Two minutes
Blood Gas Tension Sampling - Samples of the blood perfusing the carotid
bifurcations were taken from a three-way tap sited upstream of the Watson- <
Marlow pump so that sampling did not affect carotid sinus pressure.
The following samples \irere taken:-
Baroreceptor test - Control sample taken just before the start of the
control adrenal venous blood collection.
Chemoreceptor test - Control sample taken just before the start of the
control adrenal venous blood collection.
Test sample taken just before the end of the period
of hypoxic chemoreceptor stimulation.
Adrenal Venous Blood Collections for each test were as follows:
CONTROL - For the one/two minute period prior to the period of reflex
adrenal stimulation.
TEST - Started half a minute after the commencement of the period
of reflex stimulation in order to allow for the dead space
of the collection system.
For the chemoreceptor tests we also allowed for the time
(about ten seconds) taken for the hypoxic blood to pass
through the carotid perfusion circuit.
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We used larger stimulation and collection periods in the
cats so as to obtain for the assay, quantities of cate¬
cholamine similar to those obtained in the dog.
Splanchnic Nerve Stimulation
This was only performed in dogs.
The greater splanchnic nerve to the adrenal gland was dissected
out - (checked by observing the small rise in blood pressure when the
nerve was electrically stimulated).
i
The nerve was then sectioned and the peripheral end placed on
bipolar electrodes connected to a Grass stimulator. The nerve was kept
moist under damp gauze.
Stimulation periods were of one minute duration and were performed at ten
minute intervals (frequency = 10 per second; pulse duration = 2 msec
voltage = 10 volts).
Adrenal venous blood collecting
For each test we took a control adrenal venous sample and
started collecting the test sample thirty seconds after commencing stim¬
ulation.
Recordings
The folloxving parameters were recorded during each experiment
and are given in the Tables of Results. p29
Arterial Blood Gas Tensions - Samples were taken specifically for the
baroreceptor and chemoreceptor -tests (see protocol for reflex tests). p97
Systemic Blood Pressure - Taken from the femoral artery or common carotid
artery not used for the carotid perfusion.
Carotid Sinus Pressure - Taken from the pressure transducer in the
carotid perfusion circuit which also operated the servo control
system.
Adrenal Blood Flow - The samples were collected in graduated 10 ml
centrifuge tubes and the volume of each was recorded - (the volume
of sucrose solution was subtracted).
Catecholamines - The noradrenaline and adrenaline contents of the
adrenal venous blood samples were assayed and are given in
ng/kg. min. in the Tables of Results.
The weight' and sex of each animal was also recorded.
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OUTLINE Ox? SELECTIVE R5LBASE EXPEDIENTS
Introduction
I shall now outline the experiments we performed in dogs and
cats to investigate specifically the possibility of selective adrenal
catecholamine release. The details of the individual experiments are
given in the tables of results. I have excluded experiments which





Our standard surgical protocol was used (i.e. with, carotid
perfusion and adrenal blood collection). p85
Alternate baroreceptor and chemoreceptor tests performed,
through
Halfway/experiments DR1 - 3, guanethidine (2 mg/kg) was given
in order to abolish the reflex increase in blood pressure which resulted
from each test. (This was done to exclude the possibility that the
increased adrenal blood flow during the reflex test was responsible for
the increased catecholamine secretion).
DN 1 and 2
Our standard surgical protocol was used without setting up
the carotid perfusion.
The greater splanchnic nerve was stimulated at ten minute
intervals.
Near the end of experiment DN1 atropine (20 ^ig/kg) and later
hexamethonium (2 mg/kg) were given. In DN2, the effects of the drugs




Our standard surgical protocol was used (N.B. the perfusion
system for obtaining adrenal venous blood from cats). p95
I
Alternate baroreceptor and chemoreceptor tests performed.
i
At the end of experiment Cat 2 suberyl dicholine (100 ^ug/kg)
. was given into the carotid perfusion as a chemoreceptor stimulant.
In experiment Cat k~7 hexamethonium (2-6 mg/kg) and later
i
atropine (20-100 jug/kg) were given part way through the experiment.
(N.B. Order of drug administration reversed in Cat 6 and 7)-
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B-ENPOCRIHE MECHANISM OF ADRENAL MEPU1LARY RELEASE
Ob.jective
To investigate the influence of the anterior pituitary -
adrenocortical axis on catecholamine secretion from the canine adrenal
medulla with respect to:
1. Resting output
2. Reuronally mediated release evoked by the
baroreceptor reflex.
Introduction '
We required a stable preparation which would last for several
hours and a method of delivering discrete and reproducible neural stimuli
to the gland for we expected any humorally mediated adrenal medullary
response to be of slower time course than the direct neural reflexes
previously investigated. We also wanted to minimise any adrenocortical
activity resulting from the generalised stress of our surgical and
experimental procedures.
Our carotid sinus perfusion technique had the potential for
delivering reproducible baroreceptor stimuli (See Figure 3) to the adrenal p9
medulla and we decided to employ it in our investigation of the influence
of the adrenal cortex on catecholamine release from the medulla.
The following procedures were performed as described for dogs
in the selective release experiments section:-
1. Anaesthesia - Chloralose-urethane after premedication with morphine p85
sulphate.
2. Surgical protocol p85
3- Carotid bifurcation perfusion - p88
k. Chernoreceptor stimulation using venous blood (10 or 20 minutes
duration).
5- Baroreceptor tests (1 minute duration) - five or ten minute cycles.
6. Adrenal venous effluent collection.
I shall now outline our two series of experiments. Further
details of the individual experiments (e.g. timing, blood values) can
be obtained from the tables of results.
First Series
In view of any background adrenocortical activity, we
attempted to induce a maximal adrenocortical response by administering
exogenous corticotrophin or provoking its release by means of prolonged
carotid chemoreceptor stimulation. The preparation of corticotrophin
used was Synacthen (Ciba).
1. Exogenous Cortictrophin
In experiments DA1-3 (with baroreceptor tests) and DNJ
(denervated and with splanchnic nerve stimulation) we investigated the
action of a dose of 1 I.U./kg Synacthen.
Comment - from the work of Ganong (1963) we expected this dose to give
a maximal adrenocortical response lasting for half an hour and Marotta
(1972) had produced near maximal 11-OHCS secretion in dogs with a dose
of 1.5 I.U./kg.
2. Endogenous Cortictrophin
DC1 - Influence of twenty minutes of carotid chemoreceptor
stimulation on denervated left adrenal gland - (baroreceptor tests used
to confirm denervation).
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DC8 - Influence of 10 minutes of carotid chernoreceptor
stimulation on innervated left adrenal gland which, was subjected to
baroreceptor tests at five minute intervals (the right adrenal gland
had been donervated to prevent any central or other effects from the
circulating catecholamines released from it by reflex adrenal stim¬
ulation).
Comment - Marotta (1972) produced a near maximal adrenocortical response
in dogs with fifteen minutes of 10% oxygen breathing. This increa.se
in corticosteroid secretion was greatly reduced by carotid sinus nerve
section and completely abolished when both the carotid and aortic
bodies were denervated. Anichkov, Malyghina, Poskalenko and Ryzhenhov
(i960) had also previously shown that peripheral chemoreceptor stim¬
ulation activates the anterior pituitary-adrenocortical axis.
Second Series
We had two objectives when we planned this series of experiments.
Firstly, to find out if the delayed release of catecholamine which we had
observed after Synacthen administration and prlonged chemoreceptor
stimulation was prevented by the administration of cycloheximide. Garren, N«
and Davis (19^5) had shown in rats that cycloheximide blocked the re¬
lease of corticosteroids in response to corticotrophin and we decided to
use their dose (i.e. 50 mg/kg).
Secondly, we wanted to find the threshold of the hypoxia
required during prolonged carotid chemoreceptor stimulation to produce
an appreciable delayed-type catecholamine release. Thus, we used only
moderate degrees of carotid hypoxia for the first prolonged chemoreceptor
stimulus in each experiment.
DC2 - 7 had the following protocol:-
Control collections of testing and baroreceptor test adrenal
venous output (this base line determined over ten minutes).
Moderate hypoxic carotid chernoreceptor stimulation (ten minutes
duration).
Collections of resting and baroreceptor (one or two) test adrenal
venous output (thirty minutes).
Cycloheximide - 50 mg/kg intravenously.
Collections of resting and baroreceptor test adrenal venous out¬
put (twenty minutes)
More severe hypoxic carotid chemoreceptor stimulation (ten
minutes duration).
Collections of resting and baroreceptor test adrenal venous out¬
put (twenty or thirty minutes).
"Synacthen" 1 I.U./kg intravenously.
Collections of resting and baroreceptor test adrenal venous out¬
put (twenty minutes).
SOME COMMENTS ON OUR WHOLE ANIMAL
EXPERIMENTAL TECHNIQUES
A. CHOICE OF ANAESTHESIA
By their very nature, all anaesthetd.es must cause some
depression of the central nervous system and there was a case for using
decerebrate animals. However, as this is a difficult operation to
perform in dogs and any additional major surgical procedure would have
increased our experimental failure rate, we decided to use anaesthesia
for financial reasons.
The influence of various anaesthetic agents on cardio¬
vascular reflexes has been shown by comparing the response to the
relevant stimulus before and after administering the agent to a decere¬
brate animal. (See Heymans and Neil 1958). In dogs it is claimed by
these authors that ordinary anaesthetic doses of chloralose and pento¬
barbitone do not unduly reduce reflex responses although the latter
compound tends to produce more depression than does chloralose.
However, there appears to be a species difference between the dog and
the cat as shown by Neil, Redwood and Schweitzer (19^9) who demonstrated
that, in cats, chloralose selectively depresses the baroreceptor as
compared to the chemoreceptor reflex. This phenomenon does not occur
in the dog.
The early work of Elliot (1912) showed that various anaesthetic
agents induced a depletion of catecholamine from the adrenal gland.
Elmes and Jefferson (19^2) found that in cats a pentobarbitone-morphine
mixture gave the lowest rate of depletion (j>°/o per hour) out of a number
of anaesthetic regimes. Also with this species, Emmelin and
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Stromblad (1952) found that chloralose gave a remarkably low rate of
loss (0.1$ per hour) compared with morphine-ether anaesthesia (11$ per
hour). This difference may he due in part to a combination of morphine!s
excitatory effect and the selective baroreceptor depression seen with
chloralose in cats.
A further disadvantage of pentobarbitone is its hexameth-
onium-like action which is seen with high doses.(Exley 1959)
Thus for our work in dogs we decided to employ chloralose-
urethane anaesthesia because it appears to have relatively little reflex
depressant or adrenal depleting action and it is commonly used in studies
of cardiovascular reflexes. The use of chloralose alone has the dis¬
advantage that the animals tend to awake suddenly during an experiment
and so urethane is added.
However, we could not use chloralose for our cat experiments
because of its effect on the baroreceptor reflex and instead, we chose
pentobarbitone. The latter drug's ganglion-blocking action was a cause
for concern and we took great care not to over-anaesthetise the animals.
However, if it had not been for the cost of cats, we would have done
some experiments on decerebrate animals.
Morphine premedication in dogs
We had to inject a large volume of anaesthetic into the dogs
and in order to make handling easier (and less traumatic), we pre-
medicated the dogs with 1 mg/kg of morphine half an hour prior to in¬
ducing anaesthesia.
When given in large doses to cats, morphine has been shown to
release adrenal catecholamines. Elliot (1912) detected significant
108
depletion after a dose of 25 mg as did Vogt (195*0 using 30-60 rag/kg.
Outschoorn (1952) observed no loss after a single dose of 20 mg/kg but
repeated injections every hour did result in adrenal loss. This may
in part be due to morphine's excitatory action in the cat which is not
found in dogs or man.
However, in dogs our premedication dose of 1 mg/kg was less
than a tenth of the doses used in cats to obtain depletion and as it
was given four to six hours before our sample collection began, we
thought that its effect on our results would be negligible.
B. CAROTID BIFURCATION PERFUSION SYSTEM p88
We established the servo-amplifier controlled carotid bi¬
furcation perfusion system as a method of delivering discrete repro¬
ducible reflex stimuli to the central nervous system, (See Figure 3)» P 93
It is a simple system and when being used solely for baroreceptor
mediated stimuli, it involves only minor surgery (i.e. that surgery
necessary to reduce the flow requirements of the system such as tying
off the external carotid arteries).
0. ADRENAL VENOUS BLOOD COLLECTION TECHNIQUE p94
Our adrenal venous blood collection technique (i.e. the
double lumen cannula) which we devised for cats enabled us to use much
shorter collection periods than had been employed by other workers.
(e.g. Ten minutes - Fuerstein and Gutmann, 1971)• Furthermore, that
error involved in collecting small blood samples which is related to
size of the individual drops was reduced.
D. THE USE OF DITHIONITE IN CHEMORECEPIOR STIMULATION
Introduction
The most straightforward way of stimulating the chemoreceptors
in our preparation, was to change the carotid bifurcation perfusion from
arterial to venous blood taken (centrally) from the jugular vein.
However, when we were comparing the chemoreceptor and baro-
receptor reflexes we needed a high arterial oxygen tension to avoid a
chemoreceptor component during the baroreceptor tests. Thus the venous
i
p°2 was usually not low enough to evoke significant cardiovascular
responses and we did not want to alter the arterial PO^ for the chemo¬
receptor tests because of possible central effects. We therefore
needed another method of stimulating the chemoreceptors and there v/ere
a number of possible approaches.
1. Use of a drug to stimulate the chemoreceptors.
(a) Histotoxic drug such as potassium cyanide. This has the
following disadvantages
(i) Difficult to judge the dose required for a
short discrete stimulus
(ii) Tachyphylaxis and cumulation if drug used repeatedly
(iii) Recirculation
(iv) Central toxic actions
(b) Nicotinic agonist such as suberyl dicholine. This drug is
superior to cyanide as it is broken down by pseudocholines-
terase but still has some disadvantages:-
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(i) Its action may not be specific to the ohemoreceptors
(ii) It would have been useless when we came to investigate
the action of hexaraethonium on the chemoreceptor and b&ro-
receptor reflex as the ganglion blocker would abolish
suberyl dicholine's stimulant effect on the chemoreceptors.
(iii) Responses to chemoreceptor stimulant drugs cannot be
expressed in terms of the physiological stimulusj that
is hypoxia.
2. Use of a donor animal to supply the blood perfusing the carotid
bifurcations. This is the ideal method but was economically un¬
feasible .
3. Lower the PO^ of the animal's own blood by:-
(a) Changing arterial PO^ - but this may have central effects.
(b) Using a deoxygenator
M. Scott who has done a lot of work in this field, claims that they are
easy to use, give very stable blood gas levels and frothing does not
present a problem. She also considers that the release of vaso-active
substances from the blood is of no consequence. However, such a
system has a large extracorporeal volume which needs to be primed with
blood from a donor animal or else the volume of plasma substitute
required would cause considerable dilution of the blood.
(c) Electrically stimulate the nerves to a limb and thus lower the
venous PO (and raise the PCO^) by working the muscles. We had never
tried this method and considered that its establishment as a satisfactory
technique would be difficult and costly in animals.
Ill
(d) Chemically lower the PO^, of the arterial blood used to perfuse
the carotid bifurcation by infusing a reducing agent. Sodium dithionite
had been used for in-vitro studies of haemoglobin to reduce oxyhaemo-
giobin and methaemoglobin.
Sodium Dithionite
This chemical compound reacts rapidly with dissolved oxygen
to yield sulphate and hydrogen ions.
It had the following advantages
(a) Graded stimuli could be applied to the chemoreceptors depend¬
ing on the amount of dithionite infused into the blood and a blood gas
sample would indicate the degree of the stimulus.
(b) The dithionite was acting through the physiological mechanism
of hypoxia potentiated by acidaemia and also there was no evidence of
tachyphlaxis.
(c) We did not have to change from arterial to venous blood and
the animal could be continuously breathing an enriched oxygen mixture.
As a consequence of the haemoglobin dissociation curve,it makes little
difference to the amount of dithionite required to lower blood PC^ to
chemoreceptor stimulant levels whether the PO^ is 100 or kOO torr.
(d) There is no recirculation problem as the small amount of
sulphate which may build up in the blood appears to be harmless and it
should be excreted by the kidneys.
I will later describe the ejq>eriments done to justify (1 - k). p11C
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Chemistry
Sodium dithionite (Na2S O^.SELp) is a salt of dithionous acid
(hypo/hydrosulphorous acid). The ion consists of two S0^ groups joined
by a long bond between the sulphur atoms.
It is used in the dye industry and also in Fieser's solution
for removing oxygen from inert gases (Fieser's solution is aqueous sodium
dithionite with 2-arithraquinonesulphonate as a catalyst).
Although it is reasonably stable in the solid form (Na2S20^.2H20)
it decomposes in solution to form metabisulphite and thiosulphate.
2Na2S20Zf—> Ka2s2°5 + Na2S2°3
Thus we kept measured amounts of the salt in sealed pots.
Just before the chemoreceptor test we dissolved it in 10 mis of water and
covered the solution with liquid paraffin.
Both metabisulphite and thiosulphate are oxidised in the
presence of oxyhaemoglobin to sulphate.
The overall reaction for the oxidation of sodium dithionite is
as follows, although the detailed chemistry of the higher oxy-acids of
sulphur has not been fully elucidated.
2Na S 0^ + 302 + 2H20 > toaHSO^
The formation of bisulphite increases the hydrogen ion con¬
centration of the blood and further potentiates the hypoxic stimulus.
1
Experiments to validate the use of sodium dithtontte
To justify the use of sodium dithionite as a chemoreceptor
stimulant we had to confirm the following
"In vitro"
1. It combines in a quantitative manner with the oxygen in the blood
2. The reduction of oxyhaemoglobin is reversible
"In vivo" - when infused into the carotid bifurcation
3. The responses to chemoreceptor stimulation are dependent on the
rate of infusion and the degree of hypoxia obtained.
A. The response to chemoreceptor stimulation is abolished by dener¬
vation of the carotid bodies.
In vitro experiments
100 mis of fresh blood in a beaker were covered with liquid
paraffin and continuously agitated with a magnetic stirrer.
A Watson Marlow pump continuously sampled the blood (0.1 ml/min
and passed it through our Radiometer blood gas machine which gave a
continuous record of PO^ on a UV recorder.
We oxygenated the blood to a PO^ of over 200 torr and then
slowly infused sodium dithionite solution. The infusion of the reducing
agent removed a constant amount of oxygen with respect to time and thus
we drew a haemoglobin dissociation curve. This demonstrated the
quantitative combination of dithionite with the oxygen in the blood.
We then bubbled oxygen through the blood and returned it
to a PO^ of over 200 torr. A second infusion of dithionite at th
same rate drew an identical curve and demonstrated the reversible
nature of the reaction.
The above procedure was repeated in many samples and an
example is illustrated (see Figure 5)«
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HAEMOGLOBIN DISSOCIATION CURVES OF WHOLE BLOOD PRODUCED BY
INFUSION OF SODIUM DITHIONITE SOLUTION AT A CONSTANT RATE IN VITRO
(Blood reoxygenated between top and bottom curves)
FIGURE 3.
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In two dogs we set up our carotid bifurcation perfusion system
and recorded ventilatory responses with a pneumotachograph.
We examined the response to a series of one minute infusions
of sodium dithionite into the carotid perfusate in either increasing or
decreasing dosage.
One series of six different doses is illustrated
(a) Figure 6b shows the relationship between infusion rate of
dithionite and degree of hypoxia achieved,
(b) Figure 7 shows the increase in ventilatory response with
increasing stimulus
Using all the carotid perfusate blood samples I have plotted
the relationship between pH and the PO^ achieved with dithionite
(Figure 6a).
Finally, we showed that the response to dithionite is abolished
by injecting local anaesthetic (lignocaine 2%) into the regions of both
carotid sinus nerves (see Figure 8).














































- THE EFFECT OF CAROTID BODY DENERVATION
ON THE RESPONSE OF VEI'TOILA.TIQN TO DITHIONITE
Infusion rate of dithionite into carotid perfusate = 150 mg/min




CHEMICAL SPECTttOPKOTOmroaiMETRIC CATECHOLAMINE ASSAY
Objective
Our main objective was to establish a reliable physico-
chemical technique in order to assay the noradrenaline and adrenaline
of adrenal venous blood. However, we also wanted to extend our method
to peripheral plasma and urine samples.
We therefore required an assay which would:-
1. Adequately differentiate between noradrenaline and adrenaline
2. Enable samples to be assayed together in batches of twenty to
thirty with consistent recoveries so that we could confidently
compare total catecholamine outputs and adrenaline and nor¬
adrenaline ratios within each batch. (Assays are bound to vary
due to human and technical factors and thus comparisons are more
reliable between samples assayed in the same batch).
Each type of sample had its own problems:-
(a) Adrenal Venous Blood
The two catecholamines are present in relatively large amounts
with little contamination. Thus only a simple extraction procedure
is required and our main concerns were with our ability to differ¬
entiate adequately betiveen noradrenaline and adrenaline and with
maintaining good consistent recoveries.
(b) Peripheral Blood Plasma
The quantities of catecholamine found in peripheral blood are
so small that all the available biochemical techniques are stretched
to the limits of their sensitivity.
121
(c) Urine
This is the only situation where closely related compounds to
adrenaline, such as their metabolites, are found in quantities
significant enough to influence a biochemical assay. Thus
purification is very important and required a great deal more
attention than it did with the other types of sample.
Introduction
Vulpian initially described the property of the adrenal gland
to form lightly coloured compounds and Loew (1918) noted that adrenaline
fluoresces in alkaline solutions. Gaddum and Schild (193;0 showed
that the presence of oxygen was vital for this reaction but their attempts
to develop it into an acceptable assay failed due to the transient nature
of the fluorescence. A few workers tried to exploit this fleeting
fluorescence but success only came when Ehrlen (19^8) managed to stabilise
the fluorophors with ascorbic acid.
The reaction appears to involve the oxidation of noradrenaline
and adrenaline to coloured "chrome" derivatives which are rearranged in
alkali to form "lutines". The latter compounds readily oxidise further
losing their fluorescence but can be stabilised with an antioxidant such
as absorbic acid. This is known as the trihydroxindole (THX) reaction
and is so named because of the formation of an indole structure. Most
fluorimetric catecholamine assays are based on this sequence and only
differ in the choice of oxidising reagent and also the stabilising reagent.
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Adrenoiutine
Weil-Malherbe (1952) introduced a similar procedure which
involved the condensation of the chrome derivatives 'with ethylene
diamine to form quinoxaline derivatives. When he used the ethylene
diamine condensation reaction to assay peripheral plasma he calculated
catecholamine levels to be an order higher than those reported using
the Till technique. Weil-Malherbe's method was criticised for being
less specific than the THI reaction and fell into disrepute (See reviews
by Udenfriend and Callingham), although he claimed subsequently to have
made improvements so that he obtained results comparable with the more
widely used THI method. There is probably little to choose between the
two methods for adrenal effluent assay although the condensation reaction
introduces another step and thus increases the variability. One
advantage of the ethylene diamine condensation method is that the
fluorophors are claimed to be very stable which appeals to those workers
who intend leaving their samples for long periods before "reading" them
in the fluorimeter.
The situation regarding the multitude of fluorescence assays
published is well put in Udenfriend's (19&5) remark that "there are almost
as many variations as there are scientists who.use them". This would
never have come about if workers had only been interested in assaying
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adrenal venous samples and urine. However, the search for a satisfactory
peripheral plasma assay has resulted in a plethora of methods which
differ only by minor modifications. The catecholamine concentrations
found in peripheral plasma are really too low for this technique and
it has had to be stretched to the limits of its discrimination.
All the established versions of the trihydroxyindole technique
would have been sensitive enough for our adrenal venous sample assay.
Our main decision was concerned with the differentiation between
adrenaline and noradrenaline and whether the assay was to be based on f
a one or two reaction tube method.
The former depends on the differences in their fluorescent
spectra (as previously described) while the latter involves splitting p145
each sample and exploiting slight differences in the ease of oxidation
and stability characteristics of the two catecholamines. Thus it
attempts to have fluorescence from only one catecholamine in one of the'
tubes,and this isusually achieved by oxidising the two samples at different
pH's.
Both discussion with other workers in the field and our own
experience persuaded us not to use a two tube technique. Although it
would theoretically have given a better discrimination, it depends on
getting the reaction conditions in each tube "precisely right" and is
thus more difficult to use for reliably estimating large batches of
samples.
The grounds for choosing our technique were that it had been
recommended, it was quite widely used and the various procedures appeared
simple and easy to standardise.
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The chemical assay of catecholamines has been reviewed in detail
by Udenfriend (1958, 1962) and Callingham (19&7) an^ ^ shall only mention
the other THI variants very briefly before discussing our ov/n method.
The following oxidising and stabilising reagents are commonly
used in the THI technique
Oxidising agents
(a) Manganese dioxide e.g. Lund (1951)5 Cohen and Goldberg (1957)
(b) Iodine e.g. Grout 1961 .
(c) Potassium ferricyanide e.g. Price and Price, (1957) Anton and
Sayre (1962),Bertler et al (1958), Vendsalu (i960), Haggendal
(1963)
Stabilising reagents .
(a) Ascorbic acid (Lund, Anton and Sayre, Price and Price and Grout)
(b) Sulphur containing compounds
1. British anti-Lewisite (BAL)
2. Cysteine Hydrochloride
3. Sodium pyrosulphite.
In addition, in the search for a reliable peripheral plasma
assay other factors such as sources of reagents, redistillation, variations
in buffer composition etc., have been.put forward by various workers for
blank
their supposed merits in reducing/values, or increasing fluorescence or
reproducibility.
Nearly all workers emphasise the importance of precise time
keeping when adding reagents and reading the fluorescence and also the
125
need for adequate washing of glass ware.
We thus used the purest reagents we could afford for the
fluoriraetry hut used Analar grade reagents in the column extraction




OUTLINE Or OUR TECHNIQUE
After separation from the cellular elements of the blood and
precipitation of the plasma proteins, the catecholamines were extracted
by passage through a cation exchange resin.
Tine extraction procedure depends on the positively charged
nature of catecholamines at around neutral pH which results in them
being retained by the negatively charged groups on a sulphonated resin.
However, the catecholamines have a similar affinity to any negative ions
in the solutions passing through the resin-columns.
Thus any anions in solution tend to wash the catecholamines off
the columns and it was essential to keep the ionic content of our samples
as low and as constant as possible if good and consistent recoveries were
to be obtained.
Hydrochloric acid (1N) was used to elute the catecholamines from
the columns and the eluate can be stored at this pH or neutralised ready
for the fluorimetric estimation.
1
The fluorine trie reaction used is known as the trihydroxyindole
(THI) reaction. Our technique was based on one originally described by
Bertler, Carlsson and Sosengren (1958) but slight modifications were made
by Vendsalu (i960) and Haggendal (1965)- It. consists of the following
steps, (see diagram on p.122)
1. Oxidation of the catecholamines for three minutes with potassium
;
ferricyanide at pH 6.5.
2. Oxidation stopped and the products stabilised by addition of a
sodium sulphite and British anti-lewisite (BAL) mixture.
3. Alkaline rearrangement of the oxidation products for maximum
fluorescence with sodium hydroxide (10 N)»
k. Samples "read" in the spectrophotofluorimeter by scanning the
excitation wavelengths from 300-500 mp while set at a maximum
wave length of 515 rap.
5. The differentiation between adrenaline and noradrenaline in our
technique is based on the different fluorescence spectra of the
derivatives of the two compounds. By measuring the unknown's
fluorescence intensity at two wave lengths and comparison with
standards at these wave lengths, two simultaneous equations are
built up and the amounts of the two catecholamines calculated.
Use of native fluorescence
Their phenolic group gives the catecholamines a native fluor¬
escence in the ultraviolet region of the spectrum (285 mu : 325 rap) which
is maximal at around pH 1. This fluorescence is the same for all cate¬
cholamines and is much less intense than that of the derivatives mentione
above. For this reason and the fact that the assays were developed in
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the days before instruments could use the "quartz ultraviolet" part of
the spectrum, this property has been little exploited. However, we
found that it was extremely useful when investigating the column
extraction techniques as elution profiles, etc. could be performed by
directly reading the fluorescence of the eluates.
Stability of the catecholamines
Catecholamines have been shown to keep for very long periods
at pH's between 0 and ^ x^hen deep frozen, (Callingham 1967).
t
With regard to room temperature, they are stable for days at a
pH of b or less. Their stability at neutral pH depends on the presence
of catalytic ions and oxidising agents, including oxygen. Thus standards
and samples waiting to be processed should not be left at room temperature
and/or neutral pH. However, our recovery experiments (see p.139 & 267) show
that they are stable under the ionic conditions found on the columns.
At an alkaline pH, catecholamines oxidise very rapidly, but again this
is very dependent on the presence of catalytic ions, oxygen and temperature.
129
DETAILS OF THE CATECHOLAMINE ASSAY
N.B. The letters underlined, in parenthesis refer to the notes which
follow this section. P133
Collection of Samples
Heparinised "blood from the left adrenal gland was collected P94
(as previously described) in a measured volume, of 10% sucrose (a_) and
0.3% EDTA.
Preparation of the Plasma
i
Centrifuged immediately at 3^000 r.p.ra., h°C for 10 minutes Cb)
The plasma supernatant and packed red cell volumes were recorded
and the plasma carefully removed with a syringe and cannula. The plasma
was either loaded directly onto the columns (d_) or the plasma proteins
were precipitated.
Precipitation of the plasma proteins was achieved by thorough mixing with
0.1 volume of ^ N perchloric acid (c_). The samples were then frozen (d)
and could be stored in this form in the deep freeze.
Neutralisation to pH k (e_) using 5N Potassium Hydroxide (f). The pre¬
cipitated proteins had been previously removed by centrifugation at *f°C.
After neutralisation the samples were again frozen, thawed and centrifuged
at 0°C for 15 minutes.
i
Extraction and Purification of the Catecholamines
The samples were loaded onto Amberlite CC120 (mesh size 100-200)
resin columns (g) of 2 cm length and 0.25 cm. diameter.
The glass columns consisted of a reservoir (20-^0 ml capacity)
above a narrow bore tube which held the 2 cm column of resin at its lower
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end. The resin was converted from the hydrogen to the sodium form (h)
prior to loading on of the samples.
Purification (i_) was perfoi-rned by rinsing the columns, after loading on
the samples with the following solutions
1. H 0 + 0.1# EDTA - 20 ml.
2. Phosphate Buffer (pH 6.5) +0.1# EDTA - 2.5 ml.
5- H20 - 5 ml.
Elution (j_) v/as with A ml of IN hydrochloric acid (Aristar Grade) into
centrifuge tubes (10 ml). The samples were stored in this form (0°C).
The Spectrophotofluorimetric Assay
Neutralisation of the samples to pH 6.5 (measured on a pH meter) using
5 N potassium carbonate soTution.
All the adrenal venous samples Xirere assayed according to the
following protocol. Reagents were dispersed manually with Eppendorf
pipettes and Repette syringes and mixing was performed mechanically with
a "whirleymix".
Assay tubes were prepared as follows
1. Samples - Done in duplicate. 0.7 ml aliquots taken from the
neutralised samples (l)
Standards - Noradrenaline and adrenaline standards (in duplicate)
prepared by taking 0.5 ml of standard solution (200 ng/rnl
in 0.0001 N KGl) and 0.2 ml HgO.
3. Blanks (s_)
(a) Reagent Blanks - 0.7 ml water
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(b) Faded Blanks - 0.7 nil sample to which potassium ferricyanide
and sodium hydroxide solutions were added
together ten minutes before the BAL/sulphite
mixture.
The samples were usually assayed in batches of six (duplicates -
twelve tubes) with two pairs of standards and a reagent blank set up in








To each tube the following reagents were added:-
1. 0.1 ml 0.1 M phosphate buffer (pH 6.5)
2. 0.02 ml 0.002p$ cupric chloride (jd)
Using a stop-clock, the following reagents were added to the
tubes according to a strict time schedule. Each reagent was added to the
individual tubes at ten second intervals. ■ The size of the batches was
ten
thus limited by the number ojy second intervals which could be conveniently
fitted into the three minute oxidation reaction time.
1. Potassium ferricyanide (0.25$) - 0.05 ml (u_)
2. After three minutes -
Sodium sulphite (20$) containing 0.5$ British Anti-Lewisite
(BAL) - 0.125 ml (.2.)
3. A.fter ten seconds
Sodium hydroxide (10 N) - 0.2 ml
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In our later experiments i.e. after we had completed our whole animal
work:-
^f. After four minutes -
Glacial acetic acid - to give final pH 5-0 - 0.22 ml (ry
Fluorescence measurement - After a time delay of at least
seven minutes, the contents of each tube in turn were transferred to a
clean quartz cuvette and read in the Aminco-Bowman Spectrophotofluorimeter
(t)
(a) Without acetic acid
Excitation spectrum scanned over range 300-500 mp
Emission wave length = 515 mp
N.B. The samples were read as quickly as possible in order to minimise
the effects of the gradual fading of the fluorescence.
(b) With acetic acid
Excitation spectrum scanned over range 300-500 mp.
Emission wave length 500 mp
N.B. The fluorescence was"stable for over an hour.
The index of discrimination and the relative fluorescence of
adrenaline were both increased when we used an emission wave length of
520 mp (See p.146 and Figures 11 and 12)- p148 & 149
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NOTE'S OH THE ASSAY TECHNIQUE
The method which I have just described for the quantitative
determination of adrenaline and noradrenaline in adrenal venous blood
is based on that used by Vendsalu (i960) for the estimation of these
amines in samples of human peripheral blood. His technique was based
on one worked out by Bertler, Carlsson and Rosengren (1958) for the
determination of the two catecholamines in animal tissues. Haggendal
(1963) made a number of modifications to Venasalu's technique and in
the following footnotes I shall comment on our method and its deviations
from that used by the latter two authors.
Notes on Extraction Procedure
(a) The use of Sucrose rather than 0.9?^ saline (used by Vendsaiu and
Haggendal) was found to speed up the centrifugation step (possibly due
to erythrocyte cell membrane changes) and did not add to the ionic content
of the sample.
(b) Immediate centrifugation followed by refrigeration is essential as
loss of catecholamine occurs rapidly in whole blood (11% lost after ten
minutes - Mangan and Mason (1958)). However, in plasma,Jones and Blake
(1958) found little loss even after twenty four hours at 20-26°C.
Iversen (196'+) claims that the presence of EDTA also helps to reduce loss.
(c) Omission of the protein precipitation seeps was initially tried by
Haggendal (1963) who claims that he could run 5-10 ml plasma through the
columns without affecting recovery of fluorimetric blank values. However,
we found that such volumes of plasma were very slow running, on the columns,
even after dilution, and the blanks were high and variable. Thus we
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were unable to omit the protein precipitation stage when performing
human peripheral plasma assays. p 267
However, with the smaller volume of plasma (1-3 ml) and much-
higher catecholamine content of our adrenal samples, we found that we
were able to omit the deproteinisation stage. By washing the sample
through with 20 ml HO + 0.1# EDTA we achieved a reasonable flow rate
and acceptable blank values. In fact the fluorescence spectra in our
recovery experiments were indistinguishable whether the catecholamine
was washed through.the column with water or plasma. t
(d) Freezing after the addition of the perchloric acid^appeared to
give more complete precipitation of the proteins and it was convenient
to store the samples overnight or longer in this form.
(e) Neutralisation to pH 4 at which catecholamines are still very
stable.
p 1 2f
(f) Potassium hydroxide not only neutralises the acidified samples
but also precipitates out most of the perchlorate ions. The samples
were refrozen after neutralisation as potassium perchlorate is relatively
insoluble at low temperatures.
Freezing was performed rapidly by using an alcohol/solid
carbon dioxide mixture and on thawing the samples were rapidly centrifuged
at 3,000 r.p.m. for fifteen minutes at 0°C. Removal of the perchlorate
ions is essential as the ionic content of the samples must be reduced to
a minimum before loading them onto the columns in order to avoid loss of
catecholamines from the resint The samples were frozen twice because .
omission of the first freeze (i.e. that after protein precipitation)
resulted in a faint opalescence which was not removed by the second freeze
*see p.126
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(at neutral pH}. This was not inconvenient as the samples were usually
stored in the freezer after the addition of the perchloric acid.
I found that neutralisation at this stage with potassium
carbonate (as used by Vendsalu and Haggendal) usually lead to bubbling
on the resin column which stopped the flow. Furthermore, the gradual
loss of carbon dioxide while the samples were in the reservoirs above
the columns resulted in a slow rise in pH, which would increase the
susceptibility of the catecholamines to oxidation. However, both these
problems were avoided by neutralising the samples with a carefully
measured volume of potassium hydroxide (5N) and the final end point
was achieved by dropwise addition of 0.5N potassium bicarbonate which
has a near-neutral pH. A tiny magnetic stirrer was used to prevent the
formation of regions of local alkalinity during the neutralisations.
(g) Choice of extraction technique. We employed a strong cation
exchange resin of the sulphonic acid type. The other widely used extraction
technique involves the absorption of the catecholamines onto alumina by
either a batch or a column procedure and appeared to have a number of
disadvantages. Firstly, most workers recommended a tedious preparation
process for the alumina and each batch has to be tested for its recovery
properties. Secondly, the absorption stage requires an alkaline pH
and although performed in the presence of the antioxidants, this is very
likely to increase the variability of the recoveries. Finally, most
authorities considered that when using alumina, better results are
obtained with the batch rather than the column approach, although the
former is inherently more tedious and exacting. Thus as there appeared
to be little to choose between the alumina and ion exchange techniques
regarding published recovery figures and as the reliability of any
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procedure must be in part inversely dependent on the number of exacting
steps, we decided upon the latter technique.
The resin chosen was Amberlite CG 120 (- recommended by
Haggendal) and is equivalent to the Bowex 50 which was employed by
Bertler et al and Vendsalu. The resins can be used in either the
hydrogen or the sodium form but Haggendal claims that the latter gives
better recoveries. This is, possibly because the change in resin size
during elution helps to "dislodge" the catecholamines.
We used a more coarse form of resin (i.e. 100 - 200 mesh)
rather than the 200 - ^00 mesh used by Vendsaltt and Haggendal. Our
mesh size gave a very satisfactory flow rate by gravity alone and thus
did not require pumping devices to aid the passage of solutions through
the columns (e.g. Bertler et'al). Such devices require constant super¬
vision to prevent air being forced into the columns when all the solution
has run through. However, with our technique, surface tension stopped
the flow before the columns ran dry.
Two problems which HMggendal discussed are the presence of
fluorescent contaminants in the resin and loss of catecholamine during
passage through the columns. The fluorescent contaminants can be
eliminated by careful preparation of the resin. The fines are removed
by repeated washes with water. This is followed by recycling the resin
several times between the sodium and hydrogen forms so that alternate
expansion and contraction of the resin helps to expel impurities.
Haggendal found that the loss of catecholamines on the columns
is a function of their length. Shorter columns are also faster flowing
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arid require a smaller elution volume. We found that the recovery of
standards from our short (2 cm) columns v/as over 90$. (see fig 9) Further
shortening of the columns would have decreased the required elution
volume but greatly increased the chance of catecholamine loss if the
salt content of the sample was high (see p.126, 139 & 267)-
(h) Preparation of the columns The resin was stored in the hydrogen
form. The columns consisted of 2 cm of resin retained by quartz wool
and were prepared by running through the following solutions
(i) 10 ml H^O - to wash off any excess acid f
(ii) 10 ml Phosphate Buffer (pH 6.5) - converted resin to
the sodium form (N.B. final effluent pH - 6.5 -
checked with Litmus paper).
• (iii) 10 ml HO + 0.1$ EDTA to remove divalent metal ions
(i) Rinsing to remove contaminants No more than. 5 ml of Phosphate
Buffer was used at this stage although recovery experiments showed that
up to 10 ml buffer could safely be used without resulting in a detectable
amount of catecholamine being washed off the columns. (See Figure 9). P13
The final rinse with water did not contain E.DTA in case its presence
affected the fluorimetry. (However, when fluorimetry was performed on
standards using phosphate buffer with and without 0.1$ EDTA no effect
could be detected).
(j) Elution The volume of 1N hydrochloric acid chosen (h mis) had
been shown by elution profiles and recovery experiments (see Figure 9
and p. 267. ) to be adequate for virtually complete elution. More
concen trated acid can be used to elute into a correspondingly smaller
volume but we found this to disproportionately increase our blank values -
(presumably due to contaminants washed off the columns).
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Haggendal recommended, discarding the first couple of drops of eluate
claiming that this contained a high proportion of the contaminants and
no catecholamine. However, we did not find that this reduced our
blank value and it was very risky as the catecholamines appeared at a
variable point in the elution profile which depended on the salt content
of the sample. Also, it was easy to forget to start collecting]
There is a difference of opinion on the subject of whether
it is essential to elute without interruption or whether it is better
to elute in stages and thus give time for the catecholamine to diffuse
out of the resin. We found no difference between these two methods.
FIGURE9- ng





























Notes on the Fluorimetric Technique
(k) Oxidation pH A pH of 6.5 was chosen as, at this pH, the
derivatives of the two catecholamines have about equal fluorescence
and fluctuations of about 0.5 pH units make negligible difference
to the final fluorescence.
Prior to oxidation the acid eluates are carefully neutralised
with 5N potassium carbonate using a pH meter. With practice, the
calculated neutralising volume can be pipetted out with safety but the
pH should not be allowed to exceed about 7«5» Potassium bicarbonate
would have been much easier to use but it is far less soluble and thus
its use would have involved a much greater dilution factor.
(l) Use of duplicates Samples and standards were always in duplicate
in each batch in case a tube was dropped and also because it was
encouraging to watch the two traces being drawn on top of (or very near
to) each otherJ This is one of the ways to keep up interest in a
tedious assay and thus maintain good results. Such considerations are
vital for success in an assay technique that depends on an important
human contribution. Therefore, .. I have tried to avoid tricky
manipulations etc. and make each step as simple and "fool proof" as /
possible.
(m) Timing The importance of very accurate timing during all stages
I
of the fluoremetric procedure has been emphasised. Before the intro¬
duction of the automated technique described later, we achieved this
by using "Repette" syringes to rapidly deliver consistent volumes of
each reagent and timed ourselves with a stop-clock. The technique was
very reliable but required the presence of an assistant, unless small '
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batches of tubes (less than twelve) were used.. With an assistant,
the maximum number of tubes per batch (not including blanks) was
eighteen. Reagents were added to each tube in turn every ten (two
operators) or fifteen (single operator) seconds and thorough mixing
was performed after the addition of each reagent by the use of a
"Whirlymix".
(n) Potassium ferricyanide Most workers preferred this oxidising
agent, as iodine, the only other widely used agent, takes much longer
to oxidise the catecholamines and the reaction appears to be greatly
influenced by the laboratory lighting conditions, (Callingham 196$).
(p) Use of Copper Ions Throughout our work cupric ions were added
prior to oxidation. Bertler et al used zinc ions as a catalyst but
Vendsalt! observed that this resulted in the final solution becoming
cloudy (probably due to the formation of zinc hydroxide), and thus
necessitating centrifugation before reading. Later workers (Sandhu
and Freed) also encountered this problem with zinc.
Kaggendal used cupric ions claiming that they accelerated the
oxidation process and increased the stability and intensity of the
fluorescence. He also comments that a weakening of fluorescence occurs
in alkaline solution due to the formation of complexes between the cupric
ions and the'lutines but this is eliminated when BAL/sulphite is used as
an antioxident. (He presents little evidence to support these remarks).
Valori et al confirmed that cupric ions had a catalytic effect but mainly
in relation to the oxidation of adrenaline.
We investigated the effect of cupric ions by running standards
with and iiiithout their presence and could show no significant difference.
However, they definitely do have a catalytic effect under some circum-
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circumstances because they were essential for the oxidation of adrenaline
at a low pH (around 3)= Furthermore, we found that they made a great
difference to the amount of fluorescence obtained when the THI.
reaction was employed with the metanephrines. (See p.28l)
Thus as we had shown that they did no harm and knowing that
metal ions play some part in the oxidation of catecholamines and. their
derivatives, we always added a small volume of cupric solution prior
to the oxidation.
(q) Stabilisation of the Lutines Much previous work has been done
on this aspect of the reaction. Ascorbic acid was widely used by many
workers including Vendsalu but he noted that it contributed considerably
to the blank value in a time dependent manner. (Dr. T.B.B. Crawford
says that this is due to impurities in the ascorbic acid and thus he
keeps a special supply).
H&ggendal investigated the use of many other agents and found
that the best results were obtained with sulphur containing compounds.
A solution of dimercaptopropanol (BAL) in sodium sulphite gave the most
reproducible results with lower and more stable blank volumes without
reducing the fluorescence of the lutines. In the presence of BAL the
shape of the fluorescence spectra was altered to give two peaks instead
of the single peak obtained with ascorbic acid. Haggendsl considered
that ascorbic acid obscured the peak at the lower wave length. These
two peaks viere very helpful, for identifying the catecholamines and
served as what can best be described as a "quality control" for the
fluorimetric reaction. However, the best wave lengths for the differ¬
ential equations were on either side of the second (original) peak.
1
It is important to avoid contact between solutions containing
BAL and other reagents involved in the T H I reaction in order to
prevent premature interference with the oxidation. Furthermore, BAL
is somewhat unpleasant to handle and should be kept in a fume cupboard.
Valori et al (1970) found, that solutions of BAL in sodium
sulphite were often cloudy which lead to what they described as
"quenching" (a term loosely used by many writers) and also variability
in the blanks. We also observed this cloudyness but found that it
could be minimised by vigorous mixing of the two reagents (BAL is not
very soluble) and by using fresh solutions which were not more than
two hours old. Reducing the concentration of BAL also prevented this
effect but as a consequence, the fluorophors were less stable and the
standards showed more variability. Valori and his colleagues investig¬
ated various reagents which would increase the solubility of BAL in
water in order to use a more concentrated solution and so dispense with
other antioxidants. They describe a technique in which a BAL-formal-
dehyae solution is used followed by glacial•acetic acid to bring the
final pH of the mixture to 5*3- We found that their stabilising mixture
rapidly became very dirty, produced poor fluorescence and used up large
quantities of BAL. However, it gave us the incentive to investigate
the effect on the final fluorescence of adding glacial acetic acid -
the use of which had been previously suggested by Dr. T.B.B. Crawford.
(r) Use of Glacial Acetic Acid Using our standard fluorimetric
reaction we added glacial acetic acid in 0.05 ml aliquots to the final
mixture and observed a shift in the fluorescence spectra. The first
peak was greatly diminished for both catecholamines. However, the
second peak for noradrenaline was reduced by about 20?o without affecting
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the adrenaline peak. The alteration in the relative sizes of the
second peaks (previously NA had been higher) greatly increased the
discrimination ox our assay. (Compare the diagrams of the fluorescence
scans, Figures 10-12). The shift was complete at pH 5 and at this pH
a change of 0.5 pH units either way had negligible effect. Furthermore,
unlike our previous alkaline fluorescence mixtures which faded with
time (this was very variable but was by about 20-30/ over by minutes)
the acidified samples could be read repeatedly over half an hour and
showed little tendency to fade.
(s) Blanks Background fluorescence from the reagents and from any
contaminants which were not removed by our purification procedure,
contributed to the measured fluorescence of our samples. Thus a "blank"
value was required in order to determine the fluorescence due solely to
the catecholamines.
A reagent blank is prepared for calc ulations with the standards.
For the sample blank, the fluorescence of the catecholamines must be
prevented without omitting any of the reagents. There are two possible
approaches :-
1. Non-oxidised blanks - The antioxidant/stabilising mixture (BAL)
sulphite is added before the oxidising solution (ferricyanide).
2. Faded blanks - The lutines are allowed to undergo further oxidation
to non-fluorescent derivatives. Oxidant and alkali are added
and the sample left for at least 10 minutes. Thus the cate¬
cholamine fluorescence has "faded" by the time the antioxidant/
stabilisation mixture is added.
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We found that the non-oxidised blanks showed catecholamine
presumablelyfluorescence peaks/aue to spontaneous oxidation during the neutralisation
of the column eluates. Haggendal suggested removing an aliquot from
the eluate prior to neutralisation in order to obtain satisfactory non-
oxidised blanks. however, it was simpler to use faded blanks and we
used these throughout our assays.
(t) Fluorescence reading and calculation
The intensity of the fluorescence emitted by the sample was
displayed on the linear scale of the Aminco-Bowman Photomultiplier '
Microphotometer. The scale is from 0 to 100 and is multiplied by the
setting on the Meter Multiplier switch which was calibrated in steps
from 0.001 (—0.003, 0.01,—) to 1.0. The latter switch was altered
for each individual sample's fluorescence so as to give the maximum
possible reading on the 0-100 scale. This minimised the error in
reading the meter for if the scale can be read to, say, one division,
error in
tilery the reading at 100 is "\°/o while at 10 it is 10?o.
In our set-up, the meter was linked to a Servoscribe pen
recorder which followed the deflection of the meter (The paper chart
was conveniently graduated from 0 to 100). The chart drive was
synchronised to the scanning motor switch on the Aminco-Bowman so that
the paper only moved when the scan was in progress. The scans v/ere
commenced at precisely 300 mji and the pen was always lined up with one
of the heavy (1 cm) lines on the Servoscribe paper. As the speed o?
the chart drive and wave length scanning motors were never altered, we
could determine the wave length of each position on a fluorescence trace
by its distance from the start of the scan, (see tracings of scans-
Figures 10-12). p 147 - 9
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We always superimposed the noradrenaline and adrenaline
standard traces on top of one another as this enables us to easily ■
assess the degree of differentiation. When choosing the two positions
to read the fluorescence intensity for the differential calculation, I
tried to keep a balance between obtaining the greatest possible ratio
between the two catecholamines and:-
1. Having a reasonably high intensity of fluorescence above
the blank value.
2. Avoiding interference from the scatter peak which was
around the emission wave length and became relatively
larger as the catecholamine content of the samples decreased.
The wave lengths chosen for each set of fluorimetric conditions
are shown in their respective fluorescent scans (Figures 10-12).
In my discussion I have used the concept of "Index of
Discrimination" by replacing "activity" with fluorescence intensity
(see Gaddum, 1959) to compare, our variant of the fluorimetric assay with
the techniques cn which it is based.
(i.e. Fluorescence intensity of A NA at the higher wave length ~ the
ratio at the lower wave length).
For the three sets of fluorimetric conditions which v/e used, the
Indices of Discrimination were
(a) No Acetic Acid: I. of D. = k
(b) Acetic Acid with emission wave length 500 nip.: I. of D. = 8
(c) Acetic Acid with emission wave length 520 mp: I. of D. = 13






To calculate the NA and A contents of the mixture, two
assumptions are made:-
(a) Trie relationship between intensity of fluorescence and concen¬
tration is linear.
(b) The fluorescence of the two catecholamines is additive.
N.B. The previous workers in the field and our own standard curves show
that these assumptions are justified for the range of concentrations with
which we were concerned.
For a catecholamine mixture a pair of simultaneous equations
can be built up using the standards and from these equations the amount
of NA and A present is calculated. (See Bertler et al 1958).
We wrote and used an Olivetti programme to solve these equations
when analysing our samples.
Discrimination of our assay
An appreciation of the ability of our assay to discriminate
between noradrenaline and adrenaline can be obtained by considering
1. The assay of known mixtures of standards.
2. The comparison of our technique with those from which it was derived .
1. Mixtures of standards
Two examples are given in which we used the technique without
Acetic Acid and thus the I.O.D. was four.
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MIXTURE CALCULATED
n A HA A NA
b 90 10 91.1 -u 0.5 7.3 _+ 1.5
L 70 30 71-3 + 1.5 27.0 _+ 1.8
b 50 50 52.8 + 1.1 49.8 + 0.9
b 30 70 . CM•IP-CM + 2.4 67.8 + 2.8
b 10 90 11.5 + 2.0 -d-•coco _+ •CM
10 90 10 88.5 1.4 9.2 -h 1.0
8 80 20 78.1 + 2.3 19.6 + 1.1
11 70 30 68.2 + 1.8 27.9 1.1
(Mean + S.D.)
2. Comparison with other techniques
All the three publications on which we based our assay give
examples of their standards and blanks and from these I have calculated
an I.O.D. for each case. p146
(a) Bertler et al
Wavelengths = 410/540 and 455/540 I.O.D. = 5
(b) Vendsalu
Wavelengths = 410/540 and 455/540 I.O.D. = 4
(c) Haggendal
Wavelengths = 400/515 and 450/515 I.O.D. = 7
Haggendal quotes uncorrected instrument values for his wave
lengths. From a comparison of his fluorescent ratios with our curves
it appears that his spectrophotofluorometer was calibrated slightly
differently to our machine and he was achieving a higher I. of D. by taking
his second reading at a longer wavelength. However, as a consequence,
the fluorescence was reduced and closer to the blank value.
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ISOLATED ADRENAL GLAKD PEPFUSION EXPERIMENTS
Introclaction
We decided to investigate whether our whole animal studies
were supported by the results obtained using isolated perfused adrenal
glands,
Firstly, there appeared to be a species difference between
the dog and the cat with respect to the distribution of muscarinic p 63
receptors in the adrenal medulla in parallel with the physiological
difference we had already investigated with regard to the baroreceptor
and chemoreceptor reflexes. Thus we compared the responses of dog
and cat adrenal glands to specific muscarinic and nicotinic stimulant
drugs. We chose acetyl f> methyl-choline as our muscarinic drug and
meta-hydroxy phenylpropyl trimethylammonium (hpp TMA) which Dr. R.B.
Barlow recommended as being a very specific nicotinic agonist.
Secondly, if we could show that corticosteroids,in the con¬
centrations expected within the adrenal medulla during stress, released
catecholamines, this would be a crucial piece of evidence in favour of
a humoral mechanism participating,via the anterior pituitary -
adrenocortical axis, in the control of the secretion of adrenal cate¬
cholamines .
Source of Glands
The animals were heparinised prior to removal of the glands
which were cannulated in a retrograde fashion via. the adrenolumbar vein. p16
It was acceptable to use a very small cannula for cannulating the adreno-
lumbar veins in the cats because the high resistance was now sited up¬
stream of the gland.
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The glands were either used that evening or stored overnight
in refrigerated (^°C) Locke's solution. In the latter case, they
responded better to drugs if they had been perfused for 10-20 minutes
prior to storage.
Perfusion
The glands were perfused with phosphate buffered Locke's p165
solution at a constant flow of 1 or 2 mis/minute delivered by a V/atson-
Marlow Pump. The Locke's solution was oxygenated and maintained at
37°C by passage through a heating coil connected to a water bath. A ,
pump circulated water through the coil and a jacket which surrounded
the gland. (Hie jacket and coil were taken from a Langendorff isolated
heart perfusion apparatus). The gland was suspended in a small glass
funnel (surrounded by the heating jacket) from which the effluent dripped.
In the early experiments, the effluent was collected by hand
for one minute intervals and the gland perfused at 1 ml/minute.
The main series of experiments used the on-line automated
assay system which we had developed. The gland was perfused at a flow
of 2 mis/minute and samples \^ere collected for 30 second periods by
using the moving conveyor belt of the Unicam AC60 Chemical Processing
Unit.
Drug Infusions
The gland was initially allowed to equilibrate with the
perfusate over a period of 1y to 2 hours. The drug tests were then
commenced with infusion times lasting between 1 and 10 minutes. In
each case sequential samples were collected before, during and after the
drug infusion at either thirty second intervals or continuously depending
on the duration of the drug infusion.
FIGURE 13.
ADRENAL GLAND PERFUSION SYSTEM
1 Watson Marlow pump
2 Heating coil 3 Bubble trap
4 Multitap - for perfusate change over
5 Cannula to gland (tied into adreno-lumbar vein)
6 Heating jacket
7 Funnel with portex tubing end piece
8 Track of AC 60 - holds sample collection tubes
NB This is the earlier arrangement when the Watson Marlow pump was sited
upstream of the multitap.
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The drugs were made up in Locke's solution, oxygenated ana
heated to 37°C in the water bath prior to and during the infusion.
The change-over from perfusion with Locke!s solution alone to that
containing a drug was achieved rapidly and smoothly by means of a single
lever action gang of three-way taps interconnected by a system of short
tubes. (This tap arrangement was taken from a semi-automatic reagent
delivery device - see photograph, Figure Y$). The mechanism ensured
that there was no interruption in the flow through the gland when the
perfusate was changed. Periodically we performed control changeover
tests using Locke's solution that did not contain drugs in order to
confirm that the actual change-over itself did not provoke a release of
catecholamines from the gland.
At least 15 minutes was allowed to elapse between individual
drug infusions so that the gland had returned to a steady resting output.
After repeated drug infusions a gradual fall off in the responsiveness
of the glands was observed. This varied from gland to gland but was
also reflected in a progressive reduction in the resting output.
Drug Infusion Protocol
(a) Studies on Selective Release
Tne following solutions were infused into both the dog and
the cat glands.
1. Acetyl j3 Methyl Choline (Methacholine)
Concentrations
-8 -h
Dog: 10 " - 10 Molar
-6 -It-
Cat: 10 - 10 Molar
2. M-hydroxyphenylpropyl trimethyl ammonium iodide (hpp TMA)
Concentrations:-
-8 -5
Dog: 10 - 10 J Molar





5 x 10 - 10 Molar
N.B. only used with cat glands.
All three drugs were infused for three minutes and the 30
second sample collections taken before, during and after the drug infusions.
Collection Schedule






























In the work on cat glands either Atropine (3 x 10 Molar) or
Hexamethorium (3 x 10 ' Molar) was added to the perfusion fluid in the
second part of the experiment and, after allowing at least 30 minutes
for equilibration, a series of drug tests was performed as above. The
agonist drugs were also made up in the Locke's solution which contained
the blocking drug.
(b) Studies on the humoral mechanism
These studies were performed only on dog glands. All
collections were made for 30 seconds with 30 second intervals between
collections. The following drugs were infused.:-
1. Hydrocortisone sodium succinate (Efcortelan - Glaxo)
Concentration
23 ug/ml - 200 ug/ml
Infusion time - 8 mins.
Collections - h controls
8 tests
3 recovery
2. Aldosterone (Aldocorten - Ciba)
Concentration
5 ug/ml - 20 ug/ml
Infusion time - 5 to 10 mins.





hO ug/ml - 100 ug/ml
Infusion time - 8 minutes
Collections - as for Hydrocortisone
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AOTOHAIEP GLAND ASSAY
Our initial work with isolated perfused adrenal glands was
done entirely by hand. Both the sample collection and fluorimetry was
done with "one eye on the stop-clock" while the drug - perfusate change-
overs involved turning a number of plastic three-way taps simultaneously
(we had not introduced the single action change-over device). The
technique was tedious and unless there were two or three participants,
each drug test took over an hour or else the samples had to be stored
in the freezer for assay at the end of the experiment. '
Apart from the obvious frustrations of this approach, the long
delay between drug test and result meant that the drug infusions had to
be done blind. Both,matching doses of different drugs so as to give
releases of equal magnitude and producing dose-response curves,were very
difficult.
A few automated techniques had already been published (e.g.
Fiorica (1965)» McCulloch (1968)) but these were all based on continuous
flow systems such as that used in the Technicion "Auto-Analyser". In
these,the samples are separated by bubbles as they move along a pipe
into which reagents are fed at intervals and then pass through a flow-
through cuvette. It is easy to use this type of system when the
reading of fluorescence is made only at the one wave length (i.e. to
determine the total catecholamine content of each sample). However, a
continuous flow system is unsuitable in a technique in which a scan has
to be performed or two wave lengths read as was necessary for our differ¬
ential assay. Thus for estimating the two catecholamines individually,
automated methods usually involve splitting the sample and make use of
two different oxidation pH's or stabilising reagents to prevent
fluorescence of one or other catecholamine (e.g. Merrils 19&5)• I
have already commented on the disadvantages of the latter types of
technique.
We wanted a system which would handle the samples discreetly
and then scan each one. A fluorescence curve not only gives the data
required for differential assay but also serves as a useful check on
the performance of each individual assay (i.e. from the shape of the
curve showing contamination, etc.).
A Unicam AC60 Chemical Pressing Unit was available and instead
of using one of the published continuous flow methods, we decided to
adapt this instrument to perform a modification of the manual technique
with which we already had much experience - (in any case there was no
hope of obtaining a Technicion "Auto-Analyser").
The AC60 is a discreet handling system in which a conveyor belt
carries test tubes containing the samples past a series of stations which
each add a reagent and then stir the mixture. One station has the added
facility of being able to transfer to each individual test tube a precise
amount of fluid from a plastic cup riding beside the tube. We used this
to dispense standards with great precision. When all the reagents have
been added, the AC 60 has a pick-up station designed to transfer the
final mixture to a flow-through cell. However, we did not attempt to
use this station as we did not have a flow-through cell for the Aminco
Bowman Spectrophotofluorometer.
The endless track (conveyor belt) consists of 120 sample
carriers which move on by one position every half a minute and thus the











f Plastic cup for standard
g Lead pin
Adrenal gland perfusion system
h Perfusate change over multitap
i Heating jacket with inner funnel - holds Adrenal gland
1
the stations. The reagents are dispersed by an ingenious mechanism,
whereby syringes are imc/ed pneumatically and the actual volume is
determined by the travel between two rigid metal templates. (Figure 1*f).
Each of the 120 carriers on the track can hold a small plastic
cup, a 5 ml test tube and an activating pin. Such a pin is placed
beside the first sample in a batch of tubes and "switches on" the
dispersing station as it passes. Similarly, a pin placed at the end
of the batch turns off the stations.
Sample Collection
We used the moving track of the AC 60 as a fraction collector
for the adrenal glandfe effluent and thus samples were collected over
thirty seconds (i.e. 1 ml).
Hie adrenal gland, surrounded by its heating jacket,was
suspended in a small funnel over the track. A short piece of Portex
tubing from the spout of the funnel was positioned' so that it just
touched the rims of the moving test tubes and thus prevented loss of
effluent as each tube moved on. (See diagram). A funnel attached to
a waste pipe was fixed beneath the collection point in order to catch
the effluent between collections.
Catecholamine Estimation
Once a.drug infusion test was completed the batch of tubes
was lined up as follows in preparation for the addition of reagents:-
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(i) Lead tube - a control collection which became the faded blank,
(ii) Reagent blank - Locke's solution (l ml) with drug which had not
perfused the gland -
(iii) Standard tubes - One for adrenaline and one for noradrenaline,
(iv) Samples - Before, during and after the drug infusions,
(v) Standard tubes - (as for iii).
A metal pin is placed beside the lead tube and another in the
position behind the last tube, which will later be occupied by the faded
blank tube .
Reagents
The concentrations of the reagents was altered from that used in
the manual technique in order that:
(a) The final volume would be sufficient for the tubes to be "read"
directly in the modified spectophotofluorometer cell.
(b) With each reagent, the volume added would be adequate to mix with
the solution already in the tube.
The reagents were as follows:
Addition
Concentration Volume Time
Phosphate buffered Locke's Solution















0.5 ml 0 mins
0.5 ml 5 mins
0.5 ml mins
0.4 ml 72 rains
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Blanks
A faded blank was most convenient as it could be incorporated
easily into the reagent delivery sequence. With the arrangement of
tubes described above, the first tube of a run received none of the BAL/
sodium sulphite mixture while the last tube received only this mixture.
Therefore, by transferring the lead tube to the end of the run after it
had passed all the stations, it received its BAL/sodium sulphite after
sufficient time had elapsed for its fluorescence to fade. We normally
took one of the control adrenal collections for the faded blank but
i
from time to time we used one of the collections taken during the drug
infusion in case the drug released fluorescent contaminants from the
gland.
Reagent blanks had 1 ml of the drug containing Locke's solution
which had not perfused the adrenal gland.
Standards
Tubes containing 1 ml of Locke's solution were prepared and
incorporated in the above described sequence alongside a small plastic
cup containing catecholamine standard solution (10 jig/ml). The AC 60
transferred a precise quantity of standard (200 mg) from the plastic cup
to the test tube.
We usually had two pairs of standards with each batch of samples -
one pair before and one after the samples.
Reading the Fluorescence
The AC 60 holds pyrex test tubes (12 x 75 ram) and these were
found to have no more absorbance than quartz in the range of the spectrum
covering the excitation and emission wavelengths for the differential assay.
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It was possible to modify the Amincc-Bowman spectrophotofluorometer
(using a plastic pill container) so that it would hold the round pyrex
tubes. (We took great care to rinse and wipe the outside of the tubes
before insertion into the Amineo-Bowman).
Thus we eliminated the potentially expensive and very time
consuming process of filling and rinsing quartz cuvettes..
Flaws in the pyrex tubes could be detected by rotating them
while in the fluorimeter and seeing if the fluorimeter reading was
affected. Any such tube would have been discarded but no flaws were
found. In addition,the tubes were found to be of constant diameter -
judged by their precise fit into the conveyor belt holes and the modified
cell on the Amineo-Bowman.
The manual transfer of samples to the Aminco-Bowman was so
simplified that it would have been pointless - (for our requirements)
to have attempted to use the automatic transfer system. The time
required to perform the fluorescence scan was now the limiting factor
in the assay.
SOME COMMENTS ON THE ISOLATED ADRENAL
GLAND PERFUSION SYSTEM
The retrograde perfusion of the adrenal gland via the adreno-
lum'bar vein was necessary because the gland is supplied by a multitude
of arteries v/hile there is, usually only one vein. Thus in order to
perfuse the gland through its arterial supply we would have had to
perfuse the adrenal glands,in situ,via the aorta. It was far easier
to cannulate the adreno-lumbar vein and avoid the various practical
problems involved in the routine use of a whole animal experiment.
Also, retrograde perfusions avoid the influence of any adrenocortical
mediated effects on the medulla.
Phosphate buffered Lockessolution was well established as an
adrenal perfusate and had been employed by both M. Vogt and W.W. Douglas.
Vogt (1965) considered that when using this perfusion technique the
"in vitro" responses to bradykinin and angiotension were much less than
are found "in vivo" but considered that the receptors sensitive to acetyl
choline and potassium ions survived well. Nahas (1970) recommended
using diluted homologous blood for the perfusion of the isolated dog-
adrenal gland as his electron microscope studies had shown that this
medium preserved the fine structure of the gland. However, the use of
the latter perfusate,or even a plasma substitute,would have necessitated
an extraction procedure prior to the fluorimetric assay.
The time taken to estimate samples would have been considerably
lengthened with a consequent reduction in the number of experiments
performed and loss of the "on-line" advantages of our automated assay.
N.B. An on-line assay could have been set up using a dialysis exchanger
coupled to a continuous flow analysis system (e.g. Technicion "Auto-
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"Auto-Analyser") but this combined with the more sophisticated circulation/
gland perfusion needed to justify the expensive perfusate, was economically
unfeasible. (G.G. Nahas works for the U.S. Army).
All adrenal gland perfusion systems can be criticised on the
grounds of being "artificial" or "unphysiological". We wanted to use
the results for our isolated gland experiments to back up our "whole
animal" research and we were well aware that the artificial perfusion
technique has its limitations.
Thus we chose our technique on the grounds of its simplicity
and capacity to perform on-line estimations which enabled us to do a great
many more estimations than would otherwise have been possible.
BUlbring, Burn & De Elio (19^9) report weighing their glands
at the end of the perfusion in order to estimate the loss of catecholamines.
Our glands tend to swell during perfusion and were often several hundred
milligrammes heavier by the end of the experiment.
We also determined itfhether our glands were hypoxic during
their perfusion with oxygenated Locke's solution. This was performed by
collecting the effluent under liquid paraffin. (i.e. immersing the gland
in a small pot containing liquid paraffin) and measuring the PO^ which
was usually over 70 torr.
At the end of some of our experiments, we perfused the gland
with Locke's solution containing either Gentian Violet or Tryp^an Blue.
Following formaldehyde fixation, paraffin wax sections (some stained
with haematoxylin and eosin) were made by the Department of Anatomy. We
found that the dye was always distributed evenly throughout the whole of
the adrenal medulla. The opinion of several experienced histologists
(eg. Edward Duvall - Sir William Dunn School of Pathology, Oxford) was
that the cells in the adrenal medulla appeared to have survived the
perfusion very well.
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I have displayed our results in graphical form. The details
of each individual experiment are recorded in the Tables at the end of
this thesis. p290
INVESTIGATION OF SELECTIVE ADRENAL CATECHOLAMINE RELEASE
I have described below how the results are grouped for the
two species and in each case I have given the mean _+ S.E.M.
The noradrenaline, adrenaline and total catecholamine outputs
are shown in ng/kg.min. for the whole animal and in ng/min. for the
isolated gland experiments. '
The percentage of noradrenaline in the total is displayed
in two forms
(a) Mean _+ S.E.M. of the individual estimations of the
noradrenaline percentage in the group. p223-4
(b) A value calculated from the mean noradrenaline and
total catecholamine output for the group.
DOGS - WHOLE ANIMAL EXPERIMENTS
The results displayed in Fig. 15 are taken from all our dog p-17
experiments and show the mean noradrenaline and adrenaline outputs during
o
the baroreceptor and chernoreceptor tests with their combined resting out¬
puts. We excluded those tests performed after the administration of a
drug (i.e. Synacthen, cycloheximide, hexamethonium, and atropine).
However, those tests performed after guanethidine administration were
included and we did not observe any effect of this drug on adrenal cate¬
cholamine output (resting or reflex release) in our experiments DR1-3- p1
168
CONTROLS
Baroreceptor and chemoreceptor resting outputs are combined.
*Control Output (n = 85)
Noradrenaline = 2.5 _+ 0.3 ng/kg.rnin.
Adrenaline = 11.5 _+ 1-1 ng/kg.min.
Total Catecholamine = 14.1 + 1.3 ng/kg.min.
NA % (a) 18.9 + 1.0 (b) 18
BARORECEPTOR TESTS
These were performed by lowering carotid sinus pressure from
142 + 2 to 80 _+ 1 mmhg while the carotid perfusion "blood parameters were:
P02 = 182 + 22 torr
PC02 = 41 +- 2 torr
pH = 7.33 + 0.01
*Incremental release during Baroreceptor stimulation (n = 36)
Noradrenaline = 4.4 _+ 0.8 ng/kg.min.
Adrenaline = 18.7 +: 3-9 ng/kg.min.
Total Catecholamine = 23-0 +_ 4.7 ng/kg.min.
NA % (a) 18.7+1.7 (b) 19
CHENORECEP'TOR TESTS
The releases that were measured during the first period of
prolonged chemoreceptor stimulation have been included.
The carotid sinus pressure was maintained at 1 42 _+ 2 mmHg and
during the test the blood perfusing the carotid bifurcation was changed
from:-
PO^ = 84 _+ 7 torr to PO^ = 34 _+ 3 torr
PC0o = 41 _+ 2 torr PC02 = 58 _+ 5 torr
pH = 7.34'+ 0.07 pH = 7-27+0.03
(Control) (Test)
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incremental release during Chemoreceptor stimulation (n = 17)
Noradrenaline = 2.1 jb 0.5 ng/kg.min.
Adrenaline = 11.0 _+ 3-5 ng/kg.min.
Total Catecholamine = 13-1 +_ 3-9 ng/kg.min.
NA % (a) 20.0 + 3.0 (b) 16
Incremental release during Chemoreceotor stimulation, including those
tests after Cycloheximde infusion (n = 23)
Noradrenaline = 2.b _+ 0.*f ng/kg.min.
Adrenaline = 12.8 2.7 ng/kg.min. ,
Total Catecholamine = 15-2 _+ 3-0 ng/kg.min.
NA % (a) 18.^ + 2.h (b) 16
ELECTRICAL STIMULATION p100
Noradrenaline = 37-8 _+ 10.6 ng/kg.min.
Adrenaline = 130.^ _+ 35-3 ng/kg.min.
Total Catecholamine = 168.2 _+ ^5-7 ng/kg.min.
NA % (a) 23-3 + 2.8 (b) 23
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DQGo - ISOLATED GLAND EXPERIMENTS
The results in the Thbles are expressed in ng/rain. as control
output and incremental release for each individual drug infusion. The
control output is the average of the three resting collections. (The
fourth control tube was used in the assay as the faded blank).
The incremental release was calculated by subtracting the mean
control output from the peak output per minute obtained during the drug
infusion.
For Fig. 16 which compares the proportions of adrenaline and p,17
noradrenaline released by the glands during stimulation with methacholine
and hpp TMA, we have used the incremental releases from all the isolated
gland experiments. The controls are the combined mean resting collections
from all the experiments.
*COMTROLS (n =*+6)
Noradrenaline = 81 _+ 11 ng/min.
Adrenaline = 30? +. 39 ng/min.
Total Catecholamine = 387 _+ ^9 ng/min.
NA % (a) 20.7 +1.0 (b) 21
INCREMENTAL RELEASE WITH hpp TMA (n = 23)
-8 -5
Dose =10 - 10 Molar
In order to have incremental releases of equivalent size with
the two drugs when drawing Figure 16, we excluded the releases over
3000 ng/min. p 339
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DOGS (cont)
*Excluding releases 3000 ng/min. (n = 18)
Noradrenaline =183+, kl ng/min.
Adrenaline = 57^ _+ 1*A ng/min.
Total Catecholamine = 737 + 180 ng/min.
NA % (a) 23.^+2.0 (b) 2k
Including releases 3000 ng/min. (n = 23)
Noradrenaline = 505 ,+120 ng/min.
i
Adrenaline =1517 +. J>k6 ng/min.
Total Catecholine =2021 _+ ^38 ng/min.
NA % (a) 25-^+1.6 (b) 25
*INCREMENTAL RELEASES WITH METHACHOLINE (n = 21)
Dose = 10"8 - 10"6 Molar
Noradrenaline = 13^ +, 30 ng/min.
Adrenaline = 36'i- _+ 7k ng/min.
Total Catecholamine = k98 +101 ng/min.
NA % (a) 2A.5 + 1.7 (b) 27
*Used in Figure 16.
Response to hpp TMA abolished by Hexamethonium (3 x 10 ^ M)
Response to Methacholine abolished by Atropine (3 x 10 ^ M)
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CATS - WHOLE ANIMAL EXPERIMENTS
Only the tests and controls collected before the administration
of hexamethonium and/or atropine are included. p176
CONTROLS
Baroreceptor and Chernoreceptor test controls are considered
together.
*Control output (n = 30)
Noradrenaline = 3-2 + 0.6 ng/kg»min.
Adrenaline = 3-0 +. O.k ng/kg.min.
Total Catecholamine = 6.1 + 0.8 ng/kg^rain.
NA % (a) 45.8 + *f.O (b) 32
BARORECEPTOR TESTS
These were performed by lowering carotid sinus pressure from
150 _+ 2 to 8^ _+ mmHg while the carotid perfusion blood parameters were:
PO^ = 208 _+ 26 torr
PC02 =27+1 torr
pH = 7-36 + o.oh
*Incremental release during Baroreceptor stimulation (n - ^\b)
Noradrenaline = 3-3 +. 0.7 ng/kg.min.
Adrenaline = 1.5 + O.'t ng/kg.min.
Total Catecholamine = k.8 _+ 0.8 ng/kg.min.
NA % (a) 73-5 + 3-9 (b) 70
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CATS CHBMORECSPTOR TESTS
The carotid sinus pressure was maintained at 1^9 + 3 mmHg and
during the test the carotid perfusion blood v/as changed from:-
PO^ = 262 _+ W7 torr to PO^ = 3^ +, 1^ torr
PC02 = 29 + 2 torr PC02 = 69 + 11 torr
pH = 7.38 + 0.03 pH = 6.79 + 0.03
(Control) (Test)
*Incremental release during Chemoreceptor stimulation (n - 10)
Noradrenaline = 5«2 _+ 3-2 ng/kg.min. f
Adrenaline = 12.8 _+ 6.1 ng/kg.min.
Total Catecholamine = 18.0 _+ 9-1 ng/kg.min.
NA % (a) 16.3+5.1 (b) 29
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CATS - ISOLATED GLAND EXPERIMENTS
The results are recorded in the Tables and calculated in the
same way as has been described for dogs. Figure 18 is based on the p178
incremental releases from all the isolated gland experiments, excluding
those tests performed after addition of Hexamethonium or Atropine to
the perfusing fluid. The controls are the combined resting collections
form all the experiments, again excluding those in which a blocking drug
is present.
*Control outputs (n = 52)
i
Noradrenaline = 27 _+ 3 ng/min.
Adrenaline = 36 6 ng/min.
Total Catecholamine . = 83 +. 9 ng/min.
NA % (a) 37.0+1.7 (b) 32
*Incremental releases with hpp TMA (n = 27)
Noradrenaline = 261 +_ 6k ng/min.
Adrenaline = 168 +_ 26 ng/min.
Total Catecholine - 429 + 87 ng/min.
NA % (a) 56.5 + 2.5 (b) 61
*Incremental releases with Methacholine (n = 23)
-6 -it-
Dose =5x10 - 10 Molar
Noradrenaline = 99 _+ 11 ng/min.
Adrenaline = 189 +. ^9 ng/min.
Total Catecholamine = 288 _+ 28 ng/nin.
NA % (a) 3k.k +1.5 (b) 3k
Response to hpp TMA abolished by Hexamethonium (3 x 10 ^ M)
Response to Methacholine abolished by Atropine (3 x 10 M)
*Used in Figure 18.
17 8
FIGURE 18.
ISOLATED ADRENAL GLAND EXPERIMSNTS
NA & A OUTPUTS at EE5T
and during NICOTINIC & MUSCARINIC stimulation
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We had, used the automated assay for all the isolated cat adrenal
gland work and were able to draw a log dose-response curve for both hpp-
TMA and methacholine. The results with the two drugs are shown in
Figure 19 and for each drug I have drawn
(a) A regression line using all our results (by the method of
least squares)
(b) The mean + S.E.M. for four of the doses
AT€*ISOLATEDGLANDS
PEAKC INCREMENT (ng/min) 1000- 500-
hppTMA




■THE EFFECTS OF MUSCARINIC AND NICOTINIC ANTAGONISTS IK CATS
1 ■ The Actions of Hexamethonium and Atropine on Catecholamine Re?Lease
from Isolated Cat Glands
(a) Hexame thonium
In glands and C6 Hexamethonium (3 x 10 ' M) v;as added to the
perfusing Locke's solution.
It was found.(see tables of results) to completely abolish the




In gland G7 Atropine (3 x 10 M) was added to the perfusing
fluid. This blocked release with Methacholine, while release still
occurred with hpp TMA and to a lesser extent with carbachol.
2. The Actions of Hexamethonium and Atropine on the Baroreceptor and
Chemoreceptor Reflexes in Cats
(a) Hexame thonium
- In Cat b and 5 we found that the blood pressure and adrenal
medullary responses to chemoreceptor stimulation were resistant to doses
of hexamethonium (2 - 6 mg /kg ) which abolished both these components
of the baroreceptor reflex. These results are shown in Figures 20-23.
In both these experiments, atropine administration after
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Atropine alone did not abolish the adrenal oi" the blood
pressure components of either reflex. Furthermore, in Cat 6 (see
Figure 2k) an adrenal medullary response to chemoreceptor stimulation
was only seen after atropine administration.
The phenomenon of selective release was still seen after
atropine administration. In Cat 6, following the first dose
(50 jag /kg ), the incremental releases contained 79% NA with the baro-
receptor and 98% with the chemoreceptor tests. (NB Nearly equivalent
sized releases of adrenaline). Similarly after the second dose
(1 mg /kg ), the baroreceptor reflex released 79% NA while the chemo¬
receptor reflex released 97°% NA and again the adrenaline releases were
almost equal.
Hexamethonium (2 mg /kg ) then almost abolished the adrenal
medullary component of the baroreceptor reflex while the chemoreceptor
release was halved and now contained 9"2% NA.
We then investigated the effect of synacthen (1 Id/kg ) on
the resting secretion. At the end of the experiment we obtained
releases with chemoreceptor stimulation which contained over 99% NA.
In Cat 7 although there was no adrenal medullary response to
chemoreceptor stimulation after atropine (100 ug /kg ), an equivalent
stimulus gave a release consisting solely of adrenaline following the
administration of another dose (1 mg /kg ). (See tables of results). p324
FIGURE2k.
ADRENAL OUTPUT (ng/kg.min) 0.0
m%in INCREMENT
Each,pairofcolumnsreprese ts NA&Aoutputs,withthees Outputs perimposedoncontrolfor:- B=aroreceptortes C=heraoreceptort s a=Controlwithoutreflextest
bC
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HUMORAL CONTROL OF ADRENAL CATECHOLAMINE OUTPUT
In brief our results show that:-
In Whole Animals
1. The release of catecholamines provoked by hypoxic carotid
chemoreceptor stimulation outlasts the stimulus and often continues
to rise after its cessation. (DC1 - DCS)
2. This delayed response is not abolished by denervation of
the adrenal medulla. (DC1)
3- Intravenous corticotrophin (Synacthen) produces a release
of catecholamines of similar magnitude and time course which also is
not abolished by denervation of the adrenal gland. (MB Other, workers
have shown that carotid chemoreceptor stimulation activates the anterior
pituitary-adrenocortical axis).
k. The delayed release of catecholamines in response to both
synacthen and to chemoreceptor stimulation is inhibited by cycloheximide,
which is known to block the release of adrenal steroids.
(NB We used the reflex release from baroreceptor tests as an index that in
our experiments cycloheximide \^as not blocking neuronally mediated
catecholamine release.
In Isolated Locke-Perfused. Adrenal Glands
5- The order of concentration of corticosteroids one would
expect in the adrenal gland during stress releases adrenal catecholamines.
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I have expressed in pictorial form the results of the
individual experiments done in this investigation as I consider this
to be clearer than a verbal description. (See Figures 26~3f?)• p 192-202
The details of each experiment can be found in the tables
of results. The experiments are described in the next section.
I
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WHOLE ANIMAL EXPERIMENTS P103-5
DA 1-3
These show the increase in resting output and potentiation
of the baroreceptor reflexes by Synacthen (l IU /kg ). (Figures.26-28)
DN 3
This shows that Synacthen (1 IU /kg. ) increases the cate¬
cholamine output from a denervated adrenal gland. We stimulated the
peripheral end of the greater splanchnic nerve but did not always
i
obtain a release.
This experiment demonstrated that Synacthen was not acting by
a neurally mediated mechanism e.g. potentiating transmission in the
CNS. (NB DN 3 is plotted as one of the six curves in Figure J>6). P 2 04
DC 1
A dog, with the left adrenal gland denervated was subjected
to a twenty minute period of chemoreceptor stimulation (PO^ = 32 torr)
and this was followed by a three fold increase in catecholamine output
which rose to a peak thirty minutes af-ter the cessation of the chemo¬
receptor stimulus. The denervation was confirmed by the abolition
of the immediate reflex responses to baroreceptor (or cheraoreceptor)
stimulation. (Figure 29). P196
DC 8
The dog had its right adrenal gland,(i.e. gland not used for
blood collection) denervated and was subjected to a ten minute period
of chemoreceptor stimulation (PO^ = 22 torr).
131
A massive reflex release was seen in response to the chemo-
receptor stimulus and the resting output was raised by five fold, ten
minutes after the end of the stimulus. (Figure 29). This experiment
was to exclude the possibility that circulating catecholamines released
from the right adrenal gland by chemoreceptor stimulation were activating
the anterior pituitary-adrenocortical axis.
DC 2-7
The protocol is detailed in the section on methods. The p105
magnitude of the maintained release after the end of the first chemo- t
receptor stimulus appears to be dependent on the degree of hypoxia p 206
achieved. (See Figure 37)- After the administration of cycloheximide
a more severe hypoxic chemoreceptor.stimulus did not result in a main¬
tained catecholamine release. (Figures 30~3^ )• p 197- 201
We used the response to the baroreceptor reflex as an index
of adreno-rnedullary secretory capacity before and after cycloheximide.
There is no evidence that the immediate response to baroreceptor or
chemoreceptor stimulation was impaired by cycloheximide.
At the end of experiments DC 5-7 Synacthen (l IJJ../kg ) was
given and although a response was always detected, it was very much
reduced compared to those experiments without cycloheximide.





































































































































































































































DN 3 Crossbred Collie Sheepdogs
DC 2-8
I
We noticed that the humoral type response after Synacthen
and prolonged chemoreceptor stimulation had a different timecourse in
the two "breeds" of dog. The response of the crossbred collies was
more rapid and of shorter duration than with the greyhounds. I have




THRESHOLD OF THE HUKORALLY MEDIATED ADRENAL MEDULLAR!
RESPONSE TO CHEMOREGEPTOR STIMULATION
We wanted to see if there was a relationship between the degre
of hypoxia achieved during the period of prolonged chemoreceptor stim¬
ulation and the magnitude of the humorally mediated component of the
adrenal response.
For each experiment (DC 1-8) I calculated the peak increment
of the maintained adrenal response by subtracting the mean resting out¬
put before chemoreceptor stimulation (i.e. the controls) from'the maxi¬
mum resting output measured after the end of the prolonged chemoreceptor
stimulus. (KB Only that half of the experiment before cycloheximide
administration was considered).
The increments have been plotted against the logarithm of the
minimum PO^ reached during the chemoreceptor stimulus. I also plotted
the ratio of the peak increment to the mean control resting output
against the logarithm of the minimum PO^- (Upper graph in Figure 37)*














ACTION OF CORTICOSTEROIDS ON ISOLATED PERFUSED
CANINE ADRENAL GLANDS
The responses to the eight minute periods of corticosteroid
infusion are recorded in the tables of results as the control output
before infusion of the drug and:-
(a) The peak incremental release.
(b) The average incremental release over the four minute period
of peak response.
These outputs are given as total catecholamines in ng /min
/
The percentage of noradrenaline in the control output and in
the average increment (b) are also shown.
Hydrocortisone P348- 350
The 11 glands which had been obtained from heparinised
animals, under pentobarbitone anaesthesia, fall into two groups
(a) "Unstressed" Glands from freshly anaesthetised dogs
killed by exsanguination.
(b) "Stressed" Glands from animals that had been subjected
to an acute cardiovascular experiment lasting k - 8 hours.
These'two groups are plotted in Figure 38. For each group
at three different concentrations of hydrocortisone, I have plotted the
mean _+ S.E.M. of the average incremental release. p209
20
(a) Unstressed Glands






Mf _+ 14 ng /min (n = 9)
286 _+ 53 ng /min (n = 8)
635 +, 92 ng /min (n =10)
(b) Stressed Glands






6k _+ k6 ng /min (n = k)
i
186 _+ 59 ng /min (n = 5)
301 + ^9 ng /min (n = 3)
Aldosterone P351
In three glands (A9, A10, and A11), which were responsive to
the above order of concentration of hydrocortisone, no response was seen
with aldosterone in concentrations of 5 - 20 ug /ml.
Deoxycorticosterone p352
D.O.C. was shown to release adrenal catecholamines (n - 6)
in 3 glands, in concentrations of kO - 100 ug /ml.
Cycloheximide
We subjected three glands to ten minutes perfusion with Loc1<e's
solution containing cycloheximide (l mg/ml.) and observed no change in
the output of catecholamines.
FIGURE38. INCREMENTAL TOTALCA OUTP(ng/min)
750-I 500 230











OBSERVATIONS ON ADRENAL BLOOD FLOW IN OUR WHOLE ANIMAL EXPERIMENTS
Adrenal Blood Flow After Synacthen Administration
Other irorkers had reported that adrenal blood flow increases
following Synacthen administration (e.g. Edwards, Hardy and Malinowska,
1975)- I have plotted the adrenal flows in experiments DA 1-3 and
DN 3 (Figure 39) and in each case there is a tendency for the flow to
rise after Synacthen was given.
These graphs also show that the adrenal blood flows were
maintained reasonably well throughout the main part of these experiments.
This ivas in spite of a gradual fall in blood pressure and is probably '
in part, due to the decreasing viscosity (and haematocrit) of the blood
as the losses were replaced by Dextran.
Adrenal Blood Flow Response to Splanchnic Nerve Stimulation
For DN 1-3 I have shown the ratio of the adrenal blood flow
during nerve stimulation to that flow during the control collection
(Figure AO). Most points lie on the unity line and, thus, there appears
to be no appreciable change in gland resistance during splanchnic nerve
stimulation.
Reflex Vasoconstriction in Adrenal Gland During Baroreceptor Tests
We had performed a large number of baroreceptor tests in the
dog and I thought that it would be interesting to see if there was any
change in adrenal gland vascular resistance during these tests. The
blood vessels might have responded passively to the reflex increase in
systemic blood pressure and thus dilated with a consequent decrease in
resistance. On the other hand, the sympathetic innervation to the
adrenal blood vessels could have increased adrenal vascular resistance
FTOTFRE 39.
SYSTEMIC BLOOD PRESSURE AND ADRENAL BLOOD FLOW DURING CONTROL COLLECTIONS IN k DOGS
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as part of the vasoconstrictor response to a fall in carotid sinus
pressure.
Our available data was the systemic blood pressure and the
adrenal blood flow before and. during the tests. Since the.resistance
of the dog adrenal glands and collecting tubing would vary with each
experiment, I have plotted for each test the ratio of the systemic
blood pressure during, to that before the test against the ratio of
the adrenal flow during to that before the test (Figure ). Pressure
is directly proportional to flow at constant resistance and thus, if
there is no change in resistance during the test, the points should lie
around the line at ^5° to both axis (i.e. the line with a gradient of
one ).
However, most points lie below this line (ignore tests
performed after cycloheximide) and thus there must have been an increase
in adrenal gland resistance during the baroreceptor tests. This is
most likely to be due to sympathetic vasoconstriction.
Cycloheximide appears to abolish any reflex vasoconstriction
in the gland as the points tend to lie on or above the bissecting line.
The latter would be expected if there was passive dilatation in response
to the rise in blood pressure. It does not seem to be a generalised
effect on vasoconstriction as the systemic blood pressure responses to
baroreceptor tests are not abolished by cycloheximide.
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FIGURE Vi.
Change in adrenal blood
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ADRENAL BLOOD FLOW, CORTICOSTEROID CONCENTRATION
AND CATECHOLAMINE OUTPUT
Our isolated gland experiments had demonstrated that the
secretion of catecholamines from the adrenal medulla was influenced by
the concentration of corticosteroids perfusing the gland. In the
intact animal this concentration is determined not only by the release .
the
of corticosteroids from/adrenal cortex but also by the blood flow
through the gland. Thus the transient increase in flow during a
baroreceptor test would be expected to reduce any Immorally mediated ,
component of catecholamine secretion. Normally this phenomenorn would
tend to be obscured by the neuronally mediated catecholamine release in
response to the reflex stimulus. However, in experiment DC 1 the
adrenal gland was denervated and during the period of the delayed release
the catecholamine output can be seen to fall in response to the reflex
tests. (See Figure 29). p196
I have also looked for evidence of the effects of adrenal
gland flow on catecholamine output in our other two experiments in which
serial baroreceptor tests were superimposed upon a Immorally mediated
adrenal response. (i.e. DA 1 and DA 2)
By making two assumptions, I predicted the expected size of the
output during the baroreceptor tests which were performed after corti-
cotrophin administration. One was that our experimental conditions ^l^ere
sufficiently stable and our baroreceptor tests were sufficiently re¬
producible, for us to assume that any change in resting or test output
was due to the corticotrophin administration. (See controls for DA 1 p193-4
and DA 2). The other was that the increased concentration of corti¬
costeroid would potentiate by the same factor, both the resting output
and the reflex release.
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I have plotted for DA 1 and DA 2 the ratio of each test out¬
put after Synacthen to the mean of the test outputs before Synacthen
against the ratio of each control collection to the mean of the pre-
Synacthen controls. (i.e. I have plotted B f Bra against C ^ Cm see
Figure h2).
For each test, using the C f Cm axis, I have also plotted
the increase in flow as the ratio of the test flow to the control flow.
(F 1 Fm)
In DA 1, there is a negligible change in flow during the
baroreceptor tests and the points are seen to lie on the V?° line which
is to be as expected if the resting and test catecholamine outputs are
potentiated equally.
However, in DA 2, in which the flow nearly doubles during the
tests, the test catecholamine outputs are seen to he less than predicted.
In a situation of stress involving hypotension, not only will
there be an increased coricosteroid release but also the fall in gland
blood flow will further increase the concentration of steroids in the
blood perfusing the adrenal medulla.
Walker, Zileli, Reutter, Shoemaker, Friend and Moore (1959)
had published three experiments in which they subjected dogs to haem-
orrhagic shock by initially removing over 500 mis. of blood. I have
shown their results in Figure hj> as total catecholamine output and
adrenal venous plasma 11 - hydroxycorticosteroid concentration. (I
assumed a haemocrit of ^0% to convert from their whole blood concentrations)
In each experiment the blood pressure was maintained constant at 80 mm Hg
after bleeding and it is interesting to note how the fluctuations in
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catecholamine output parallel the changes in corticosteroid secretion.
This is only circumstantial evidence but, as the stressful stimulus
apparently remained constant there .is no obvious reason why catecholamine
release should follow the Immorally controlled adrenocortical response-
if the former is solely neuronally mediated.
It was very unfortunate that it was impractical for us to
measure corticosteroid as well as catecholamine output at the time we
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EFFECT OF ADRENOCORTICAL ACTIVATION ON THE PERCENTAGE OF NORADRENALINE
IN ADRENAL CAT5CH0LAMINS OUTPUT -TAKEN"FROM DAI - 5 and DCl"HB"
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Within the limitations of our experimental conditions
(i.e. anaesthetised animals and isolated perfused adrenal glands) our
results demonstrate that:-
I. In Both Species
1. The carotid baroreceptor and chemoreceptor reflexes can
individually evoke the secretion of adrenal catecholamines.
2. Both nicotinic and muscarinic stimulant drugs can release
catecholamines from isolated adrenal glands and the responses
to these drugs can be blocked by hexamethonium and atropine
respectively.
II. In Dogs
No evidence for selective release was found.
1. The incremental releases mediated by the baroreceptor and
chemoreceptor reflexes and by splanchnic nerve stimulation cont¬
ained the same proportion of noradrenaline to adrenaline (i.e. 1:^0
Furthermore it was equal to that found in the resting (i.e. control)
output.
2. This proportion of noradrenaline to adrenaline was also
found in the increments released in response to nicotinic and
muscarinic stimulation.
III. In Cats
In this species we found evidence of selective catecholamine
release with both reflex and pharmacological stimulation.
1 * Baroreceptcr stimulation released an increment containing
predominantly noradrenaline (75% noradrenaline).
2. Chemoreceptor stimulation released an increment containing
predominantly adrenaline ("\G% noradrenaline).
3. Both of the mean percentages were significantly different
%
(P< 0.01) from one another and from that in the resting output
which contained h-6% noradrenaline.
h. Nicotinic (hppTmA) stimulation released an increment which
contained significantly (PC. 0.01) more noradrenaline (.57% nor¬
adrenaline) than that released by muscarinic (methacholine)
stimulation (5b% noradrenaline). However, at none of the doses
tested was there any evidence that either drug released solely
one catecholamine.
These results suggest that with respect to the above reflexes
and drugs, there is a species difference between the dog and the cat
regarding the selective release of adrenal catecholamines (See Figures kk
and b5)„
They are in agreement with the conclusions we reached after
surveying the previous experimental work which has been published in
our field. I have already discussed these studies in my Introduction
and shall now only make some quantitative comparisons between them and
our own observations.
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Resting Secretion in our \<rhole animal experiments (Dogs)
Much has been written on whether or not there is a resting
"physiological" secretion from the adrenal medulla and about the effects
of various experimental procedures and anaesthetics on this resting out¬
put (e.g. von Euler, 1956, De Schaepdryver 1959)- Our resting output p168
was 1*r _+ 1 ng/kg. min, and I have listed the "resting" outputs found
by some previous workers.
TOTAL CATECHOLAMINE
Workers Anaesthesia ng/kg.min
Wada et al (1955) Conscious 20
Lund (1951) Chloralose-Barbiturate 9
Rapela & Houssay (1952) Chloralose 13
Satake (1955) Conscious 25
De Schaepdryver (1959) Chloralose 6-26
Malmejac (196*0 Chloralose h6
Kayaalp + Mclsaac (1968) Pentobarbitone *f
Wurtman et al (1968) Pentobarbitone 9
Reflex Release in our whole animal experiments (Dogs)
Our incremental releases in response to the carotid baroreceptor
and chemoreceptor reflexes were 23 _+ 5 and 15+3 ng/kg.min respectively. p168
had found
Not surprisingly these were much smaller than previous workers/who used
such stimuli as haemorhagic hypotension and asphyxia, (e.g. Rapela and
Houssay 1952 - asphyxia gave an output of h~57 ng/kg.min.) It has been
our intention to use discrete reflex stimuli because we considered that
these were more likely to reveal any capacity for selective release than
the powerful stimuli in which the adrenal gland was "driven" to near maximum.
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De Schaepdryver (1959) who used the more discrete stimulus of
carotid occlusion obtained a similar sized incremental release of
14 ng/kg.min.
The incremental output in response to insulin hypoglycaemia
found by Wurtman et al,(l968) was also of equivalent magnitude (39 ng/kg.min)
to our discrete reflex stimuli.
We used electrical stimulation of the greater splanchnic nerve
in order to examine the output from the adrenal gland under more intense
stimulation than that mediated by the two carotid reflexes. With this stronger
stimulus our mean incremental release of 168 ng/kg.min (range is up to p169
ng/kg.min) is comparable with that obtained by other workers e.g.
Rapela and Houssay (1952b) - 308 ng/kg.min5 De Schaepdryver (1959) -
350 ng/kg.min. Thus in the dog we were able to compare three different
types of stimuli which gave mean incremental release from 11 to 168
mean
ng/kg.min. However, even with this fifteen fold range of/releases,
there was no evidence of a significant deviation from the 1:b nor¬
adrenaline to adrenaline ratio.
Pharmacological Stimulation in our Isolated gland experiments (Dogs)
The mean resting output from our perfused adrenal glands was p171
387 ng/min and this is well within the wide range of the control outputs
quoted by Vogt (1965)- Stimulation of the splanchnic nerve to her
isolated Locke-perfused glands gave incremental releases ranging from
838 to 5300 ng/min which overlaps with our responses to hppTmA. In the
spinal dogs of Kayaalp and Mclsaac (1968), intra-aortic injections of
microgram quantities of the following drugs gave mean releases of:-
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Acetyl Choline 1.1 ug/min. (21.3 +. 10.9/ NA)
DMPP 1.5 ug/min. (29.6 + 13.6/ NA)
Methacholine 2.2 ug/min. (t-0.5 +. 13*3/ NA)
(NB. The concentrations of the drugs perfusing their glands cannot
be determined).
These figures compare with our mean incremental release of p172
757 ng/min. with hppTmA (2020 ng/rnin. when releases over 3000 ng/min.
were included) and that with methacholine of ^98 ng/min. I have
commented in the Introduction that Kayaalp and Mclsaac's mean value p'65
of kG% noradrenaline in the increment released by methacholine is not
significantly different from the mean of 21/ noradrenaline in the
release with their nicotinic agonist.
IN GATS
Resting Secretion in our whole animal experiments (Cats)
Our control output was 6 ng/kg.min and contained ho% nor¬
adrenaline . p 174
Fuerstein and Gutman (1971 ) who also used pentobarbitone
anaesthetised cats and a very similar assay (see Introduction) reported p60
a resting output of 5-6 ng/kg.min but it contained only 18/ noradrenaline.
The higher adrenaline percentage which they found may have been the result
of hypoxia throughout their experiments as they do not mention putting
their animals on artificial ventilation and/or oxygen after they had
opened the abdomen.
Grant et al (1958) present some very interesting observations p59
on the influence of anaesthesia on "resting" adrenal catecholamine out¬
put. Their cats were subjected to hypothalamic stimulation and they
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admit that their animals were suffering from asphyxia, blood loss and
other stresses. I have calculated the following figures from the
data which they publish
Anaesthetic Resting Output ng/kg.min
A NA %k
Chloralose-Urethane 60 _+ 20 h^O _+ 80 11 _+ 2
Urethane ?0 + 10 180 + 30 33 + ^
Dial kO + 10 2000 + *f00 2 + 0.3
N.B. The three noradrenaline outputs are all significantly different
(p )> 0.01) from one another. (NB. means +S.E.M.)
The overall resting output is very much higher than that found
in Fuerstein and Gutman's and our own experiments. However, those
earlier workers who used chloralose anaesthesia report "resting" outputs
of over 190 ng/kg.min which contained between 71-81$ noradrenaline.
(Kaindl and von Euler 1951; Brucke, Kaindl and Mayer 1952; von Euler
and Folkow 1953; Folkow and von Euler, 195*0-
The finding by Grant et al that Dial anaesthesia was associated
with a considerably greater noradrenaline output than was chloralose
and/or urethane, could be explained by selective depression of the baro-
receptor reflex by the latter two anaesthetics - as demonstrated for
chloralose by Neil, Redwood and Schweitzer (19^9)* However, this is
**" f — A
pure speculation and is not supported by the results of Duner (.1953/?
who, in cats under pentobarbitone anaesthesia,obtained a resting output
of 78 ng/kg.min containing noradrenaline.
Reflex Release in our whole animal experiments (Cats)
Our incremental releases from selective reflex stimulation
are of the same order of magnitude as those obtained with similar stimuli
by other workers who used pentobarbitone anaesthesia (i.e. Fuerstein and
Gufcman, 1971 and Puner, 195*0-
(J -C
Fuerstein and Gutman found that during acute haemorrhage,
the adrenal catecholamine output rose by 61 mg/kg.min while after a
slower rate of bleeding it rose by 11 ng/kg.min and in both cases
the increment contained at least noradrenaline. (These figures
compare with the increment of 5 ng/kg.min containing 75?^ noradrenaline
which was obtained during our baroreceptor tests. p174
Duner observed releases in the order of 30 ng/kg.min during
hypoglycaemia in the cat but it took over forty minutes - (with a
steadily falling blood glucose) to reach this output. However, Kaindl
and von Euler employed chloralose anaesthesia and usually found that the
incremental release from bilaterial carotid occlusion was between 50 and
200 ng/kg.min.
This order of magnitude difference in the responses to reflex
stimulation may be due to the nature of the anaesthesia and for this
reason we would have liked to perform some experiments in decerebrate
animals.
Duner and Kaindl and von Euler assayed their adrenal venous
serum directly on the cat's blood pressure and fowl's rectal caecum.
Kaindl and von Buler describe using peripheral blood samples to show
that blood had no effect of its own on the test preparations.
However, their adrenal samples would have had high and probably
variable concentrations of corticosteroids and I wonder if they took into
account the potentiation by corticosteroids of trie smooth muscle responses
to catecholamines. (See Review by Ramey ana Goldstein, 1957)»
N.B. The permissive role of corticosteroids in the response of tissues
to catecholamines is worth bearing in mind when interpreting some of the
early work on adrenal discharge in which the responses to stimuli were
compared before and after adrenalectomy.
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Pharmacological Stimulation in our isolated gland experiments (Cats;
Douglas and Poisner (1965) observed that stimulation with
nicotine yielded an increment of about 3500 ng/min which consisted of
55% noradrenaline. Hie increment obtained with pilocarpine was about
1500 ng/min and contained k% noradrenaline/'muscarine released a mixture
containing 16/ noradrenaline - These figures compare with our incre¬
ment of ^29 ng/min (.57% noradrenaline) using hppTmA and that of 238 ng/min
(3^% noradrenaline) using methacholine. p 177
Douglas and Poisner make no mention of their standard errors <
and do not give the resting outputs from their glands. It is very
probable that, like us, they found the basal secretion of the isolated
perfused cat adrenal gland to be very low.
Hexamethonium resistance of the Cat chemoreceptor reflex P 181
Our results from Cats k and 5 indicate that both the blood
pressure and adrenal medullary responses to chemoreceptor stimulation
are resistant to doses of hexamethonium (2-6 mg/kg) which abolish both
these components of the baroreceptor reflex.
Furthermore,Tenney (1956) found in cats that hexamethonium
did not inhibit the adrenal catecholamine discharge nor the brisk hyper¬
tensive response to breathing 12-33/ carbon dioxide.
We found these observations fascinating as they are compatible
with the idea that the chemoreceptor reflex may be transmitted via
predominantly muscarinic receptors while the baroreceptor reflex is
transmitted via nicotinic receptors. The evidence for this hypothesis
is as follows:-
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1. Our work has shown in the cat that the chemoreceptor reflex releases
predominantly adrenaline while the baroreceptor reflex releases pre¬
dominantly noradrenaline from the adrenal medulla.
2. We have confirmed the work of Douglas's group which has shown that
muscarinic stimulation releases predominantly adrenaline while nicotinic
stimulation releases a greater proportion of noradrenaline from the
adrenal medulla.
3. Professor James Black*- (various personal communications) has some
evidence that in comparison with nicotinic agonists, the specific muscarinic
(Rosykowski 1961)
ganglion receptor agonist, McNeil A - 3^35/has relatively greater
constrictor effect on veins than on arteries. For this x^ork, he used
the constant volume (i.e. equal inflow and outflow) capacitance technique
on loops of cat small intestine, (see p.283)
k. Finally, there is evidence from the work of Pelletier, Shepherd
and Webb - Peploe (see Pelletier 1972, Pelletier and Shepherd 1972 and
Webb - Peploe and Shepherd 1968) that the carotid chemoreceptor reflex has
a greater influence on hind limb veins than has the baroreceptor reflex.
These experiments were performed on dogs and I will refer to this later.
One can see two distinct patterns connecting these four separate
sets of observations which are:
(a) chemoreceptors - muscarinic receptors - adrenaline - veins
(b) baroreceptors - nicotinic receptors - noradrenaline - arteries
Furthermore, an important observation from our pharmacological
studies on cat glands was that,although muscarinic and nicotinic stim¬
ulation released different proportions of the two catecholamines, there
was no evidence,at any dose, that either of the agonists released only one
catecholamine.
* J.W. Black Dept. of Pharmacology, University College London.
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Therefore, it seems unlikely that the difference in the
distribution of the two types of receptor is simply related to whether
the adrenal medullary cells are noradrenaline or adrenaline secreting.
On the other hand, the proportions of the two catecholamines released
with pharmacological stimuli are similar to those released in response
to reflex stimulation and thus it is probable that the distribution
of muscarinic and nicotinic receptors is related to the two different
reflex pathways. The selective inhibition by hexamethonium of the
predominantly noradrenaline releasing, and presumably nicotinic, bar-
4
roceptor reflex while leaving the predominantly adrenaline releasing
chemoreceptor response undiminished, is further evidence for the existence
of two different pathways.
However, atropine in doses up to 1 mg/kg did not block either
the adrenal or the blood pressure response to chemoreceptor stimulation.
Thus it seems unlikely that the pathway is only via muscarinic receptors.
Perhaps in the cat, the chemoreceptor pathway has both types of receptor
while the baroreceptor reflex is via nicotinic receptors alone.
Although we have found no evidence of selective catecholamine
release in the Dog, there is evidence to suggest that in this species as
well,there is some difference between the two carotid reflex pathways
in the distribution of nicotinic and muscarinic receptors.
I have already mentioned the work of Shepherd's group on dogs p231
regarding the relatively greater influences of the baroreceptor.and chemo-
<x
receptor reflexes on arterial resistance and venous capfcitance respectively.
This', fits in with Black's resultsusing specific ganglion agonists in cats.
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Furthermore, we have observed in dogs that the systemic blood
pressure and hind limb vasoconstrictor responses (constant flow arterial
perfusion technique) to carotid chemoreceptor stimulation, but not the baro-
receptor reflex, is hexaraethonium (2-6 mg/Kg) resistant in a manner similar
to that observed in cats.
Ungar reports having blocked the hexamethonium resistant component
in dogs with atropine but it required very large doses (50 mg/Kg) which
were one hundred times that necessary to block the cardiac effects of the
vagus. Thus, there appears to be a difference between the ganglionic and
the more peripheral types of muscarinic receptors, with regard to the action ,
of atropine which is possibly due to a difference in the affinity constants
at the two types of receptor. This may explain our failure to block the
chemoreceptor reflex in cats with atropine alone when using doses up to
1 mg/Kg.
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HUKORALLY MEDIATED BELEASE EXPEHIMSNTS.
Our evidence for the participation of a humoral component, via
the anterior pituitary-adrenocortical axis, in the control of canine
adrenal catecholamine output can be divided into six parts.
1). We found that the release of catecholamines provoked by chemo-
receptor stimulation outlasts the stimulus and usually continues to rise
after its cessation, (see DC1-8). p190
2). This delayed component of the adrenal catecholamine discharge
6
m response to chemoreceptor stimulation was seen in a denervated gland.
Denervation abolished the immediate catecholamine release in response to
chemoreceptor stimulation and the baroreceptor reflex, (see DC1).
3). Chemoreceptor stimulation has been shown by others (Anichkov
et al i960, Marotta 1972) to release corticotrophin from the pituitary
gland.
k). We found that intravenous Synacthen releases catecholamines from
both intact (see DA1-3) and denervated adrenal glands (see DN3)- p190
5). The delay/release of catecholamines in response to both Synacthen
(sesBC5-7) and chemoreceptor stimulation (seeBC2-7) is inhibited by
p202
cycloheximide (see Figure 35/)which has been shown to block steroid secretion
(Garren, Ney & Davis 1965). There was no evidence that cycloheximide had
any effect on neuronally mediated adrenal medyfary release and it did not
appear to influence the immediate response to either chemoreceptor stimulation
or the baroreceptor reflex (see graphs of the individual experiments).
Furthermore, the output from isolated perfused adrenal glands (n=3 ) was
unaffect by ten minutes of perfusion with the drug at a concentration
(i.e. 1mg/ml.) well above its predicted maximum blood level.
OK
M 0 0
6). Hydrocortisone in concentrations between 30 and 150 ug/ml. was P20
shown to increase the catecholamine output from the isolated Locke perfused
adrenal gland in a dose dependent manner, (see Figure 38). A study of the
literature put this order of concentration in perspective. In dogs during
stress or after corticotrophin administration, the adrenal venous plasma
concentration of corticosteroids (mainly hydrocortisone) is in the range
10-20 ug/ml. However, not all the blood passing through the gland goes
through the cortex-medullary portal system as the gland has direct through
channels such as the arteriae medullae. Thus it is very probable that the
steroid concentrations in the cortical blood bathing the meduary cells are
i
higher than those in the adrenal vein and well within the range 30-150 ug/ml.
The amount of free hydrocortisone in the peripheral blood is
very dependent on the concentration and degree of saturation of the hormone's
main transport protein, transcortin. However, the latter's binding sites
are completely saturated by concentrations of hydrocortisone above *K)0 ng/ml
plasma and thus the binding protein will not significantly affect the conc¬
entration of free glucocorticoid in the blood perfusing the adrenal medulla.
It is possible that the artificial conditions of our isolated
gland preparation altered its sensitivity to corticosteroids. However,
the work of Vogt (1965) indicates that our perfusion technique would have been
more likely to reduce rather than increase the sensitivity of the adrenal
medullary cells.
Catecholamines have been shown to release corticotropin from
the anterior pituitary (Vogt 19^ & Long 1952) and this is one explanation
for the signs of Gushing's syndrome seen in some patients with phaeo-
chromocytoma. (Another explanation is the production of corticotrophin-
like peptides by the tumour). These symptoms disappear on remoxral of the
tumour (Williams et al 1960). We therefore, considered the possibility
that in our experiments corticotrophin \/as being released by catecholamines
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secreted from the other adrenal gland during the chemorecepter stimulus.
This mechanism was excluded by an experiment in which, with the other (i.e.
right) adrenal gland denervated, prolonged chemoreceptor stimulation still
gave the typical maintained output from the cannulated gland (DC 8).
We performed all these experiments on dogs and thus it is only
in this species that we have evidence of a hormonal component participating
in adrenal catecholamine control.
The association of phaeochromocytoma and Gushing's syndrome has
led to some patients with phaeochromocytoma being subjected to tests of
anterior pituitary-adrenocortical function and deaths due to severe
hypertensive crisis have followed the administration of corticotrophin to
such patients, (Moorhead, Caldwell, Kelly and Morales, 1966 ; Cowley,
Montgomery■and Wellbourn, 1970 ). These deaths.can be explained by our own
observations. Not only have we demonstrated the release of adrenal catech¬
olamines in response to Synacthen but we have also shown that deoxycortico¬
sterone (DOC), in the order of concentration that we expect in the adrenal
gland after 11-B-hydroxylation inhibition by metyrapone (see Jenkins et. al.
1958) , had a similar action to hydrocortisone on isolated adrenal glands. P:
Furthermore, corticosteroids are known to potentiate the peripheral action
of catecholamines, (Kamey and Goldstein,1957)
Bloom, Edwards, Hardy and Malinowska (1976) have recently presented
some work in which they claim that the response of the adrenal medulla to
chemoreceptor stimulation is trivial, as well as finding no evidence in
favour of a delayed humoral type component. However, they were using five
week old calves and a technique very different to that employed in our
experiments. It entailed subjecting conscious animals, each wearing a
helmet, to periods (up to ten minutes) of pure nitrogen breathing. This
is not a pure chemoreceptor stimulus, and as the calves were not vagotomised
it is very probable that secondary reflexes, such as those from lung stretch
receptors, were involved. Their conclusions regarding the threshold of
their small adrenal medullary response to hypoxia are probably unjustified
because of the non-steady state conditions existing at the commencement
of nitrogen breathing. The arterial oxygen tension would have been falling
rapidly at the time when they detected the adrenal catecholamine discharge.
Furthermore, in their calves, the adrenal medulla would not have
been fully mature (see West 1955) and examination of the earlier work
from their laboratory (Comline and Silver 1966) shows that around the time
of birth, the adrenal medulla of the calf undergoes profound changes in
its response to hypoxia and related stimuli. The degree of methylation
is known to be related to maturity and appears to depend on the cortical
supply of glucocorticoids (see p. 69)
Thus comparisons between our experiments in adult dogs and their
work on asphyxiated conscious calves may not be all that useful. This is
especially so when one considers that, due to the presence of an intact
vagus, secondary reflexes may influence the primary chemoreceptor reflex
to the adrenal medulla in a fashion similar to the modification of the
vasoconstrictor response.
However, it is interesting to note that the time course of the
adrenocortical response to ten minutes of anoxia in the calf is very
similar to/cfieRange in catecholamine secretion which we observed in the
dog in response to corticotrophin and chemoreceptor stimulation. They
also comment that the extent of this increase in corticosteroid output
vi
was equivalent to that/after supramaximal doses of ACTH in calves of the
same age.
In an earlier paper (Edwards et. al. 1975)? they describe how
the administration of cycloheximide (10 mg/Kg intravenously) inhibited the
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steroidogenesis but riot the increase in adrenal blood flow in response to
an infusion of Synacthen.
I have already discussed the evidence that the amount of the
methylating enzyme, PNMT, in the adrenal medulla is dependent on the delivery
of very high concentrations of glucocorticoids from the cortex (see p. 69)
We suggest that as catecholamine release may induce the synthesis of a new
enzyme protein, the levels of methylating enzyme in the medulla may be
related to the supply of cortical glucocorticoids through the mechanism
of catecholamine release. This is compatible with the observation that
tyrosine hydroxylase levels also fall after hypophysectomy and with a half (
life less than that of the fall after denervation (Mueller, Thoenen and
Axelrod 1970).
We wondered whether glucocorticoids could have a preferential
effect on adrenal secretion and alter the one to four, noradrenaline to
adrenaline ratio. Thus it is interesting that the mean percentages of
noradrenaline in the resting outputs after corticotrophin (17-2 +_ 1.2$) p220
are significantly lower (P<0.05) than those in the control resting output
(20.0 _+ 1.1$). However, in keeping with our results on selective release
there was no significant difference between the mean noradrenaline per¬
centages in the neuronal releases mediated by the baroreceptor reflex
before and after corticotrophin or prolonged chemoreceptor stimulation
(see p. 220 ).
Our analysis of the minimum blood oxygen tension reached during
the prolonged chemoreceptor stimulus and the size of the consequent
delayed release, indicates that the threshold of the 'humoral response
is around 50 torr (see figure 37)- As our animals were anaesthetised and
only the carotid chemoreceptors were subjected to the stimulus, the
threshold may be higher in the intact animal. It is interesting to note
that during periods of exercise, chronic bronchitics often have arterial
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tensions well below 50 torn (King et. al.)
However, significant activation of the neuronal pathway to the
adrenal medulla seemed to require oxygen tensions of around 20-30 torr and
it appears that there are at least three mechanisms through which the
adrenal glands may respond to hypoxia.
Firstly there is the humoral pathway, involving the anterior
pituitary- adrenocortical axis.
Secondly, with more severe hypoxia there is the neuronal reflex
which can come into play immediately in the emergency situation, (c.f. the
body's response to a raised carbon dioxide tension via the central and
i
peripheral chemoreceptors).
Finally, there is the possibility of a direct effect of hypoxia
on the adrenal medulla but I have seen no convincing evidence that this




A BOLE 01' CIRCULATING NORADRENALINE
OUTLINE
In man, noradrenaline is the predominant catecholamine found
in peripheral arterial and venous blood during rest and exercise.
Over the last few years, it has been established that the main source
of this noradrenaline is the peripheral adrenergic nerves and we
wondered whether noradrenaline released from noradrenergic neurones
has a role as a circulating hormone.
On bringing together the results from a number of studies
concerned with exercise and ventilation, we found good evidence to
suggest that during moderate exercise, arterial noradrenaline reaches
concentrations where it is altering the sensitivity of the chemo-
receptors to hypoxia.
We also thought that the metabolic actions of catecholamines
might explain some observations made during a study on the respiratory
response to exercise in patients with chronic respiratory failure.
However, before expanding these two themes, I shall attempt
to put studies on peripheral plasma catecholamines in perspective.
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INTRODUCTION
Sources of the Noradrenaline in the Blood
Assays of the catecholamine content of human adrenal glands
which have been obtained from the post mortem room give a noradrenaline
to adrenaline ratio of one to four.(see Von Euler 1956 p. 11.1)
A few studies have been performed on samples taken from the
adrenal vein during abdominal operations and these show that adrenaline
is the predominant catecholamine secreted by the .adrenal gland. Less
than one quarter of the total catecholamine in peripheral arterial and
venous blood is adrenaline and thus the noradrenaline of adrenal origin
must represent under ten percent of that which is circulating.
(eg. Seron, Stoppa, Plane & Bianchi 1958)
Furthermore, there is no detectable fall in noradrenaline
excretion on denervation or removal of the adrenal glands while on the
other hand, these procedures greatly reduce adrenaline excretion to
levels where discrimination from the noradrenaline becomes unreliable,
(eg. Von Euler, Frahksson & Hellstrom 195^+a-b)
N.B. To my knowledge, no one has attempted to set up a human isolated
perfused adrenal gland preparation.
Sampling Sites
In any study on peripheral blood catecholamine levels, the
choice of sampling site is of fundamental importance since there are
efficient uptake mechanisms for both hormones.
Over 90% of an infusion of noradrenaline or adrenaline disappears
on passing through peripheral vasculature such as skin or skeletal muscle.
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This was shown by Celander and Kellander (1955) who compared the
systemic effects of catecholamine infusions given either close
arterially or intravenously. Vane's group have obtained similar
results with studies on several vascular territories (see Vane 19°9)
and have also used their superfusion assay technique to demonstrate
that adrenaline passes unchanged through the pulmonary circulation
while 20-30^ of noradrenaline is taken un by the lungs (Ginn and Vane
1968).
Whitby, Axelrod and Weil-Malherbe (1961) studied the uptake
of an injection of radioactively labelled noradrenaline and adrenaline.
Although they found a preferential concentration of noradrenaline
compared to adrenaline in the lungs, very little of the radioactivity
was detected in skeletal muscle. The distribution of the cardiac out¬
put probably determined the sites of uptake and much more activity was
found in the heart, spleen and glandular tissue.
Physiological quantities of adrenaline and noradrenaline appear
to be almost completely removed from the blood within a couple of
circulations which is in agreement with the values determined for their
half life of 2y minutes in man (Vendsalu i960), and under twenty seconds
in cats (Ferreira and Vane 1967).
Many workers cite peripheral venous concentrations as indices
of "circulating" catecholamine levels. However, such a sample will be
dominated by the noradrenaline released from the skin and muscle drained
by the superficial vein (e.g. ante-cubital) subjected to venepuncture.
Thus any changes detected only represent alterations in local sympathetic
activity and possibly the effects of blood flow and metabolites on uptake,and
243
as such may be very interesting but do not reflect overall sympathetic
activity nor act as an index of adrenal medullary discharge.
We were intending to investigate the role of circulating
catecholamines as hormones and thus wanted to know their concentration
in the arterial blood which perfuses the target organs.
A possible sampling site would have been the right atrium.
However, as well as ethical and practical difficulties, there is good
evidence that separate streams of blood extend through the right side
of the heart as far as the branches of the pulmonary arteries (Claude f
Bernard 1865» Torrance and Ungar 1959). Furthermore, if pulmonary
catecholamine uptake varies with cardiac output, mixed venous blood
may not provide a reliable measure of arterial levels.
We therefore took arterial samples from a catheter in the
brachial artery (the Department of Medicine was experienced with this
procedure).
The results of other workers and the significance of the reported adrenaline
levels
Mean Peripheral Plasma Levels of Adrenaline and Noradrenaline in
Resting Subjects determined by the THI Method
Adrenaline Noradrenaline
ng/rnl (+SE) ng/ml (+SE)
Arterial Venous Arterial Venous
Price & Price (1957) 0.10 + 0.10 0.01 + 0.07 0.20 + 0.12 0.3*f +0.15
Cohen and Goldenberg
(1957) - 0.06 + 0.05 - 0.03 + 0.07
PVendsalu (i960) 0.23 + 0.02 0.07 + 0.01 0.31 +. 0.02 O.kO + 0.02
Valori, Renzini &
Brunori (1970) - 0.066 + 0.013 - 0.17^ + 0.02A-
H&ggendal (1963) 0.3 _+ 0.1
o
L,
Under most circumstances, HSggendal was unable to detect
adrenaline in arterial and venous blood and says "... probably less
than about 20% of the actual value quoted is likely to be adrenaline"
(HHggendal, Hartley and Saltin 1970).
Holtzbauer and Vogt (195^) using bioassay were only able
to state that adrenaline was less than 0.06 ng/ml in venous plasma.
However, the other groups mentioned in the table do give
adrenaline values but one would be aware of the following points when
considering such results:-
(a) These estimations are very near the limit of sensitivity of the
trihydroxyindole technique
(b) The discrimination of this type of differential assay becomes
unreliable when one of the pair of substances is in excess of
90% of the total (Gaddum 1959)
(c) As a consequence of skin and muscle uptake one would only expect
to find a tenth of the already low arterial adrenaline concentration
in peripheral venous samples.
The situation is different when there is a considerable adrenal
discharge as is seen during insulin hypoglycaemia. Vendsalu (i960)
published a graph showing a pronounced rise in peripheral venous
adrenaline concentration following insulin administration with no change
in the noradrenaline level. HMggendal (13o3) also finds adrenaline in
venous plasma after insulin administration as did Miller (1956 - using
the ethylene diamine method), and Holzbauer and Vogt (195^ - using bio¬
assay). Tims it appears that when arterial adrenaline levels are
sufficiently raised a measurable amount is found in the peripheral venous
blood, (Adrenaline is known to dilate skeletal muscle through-channels
and this may enable a proportion to bypass the uptake mechanisms),
Although most reports of resting arterial adrenaline levels
and venous levels during stress probably have some significance, I am
very sceptical of some of the more recent clinical publications and
especially those based on the double isotope derivative technique,
- (I have already discussed the limitations of this method with regard
to differential assay.)
Noradrenaline and alterations in the sensitivity to hypoxia
Asmussen and Nielson (1958) found that the respiratory minute
volume is greater in hypoxic than in normoxic exercise by an amount
which increases with the intensity of the work- Furthermore, a degree
of hypoxia which would have no effect on an individual at rest leads to
an increase in ventilation when the subject is exercising and this
increase is a function of the work load.
It is well established that arterial catecholamine levels
increase with exercise and this is supported by studies on venous blood
and urinary excretion (see below).
Cunningham, Kay, Patrick and Lloyd (19&3) showed that intra¬
venous infusions of noradrenaline stimulated ventilation under hypoxia
but not hyperoxic conditions.
Vie wondered whether the increase in arterial noradrenaline
found during exercise could explain the potentiation of the ventilatory
response to hypoxia.
From the data of Asmussen and Nielson one sees that an increase
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in ventilation with hypoxia only becomes noticeable above a V of
2
about 1-J l/rain and at 2-g- 1/min the increase is 71/»« (The rise in pH
and fall in PaGO? resulting from the hyperventilation in these experi¬
ments would tend to decrease chemoreceptor responses to hypoxia).
Arterial noradrenaline rises with increasing (Hfiggendal,
Hartley and Saltin 1970) and this agrees with studies using venous
plasma (Vendsalu 1960, Bannister and Griffiths 1972) and urinary output
(see von Euler 1969)- Significant adrenal discharge appears to occur
only with prolonged, or severe exercise (von Euler 19^9)»
With oxygen consumptions up to about 2 1/min, HSggendal et al
(1970) found that arterial noradrenaline concentration rose gradually
to just over 1 ng/ml. However, above this Vq the rise was much more
steep and at 3 1/min the concentration was over ng/ml.
It was also in the 2-3 1/min range that the hypoxic and
normoxic curves show a marked divergence on the minute volume against
oxygen consumption graph of Asmussen and Nielson (1958).
The latter authors used 12.6/ 0^ as a hypoxic stimulus which
would give a PaO^ of 38 torr (under normal atmospheric conditions).
At a higher PaO (around ^5 torr) Cunningham et al (1963) found that
an intravenous infusion of noradrenaline (10 ug/min) more than doubled
ventilation.
We calculated that in the human subject, this rate of intra¬
venous infusion would give an increase in arterial plasma noradrenaline
of 2-J - 3-J ng/ml.
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i.e. By assuming:-
Cardiac output = 5 1/min
Haemotrocit =
20 - 30/ uptake by the lungs
90/ uptake by the tissues, e.g. skeletal muscle, liver etc.
A noradrenaline infusion of 10 ug/min is being mixed with a cardiac
output of 5 1/min
Arterial Blood concentration = 2 ng/ml
Arterial Plasma concentration = 3.6 ng/ml
As 10/ recirculates and 20-30/ is removed by the lungs it seems
reasonable to assume that the above circulated plasma concentration is
attenuated by 20/.
Predicted plasma concentration of the infused noradrenaline^
3.0 ng/ml
Most users of the Trihydroxyinaole catecholamine assay technique
quote resting arterial plasma noradrenaline concentrations ox 0.2-Q.3 ng/ml
(e.g. Vendsalu (19^0), Price and Price (1957)).
Thus we would expect the steady state arterial noradrenaline
concentration achieved in the experiments of Cunningham et al (19&3) to
be in the same range as HSggendal et al (1970) found at the higher work
loads of up to 3 1/min.
Now, Cunningham's group found that this concentration of
arterial noradrenaline resulted in a doubling of ventilation at arterial
oxygen tensions of about ^5 torr.
Thus the levels of between 2-h ng/ml that would be expected at
a Vq of 2-g 1/rain (HAfggandal et al 1970) might explain the 70/ increase
o
4,
in ventilation that Asmussen and Nielson (1958} observed in response
to hypoxia at this work load.
The respiratory group at the Department of Medicine, Royal
Infirmary, Edinburgh had investigated the respiratory responses of a
group of patients in chronic respiratoru failure to breathing air and
a 30% oxygen mixture while at rest and exercising on the treadmill,
(King, Cooke, Leitch and Flenley 19735• These patients were chronically
hypoxic even when at rest (mean PaO^ = ^9 torr) and light exercise
resulted in an even lower arterial oxygen tension (mean PaO^ = ^2 torr).
King et al (1973) made a number of interesting observations
when they compared hypoxic exercise (i.e. when air breathing) with that
done at an identical treadmill speed but with the hypoxia relieved by
breathing 30$£ oxygen. (The order of air and 3C$ oxygen breathing was
randomly allocated). During hypoxic exercise the following parameters
were higher than when the patients were breathing Z'0/o oxygen:
1. Minute volume
2. Carbon Dioxide output
3. Respiratory exchange ratio
h. Plasma lactate concentration
However, the lactate to pyruvate ratios iirere not significantly
different and thus there appeared to be no change in the balance of
aerobic to anaerobic respiration during the hypoxic period.
On the other hand when the patients were at rest none of the
above four parameters was significantly affected by the change in gas
mixtures.
o
It had been shown in a similar group of patients at rest
that plasma catecholamines were two to three times normal levels,
(Keller, Lohmann and Schuren 19?'')• These estimations were made on
resting subjects and we thought it likely that exercise would further
elevate catecholamine levels. This would then be a possible explan¬
ation for the potentiation of ventilation by hypoxia (i.e. the increased
minute volume) while the patients of King et al (1973) were exercising.
Metabolic Effects
Catecholamine infusions have been shorn by many workers to
have metabolic effects such as raising plasma lactate and free fatty acid
levels as well as increasing oxygen consumption (e.g. Nahas 1970). The
combination of exercise with the hypoxic drive from the chemoreceptors
may have lead to considerable sympathetic and adrenal medullary activ¬
ation during the periods of hypoxic exercise. We wondered whether this
might explain the changes in carbon dioxide outpiit and plasma lactate
concentration. One possibility was that the increase in plasma lactate
would displace carbon dioxide from the bicarbonate buffer system. (in
their discussion, King et al (1973) consider that any changes in carbon
dioxide output due to the altered minute volume influencing the work of
breathing or body* carbon dioxide stores, would be too small to account
for the discrepancy between the two types of exercise).
The Department of Medicine was planning a series of experiments
to look at the effects of breathing 11% oxygen on normal subjects exer¬
cising at work loads of 1 and 1y litres oxygen per minute- They were
attempting to produce similar hypoxic conditions to those experienced by
the patients while breathing air. Although we could not persuade them
to try a higher work load at which any effect of catecholamines would
be more clear cut, (i.e. the 2-3 l/min range - see above discussion of
Hfiggendal et al 1970 and Asmussen and Nielson 1958) we agreed to co¬
operate in the project and measure catecholamine concentrations in the
arterial blood samples.
METHODS
Four healthy non-athletic men, aged 22-40 years, gave in¬
formed consent to the study. A catheter was inserted into the left
brachial artery to enable arterial blood sampling for measurement of
blood gas tensions, pH, lactate, pyruvate and catecholamines. We
determined minute ventilation, oxygen uptake and carbon dioxide output
and continuously recorded end tidal oxygen and carbon dioxide tensions
using a Varian M3 mass spectrometer. All measurements were made both
at rest, when standing and during the 7th, 23rd and 26th minute of
/
steady state treadmill walking. Two differential treadmill speed
settings were employed, both when breathing oxygen (balance nitrogen)
and when breathing air. Each subject walked for four separate 30
minute periods in the day, with intervals of at least 30 minutes rest.
The subject did not know what gas he was breathing.
The various respiratory and arterial blood parameters (except
catecholamines) were determined in the Department of Medicine. The





We used the method which I have described for the assay of p129
catecholamines in adrenal venous blood. The catecholamine concentration
in peripheral arterial or venous plasma taken from the resting subject,
is in the range 0.2 - O.^f ng/ml. We therefore expected our 10 ml
blood samples to contain 1-5 ng of catecholamine and thus made the
following modifications to our standard method in order to increase
sensitivity.
1. Cleanliness '
The greatest of care was taken when washing glassware or
handling the columns and all the reagents were freshly prepared (i.e.
I did it all myself).
This was necessary in order to
(a) Seduce the blank value to a minimum








The catecholamine-containing eluate (k mis of IN HC1) from the
columns was evaoporated to dryness under vacuum at pQ^C - by means ox
an Evapomix.
Under these conditions the hydrochloric acid looses water until
about 8N when both HC1 and water are lost together.
L, J
The concentration of catecholamines by evaporation to dryness
under vacuum in acid conditions had been used by Vogt (1952). As I
mentioned earlier, catecholamines are very stable under acid conditions
especially when no oxidising agents ( eg. oxygen) are present.
We found that providing the temperature was kept below 35°C
which necessitated great care with the vacuum seals, the recovery of
this stage was always over 90%.
I spent some time trying to improve on this figure and examined
the effect:
1. Polyethylene glycol - addition of 20 pi prior to evaporation
2. Ethanol (used in Vogt's technique) - addition of 1 ml prior to
evaporation
3. Neutralisation prior to evaporation
k. Evaporation down to 0.5 ml instead of to dryness - followed by
neutralisation
These modifications did not improve the recovery and only made
the technique more tedious as well as raising the blank values. The
small catecholamine loss may have been due to adsorption onto the glass
or due to spray formation during evaporation.
k. Fluorimetry
We were able to use the same centrifuge tube for collecting the
eluate, evaporation and fluorimetry.
Immediately the vacuum had been released the following was
done to each of the samples:-
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(a) 200 u'l of 1M phosphate buffer (pH 6.5) added. We used 1M buffer
instead of 0.1M in case any hydrogen chloride remained in the tube
(the fluorimetry was unaffected by the use of more concentrated buffer).
(b) 1, A ml water added.
(c) Solution "whirlymixed" for at least 1 minute - to ensure that all
the catecholamine was dissolved.
(d) pH tested - if less than pH 6.5 (which very rarely happened), it
was neutralised by dropwise addition of potassium bicarbonate (IN).
(e) 0.8 ml of the sample was transferred to another centrifuge tube
i
(i.e. sample halved).
(f) 20 ul CuGl^ was added to each tube.
(g) Our standard fluorimetric procedure as previously described was p139
performed with one tube of each pair becoming the faded blank.
(h) The photomultiplier of the spectophotofluorimeter was switched to
maximum gain and which resulted in some "random noise" on the
traces and so we scanned each sample twice.
Comment on the Assay
1. It concentrated the sample 3"J times more than the technique used
for adrenal venous samples.
2. Duplicate estimations could not be performed (however, we had found
that there was little variation between duplicates when assaying
adrenal venous samples).
3. The fluorescent spectra of the arterial plasma samples showed the
characteristic "double peak" of catecholamines.
^i-. At the wavelengths used for the differential assay the fluorescent
spectra of the resting arterial plasma samples was 2-3 times the
faded blank value.
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5- Recovery experiments - We obtained a recovery of 8k _+ 6% (S.D. n = 8)
when 10 ng of noradrenaline was added to 10 mis of plasma.
6. I could never detect any adrenaline and assumed that it was less
than 15a> of the total catecholamine content in a similar fashion
to H&ggendal. (H&ggendal et al 1970).
7. This is not the ideal assay for peripheral plasma catecholamines
and I am well aware of its limitations. However, it was the only
one we had available and as I have already discussed, no other P120
chemical method appears to be any better (especially with regard
i
to differentiation between noradrenaline and adrenaline).
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RESULTS
The arterial blood gas tensions, pH and plasma noradrenaline
concentrations, the minute ventilation (%,) and oxygen consumption (V )E - 02
for each period while standing and the mean values for each exercise
period are shown in the table. P264-5
Ventilation
At rest the minute ventilation was not consistently altered
by the breathing of y\k% oxygen.
In each subject during exercise the minute ventilation was
greater at both levels of exercise when breathing ~\k% oxygen than when
breathing air.
4
The regression equations for the V_ - V„ relationships duringili















500 1,000 1,500 2,000
For the hypoxic line:
V02 mls/min STPD
= (0.032 + 0.003)V_ - (2.03 + b-,26)
Correlation coefficient = 0.91
For the normoxic line:-
Vr, = (0.020 + 0.00'+)% + (5.15 + *U26)ill — —
Correlation coefficient = 0.8^+
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The 95%" confidence limits of these lines overlap when is
less than 1100 ml/min but are clearly separated when is 1500 ml/min
showing Vg is significantly greater during hypoxia at the higher exercise
levels.
The mean arterial oxygen tensions during the two hypoxic
exercise periods were similar but one subject hyperventilated during
hypoxia when walking at 2.0 m/s. He achieved the highest minute
ventilation and arterial noradrenaline concentrations, had a respiratory
exchange ratio of 1.3 but did not have the highest oxygen uptake. He
also hyperventilated during hypoxia when standing and his respiratory
exchange ratio was then 1
Catecholamines
NORADRENALINE - When the subjects were standing, the plasma noradrenaline
concentrations were consistently greater when breathing oxygen than
when breathing air but the differences were not statistically significant
(P <" 0.1). Walking at 1.5 m/s while breathing oxygen or air did not
significantly elevate plasma noradrenaline but plasma noradrenaline was
significantly elevated (P,<0.01) when subjects walked at 2.0 m/s breathing
1 oxygen. Normoxic walking at 2.0 rn/s did not significantly elevate
plasma noradrenaline (P ( 0.1).
ADRENALINE - The adrenaline concentrations did not appear to exceed 15%
of the total catecholamines in any of our experiments and so remained
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FIGURE 48.
Metabolic Indices
For interest, I have plotted the following graphs
1. R.Q. against plasma Noradrenaline (Fig. 49a) p261
All the respiratory quotients and their corresponding plasma
noradrenaline values have been used. There appears to be a linear
relation between the R.Q,. and the plasma noradrenaline concentration.
2. Increase in lactate against increase in pyruvate (ratios) (Fig. 49b)
The ratio of the plasma lactate while breathing the hypoxic gas
mixture to that while on air is plotted against the corresponding ratio
for the change in pyruvate with hypoxia.
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The points fall on the v5° line and thus it appears that there
was no consistent change in the proportion of aerobic to anaerobic
metabolism on altering the composition of the inhaled gas mixture.
3. Plasma lactate against plasma noradrenaline (Pig- 50a) p262
Here I have examined the effect of the change in the gas mixture
on the plasma concentration of lactate and noradrenaline. Different
symbols have been used for the two irork loads and the arrows point to
the values measured during hypoxia.
i
At the higher work load, the period of hypoxia was accompanied
by a consistent elevation of the plasma concentrations of both lactate
and noradrenaline.
However, at the lower work load, the switch to hypoxia did not
appear to be associated with any consistent change in either of these
plasma values.
k. Increase with hypoxia in the plasma lactate against that in the
plasma noradrenaline (Fig- 50b)
The elevations in the plasma concentrations of lactate and nor¬
adrenaline which were seen during hypoxia have been plotted against one
another and the arrows now show the increase in the work load.
The elevations of both the plasma lactate and the plasma nor¬
adrenaline were consistently greater at the higher work load.
5- Excess carbon dioxide output during hypoxia against the increase in
plasma noradrenaline with hypoxia (Fig. 51a) p263
There appeared to be an increase ixi carbon dioxide production
while the exercising subjects were breathing the '\b% oxygen mixture.
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We use the term excess carbon dioxide output to represent the
difference between the observed and the expected carbon dioxide outputs
during hypoxia. The expected V was the product of the V_ measured
2 ~ 2
during hypoxia and the R.Q. calculated from the values obtained during
the normoxic period at the same 'work load.
The excess carbon dioxide output has been plotted against the
difference between the plasma noradrenaline concentration during hypoxia
and that during normoxia.
6. Excess carbon dioxide output against the increase in plasma lactate(Fig. 51
The excess carbon dioxide output values used in the previous
graph are now plotted against the increase in the plasma concentration
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The changes in the various metabolic indices whichwere seen on
altering the composition of the inspired gas mixture while the subjects
were exercising at uhe higher work load, are interesting and deserve
further investigation. One can speculate that the increased plasma cate¬
cholamine concentration has a metabolic effect and possibly the excess
carbon dioxide output is a consequence of the addition of more lactic
acid to the blood.
Our results are compatible with the arguments put forward in
this appendix's introduction that increased concentrations of arterial
plasma noradrenaline contributed to the hypoxic potentiation of the
respiratory response to moderate exercise. We found that during hypoxic
exercise at a of about 1-J l/min, the noradrenaline concentrations were
double those when the Vq was around 1 l/min and it was only at the higher
treadmill speed that the V was significantly greater during the hypoxiaiii
compared to normoxic conditions.
At gas tensions very similar to those prevailing during our
periods of hypoxic exercise Patrick (196*0 found that a noradrenaline
infusion of 5 ug/min increased ventilation by about 50%. We estimate
(see P-2*f7) that this infusion rate would have resulted in a rise in
arterial catecholamine concentration of between 1 and 1-g- ng/ml which
is twice that observed in our experiments.
Thus, in our experiments, the elevated arterial noradrenaline
concentration may have contributed to the 25% increase in ventilation




FURTHER STUDIES ON PERIPHERAL PLASMA. CATECHOLAMINE ASSAY
I have described in Appendix I on our studies in Man how p252
the method for the quantitative estimation of catecholamines in adrenal
venous blood was applied to peripheral arterial plasma.
The main problem we had to overcome when assaying these
samples was the large final volume of eluate mis) i^hich would contain
only a few nanograms of catecholamine. The "Evapomix" successfully
concentrated the catecholamines and the overall recoxrery of the technique
was above 8GP/0 (e.g. 8b _+ 6%). However, the technique is unsuitable
for routine use because of the care required in using the "Evapomix".
We also tried freeze drying the samples prior to fluorimetry. This was
satisfactory, giving recoveries of over 90% for this step, but depended
on the availability of a freeze drier.
In looking for an alternative technique for the estimation of
adrenaline and noradrenaline in peripheral blood, we had two main
objectives:
1. To use as small an eluting volume as possible so as to achieve
maximum concentration of catecholamines.
2. To reduce the blank value.
We were also concerned with finding a technique which could
be performed using our existing apparatus and was simple enough for
routine vise by a technician.
We first tried to obtain more concentrated eluates by:-
(a) Eluting with stronger acid
(b) Reducing the length of the columns
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(a) Elution with stronger acid
Using catecholamine standards, we found that 1 ml of A-N HC1
would completely elute catecholamines from 2 cm columns (Amberlite
CG-120), yielding recoveries of over 9G%.
On applying this technique directly to peripheral plasma,
recognisable catecholamine fluorescence curves were obtained but the
blanks were very high and variable and some of the eluates were cloudy
(this could not be completely removed by centrifugation).
(b) Reduced volume of resin
Using pure standard solutions, we confirmed that only 2mls
of 1N HC1 are required to completely elute the catecholamines from 1cm
columns. However, the ionic content of 10 mis of plasma is sufficient
to wash k0% of the catecholamine off this size of column, hence this
approach to the reduction in elution volume is unsatisfactory.
The use of Boric Acid for Elution
Trauther and Nesser (1952) reported that noradrenaline and
adrenaline form complexes with boric acid. This property is shared
with dopamine but not with their ortho-methylated derivatives. The
complexes are highly stable at pH 7-8 and can safely be stored for
several days under refrigeration (Wright 1958).
Wright (1958) was the first to use borate complexes in the
extraction of catecholamines and more recently methods have been
described by Mattock and Wilson (1966) and Sandhu and Freed 1968).
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FORMATION OF BORATE - NORADRENALINE
COMPLEX
0^^\^,CHOHCH ,NH2
j"-° + "* ~°-\X)
Initially we attempted to elute catecholamines from our 2 cm
columns of CG-120 resin by using a 2/3 Molar solution of boric acid.
However, this could not be achieved in a sufficiently small volume and
we were unable to further increase the concentration of the boric
solution as, even at this strength, it had to be stirred and heated
continuously for several minutes before it could be completely dissolved.
On theoretical grounds, we thought that .increasing the pH of
the eluting fluid would favour the elution ox the borate-catecholamine
complexes and thus we studied the effect of adding sodium hydroxide to
the boric acid.
At a pH of 6.5 we found that 10 mis of the borate solution
was required to elute 95/ of the catecholamine that had been loaded onto
the columns and the recovery after elution with 5 mis of the solution
was only 70/. However, at a pH of 8.0, elution with 5 mis of borate
solution gave a recovery of 91%-
We felt it was undesirable to further increase the alkalinity
of the borate solution as catecholamines are known to oxidise more
readily in alkaline conditions.
So far we had failed to achieve sufficient concentration of
catecholamines in our final eluate and next turned our attention to the
use of boric acid to elute from weak cation exchange resins, e.g.
Amberlite CG-50.
The use of Amberlite CG-30
Amberlite CG-JO is a carboxylic acid, weak cation exchange
resin. We used the resin in the sodium/potassium form, after the same
preparation procedure to that previously described for the sulphonic
acid resin. p136
Catecholamines were eluted from the resin with 2/3 molar boric
acid following a single rinse with distilled water. The eluates could
be used directly in the trihydroxyindole fluorimetry process, after
adjusting them to pH 6.5 with a small quantity of 1N HC1.
The initial work was done using solutions of pure catecholamine
standards (100 ng) and columns of 2 cm length. Complete elution could
be performed with 0.6 mis of boric acid and recoveries were found to be
over 90%. When the ionic content of the catecholamine solution was
increased by the addition of a few mis. of neutralised perchloric acid
solution (after centrifugation to remove the precipitate) the recovery
was reduced to about ^>0%.
So as to overcome this loss the columns were lengthened to 5 cm.
These still had a satisfactory flow rate and elution was completed with
1 mi of boric acid giving recoveries of over 90/.
Bearing in mind that plasma has a relatively high ionic content
even before the addition of perchlorate ions, the recovery experiments
were repeated in the presence of 0.9/ saline with and without neutralised
FIGURE 52. 271
EFFECT OF COLUMN LENGTH AMD PRESENCE OF INORGANIC IONS (SALINE AND PERCHLQRATE)
ON RECOVERY OF CATECHOLAMINE STANDARDS FROM COLUMNS OF AMBERLITE CC-50.
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perchlorate. The eiution profiles and recoveries obtained are
illustrated in Figure 52 and it can be seen that the presence of all
these ions leads to very high losses from the resin.
We supported these observations by adding small amounts of
catecholamines to plasma prior to which protein precipitation had been
performed using perchloric acid, followed by neutralisation and centri-
fugation. The solutions were loaded onto the 5 cm columns and eluted
with 2/3 M boric acid.
Average recovery from 5 ^ls plasma was 7J>% Cn = 6) and from
10 mis plasma it was even lower (.60%), This -was unsatisfactory as
ve intended to subject the columns to the ionic load contained in 20 ml
blood samples i.e. (10 mis plasma); although not surprising,as ve had




A Two-column Extraction Technique
Renzini, Brunori and Valcri (1970) described a technique in
which they overcame the problem of plasma's relatively high ionic
content. They, performed an initial extraction of the catecholamines
using alumina and eluting with 0.05N perchloric acid. This eluate was
then passed through an ion exchange resin of carboxylic acid form.
Final elution was performed with 0.5 mis of boric acid. They only
dealt with initial plasma volumes of 5-10 mis because a high ionic
load also affected the recovery from alumina. They used micro- (
curvettes for the fluorimetry so as to increase the final concentration
of the fluorophors.
For reasons previously discussed we did not want to use P135
alumina. However, we found that elution of catecholamines from 2 cm
amberlite CG-120 could be performed itfith b mis of IN perchloric acid.
Recoveries were similar to those obtained with 1N hydrochloric acid i.e.
(over 90%). The elution profiles are compared in Figure 53-
The strong acid resin can cope with a higher solute load and no losses
were found in the presence of 10 mis saline although 20 mis of saline
resulted in a reduction in recovery by almost 30/4,
For the second stage of the procedure, the perchloric eluates
were neutralised, frozen and centrifuged in order to remove the
perchlorations before loading the supernatant onto 5 cm columns of
amberlite 0(3-50. The columns were rinsed with 10 mis of distilled
water before performing the final elution with 1 ml of 2/3 M boric acid.
Recovery using pure standard solutions was found to be over 89%
and equivalent values were obtained when this was repeated using standards
added to 10 mis of prepared plasma.
FIGURE 53.
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FRACTIONAL ELUTION OF PURE SgAKSARDS OF ADRENALINE AND NO'RADRENALIriE
FROM 2cm AMBERLITE CG-120 COLUMNS.





When radioactively labelled adrenaline or noradrenaline is
injected intravenously the label compound appears in the urine as
follows (See Axelrod 19^5)•
1-2$ unchanged
20 - 30$ ortho-methylated derivatives
60 - 70$ H.M.M.A. (^--hydroxy-3-methoxymandelic acid)
It is hard to asses how relevant such studies are to the meta-
I
bolism and excretion of the noradrenaline released during sympathetic
activity. However, they probably serve as a reasonable index of the
fate of that catecholamine which is washed cut of the tissues.
On the ojdier hand, an intravenous injection does mimic the
release of catecholamines by the adrenal gland. Thus the excretion of
adrenaline and its metabolite, metanephrine, has considerable potential
as an index of adrenal activity in experiments on human subjects.
Only a small proportion of the injected adrenaline is excreted
unchanged and thus any alteration in catecholamine metabolism could have
dramatic effects on the amount of unchanged adrenaline excreted - that
is, without there having been any change in adrenal discharge. As a
,quarter of an injection of adrenaline is excreted in the form of meta¬
nephrine , this would appear to be more representative of adrenal activity.
H.M.M.A. is only useful as an index of the total catecholamine
activity as it is also formed when monoamine oxidase acts on normeta-
nephrine and is thus the common end product for both catecholamines.
We had several reasons for developing an assay for catecholamines
and their O-methylated derivatives in urine:
1. As mentioned above, the adrenaline and raetaphrine levels in urine
would probably reflect the activity of the adrenal gland over the period
of the collection.
2. Greater concentrations are present in urine compared with plasma
and this makes the assay easier.
3. It would be impracticable to study adrenal activity over an extended
period of time by means of serial peripheral blood samples because of
the volume of blood that would be required, - (each plasma estimation
requires 10-20 mis of whole blood).
N.B. Trie duration of the collection periods can be greatly reduced
by water loading the subjects.
4. We intended to perform some long terra studies on patients using
24-hour collections.
Assay of Noradrenaline and Adrenaline
We first tried to apply our adrenal venous plasma assay
directly to urine. This method is described by Haggendal (19^2) who
performed his plasma assay on 5-10 mis urine and does not mention any
difficulties. We found,even after centrifugation and dilutionthat
when using larger volumes (20-40 mis) we did not obtain satisfactory
fluoresence curves and our blanks were unacceptably high. This was
due presumably to contaminants. We thought that the use of. boric
acid which selectively elutes catecholamines, should greatly reduce




Urine, assays had been described by Mattock and Wilson (1966)
and Sandhu and Freed (1968) in which catecholamines were eluted from
weak cation exchange resins using boric acid. They reported recoveries
of around 90%. However, they stressed that it is essential to dilute
the urine to achieve this degree of recovery and mention their failure
to assay, satisfactorily some, samples ivhich had a high ionic content.
Their eluting volume of boric acid was never less than half that of
the initial volume of urine being subjected to assay and thus their
concentration factor was only about two-fold.
i
We found that their technique gave good quality catecholamine
fluorescence curves, but we wanted to increase the concentration of
catecholamines in the final eluate and perform the assay on larger
volumes of urine. Thus we applied our two-column technique, which I p273
have already described for plasma estimations, to the assay of urinary
catecholamines. The results were very promising with consistent
recoveries of over 80%.
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.ASSAY OF 0-METHYLATED DERIVATIVES
Separation of Normetanephrine and Metanephrine from the Catecholamines
It is obviously advantageous to be able to perform the
estimation of both pairs of amines on the same urine sample. This v/as
done by Weil-Malherbe and Smith (1966) and Brunges, Wybenga and Johns
(1964) by passing the urine through alumina which selectively adsorbs
the catecholamines while retaining only insignificant amounts of the
metanephrines. The metanephrines are then extracted from the sample
by an ion-exchange resin. Weil-Malherbe and Smith used formic acid
while Brunges' group used acetic acid for elution.
We wanted a method in which a single column-could be used
for the extraction and the separation. We first studied the elution
pattern of pure standards'from a 5 cm column of Amberlite CG-120 when
using 1N hydrochloric acid and achieved some separation (Figure 5*+a).
We then employed a resin of smaller particle size but this only slightly
increased the separation. (Figure 5^b). These latter columns were
very slow running and we achieved even less separation when we used
urine instead of pure standard solutions. (Figure 5^b).
Haggendal (1962) \i?as able to completely separate catecholamines
from metanephrines by using 10-20 cm columns but such a size needs a
very large elution volume and runs so slowly to be of no practical value
We decided to exploit the. property of catecholamines to form
complexes with boric acid which is .not shared by the metanephrines.
Mattock and Wilson (1966) had used a weak cation exchange resin
and removed the metanephrines with dilute sulphuric acid after elating
the catecholamines with boric acid. Sandhu and Freed (1968) employed
SEPARATIONOFTHECATECHOLAMINESFR ME R0-METHYLATEDD IVATIVESUSI GION- XCHANGESI S
figure5'+.































JfN ammonium hydroxide to elute the metanephrines from similar columns
but comment that their method is not sufficiently accurate to do more
than detect, higher than normal levels, in urine.
However, the ionic content of our urine samples was very
likely to vary and so we considered it preferable to use a strong
rather than a weak acid cation exchange resin.
In some pilot experiments using-our standard 2 cm columns of
Araberlite CG 120 we first eluted the catecholamines with a borate
solution (boric acid and sodium hydroxide at pH 7-5) and then eluted
the metanephrines with 1N hydrochloric acid. Figure5^c shows that
for complete elution large eluting volumes are required. In our
recovery experiments we used 10 mis of both borate and hydrochloric
acid and obtained mean recoveries of 87 _+ 2c/o (n = 12) for the cate¬
cholamines and 70 +_ 2% < (n = 12) for the metanephrines. We also found
that with the catecholamines the blanks were much lower than when they
were eluted with hydrochloric acid.
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Fluorimetrie Estimation of Kormetanephrine and Metanephrine
Bertler, Carlsson and Rosengren (1959) first demonstrated that
the trihydroxyindole method could be applied to the O-methylated cate¬
cholamine derivatives with the production of fluorphors identical to
adrenolutine and noradrenolutine, although the oxidation has different
optimal conditions to those required for catecholamines. However, these
differences are not sufficient for differentiation between the two pairs
of amines and it is first necessary to separate metanephrine and nor-
metanephrine from the catecholamines and other related compounds.
Laverty (1963) found that both metanephrine and norrnetanephrine
are oxidised by iodine at an optimum pH of between 8.6 and 9-1.Haggendal
(1962) used iodine at pH 6.5 - 7.0 and differentiated between the two
compounds by reading at two separate wave lengths. Smith and Weil-
Malherbe (196*0 used a differential pH technique. In the latter both
compounds are oxidised by iodine at pH 7-9.and metanephrine alone is
oxidised by using potassium ferricyanide at pH 3 in the presence of a
high concentration of zinc ions. They found that the use of potassium
ferricyanide at the higher pH yielded fluorphors with less fluorescence
and stability to those obtained with iodine.
Our oiira. work confirmed this latter observation of Smith and
Weil-Malherbe. We obtained stable fluorphors by oxidising metanephrine
at pH 3 with, potassium ferricyanide. The reaction required the
presence of cupric ions In a three fold higher concentration to that
used in our catecholamine assay. At this low pH no significant
fluorescence was derived from normetanephrine while at a pH of around
7-5 both compounds were oxidised by potassium ferricyanide.(Figure 55)






THE MEASUBEMENT OP TOTAL ABDOMINAL VENOUS CAPACITANCE
AND ITS INTERACTION WITH THE POSTAL VENOUS SYSTEM
Introduction
Our own experiments and those of others had suggested that there
may be a difference between the baroreceptor and chemoreceptor reflexes in
relation to the proportions of muscarinic to nicotinic ganglion receptors
in their respective pathways (see p.229). Some of this evidence is based on
studies of the relative influences of reflexes and ganglion stimulant drugs
on arterial and venous tone. Thus, in order to extend the scope of our own
investigations, we wanted to develop a technique for studying changes in
arterial resistance and venous capacitance in the innervated preparation.
. Most of the techniques available for studying resistance and
capacitance, together with their theoretical background, have been reviewed
by Mellander and Johansson (1968). The technique of constant flow perfusion
for assessing alterations in arterial resistance was well established, and.
therefore,we concentrated our resources on the investigation of various
methods for measuring changes in venous capacitance.
Unfortunately we did not have the resources to employ any of the
methods,which we examined, in a study of the carotid reflex pathways.
However, we did develop a technique for investigating changes in abdominal
capacitance and,with it,we obtained evidence that there is an interaction
between the portal and systemic venous capacitance systems.
This interaction may result in drugs and reflex responses having
unexpected effects on venous return. Before I describe these abdominal
capacitance studies, I shall briefly mention some features of the other
techniques with which we have had experience.
We initially attempted to measure venous capacitance changes in
the dog oi- cat hind limb. This site was chosen because of the small amount
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of surgery required for access to the femoral artery and vein. An iso-
J
volumetric approach was used which depended on perfusing the vascularly
region
isolated/at an equal inflow and outflow. Thus, in this set up, the inflow
perfusion pressure was the index of arterial resistance while the upstream
outflow (i.e. venous) pressure was taken as the index of capacitance.
However, the Watson - Marlow (MHRE) pump does not reliably
deliver two equal flows. Also it was impracticable to vascularly isolate
the hind limb due to the extensive anastomosis around the head of the femur.
The same problem of anastomosis would apply to the forelimb. Other workers
have claimed to achieve complete vascular isolation using ligatures.
However, on examination of demonstrations of this technique, we found that
these permitted the passage of too fingers between the ligature anil the
tissue. (Physiological Society meeting of December 1973)- We tried using
Jubilee clips or ligating individual groups of muscle but both caused an
undesirable amount of tissue trauma.
It was relatively simple to vasculariy isolate a loop of small
intestine but we found that, after this amount of manipulation of the gut,
the preparation tended to deteriorate. Furthermore, we found that techniques
based on changes in the weight of the constant flow perfused vascular
region (e.g. hindlimb or small intestine loop) required an undesirable
amount of surgery to seperate the tissue sufficiently from the animal to
enable accurate weighing to he performed.
Hainsworth, Karim and Stoker (197*0 described a technique in which
changes in venous tone were determined by the pressure drop along the
saphenous vein which was perfused with blood at constant flow via a small
tributary in the foot. However, we found that this method required an
unphysiologically high venous perfusion pressure and suffered from the
theoretical disadvantage that, unless the vein was vascularly isolated,
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local changes in arterial inflow along its length would also effect the
pressure gradient.
The interaction beti^een the resistance and capacitance vessels
in the supply of blood to the tissues is very complex but as a broad gen¬
eralisation it can be said that alterations in arterial resistance determine
the regional distribution of the cardiac output while the importance of
changes in venous capacitance lies with their overall effect on venous
return and the cardiac output as a whole.
Thus we were interested in developing a technique which would look
at overall rather than regional changes in venous capacitance. Some methods
have been reported (see Mellander and Johansson, 1968) which required
complicated cardiac bypass surgery but we considered that it would be
economically more feasible to develope a technique to look at capacitance
changes in the lower half of the body, i.e. below the diaphragm.
Hainsitforth and Karirn had demonstrated their abdominal capacitance
technique at a Physiology Society meeting in December 1973 ana we decided
to use a similar technique with the following modifications
1) They perfused the vascularly isolated abdomen via the aorta and
inferior vena cava. We found it simpler and obtained a more stable preparation
by tying the aorta and inferior vena cava and perfusing in through a carotid-
femoral arterial connection and out through a femoral-jugular venous connection
2) We assessed changes in venous capacitance by either an isovolumetric
approach or one using our servo amplifier system which kept venous pressure
constant as well as giving an electrical signal representing outflow.
3) We considered the interaction between portal and systemic venous
capacitance and its effect on venous return.
Von Euler (1939) had demonstrated that a mixture of prostaglandins
caused a large fall in systemic blood pressure and a major component of this
fall was due to the damming back of blood within the hepatic portal system
with a consequent reduction in venous return. We thought that this type of
redistribution of blood between the portal and the systemic capacitance
beds could have a profound effect on the indices of capacitance obtained
from techniques like that of Hainsworth and Karirn (1973)-
Method
We used pentobarbitone anaesthetised dogs (30 mg/Kg) in which
the abdomen was vascularly isolated by ligation of the thoracic aorta,
inferior vena cava and both azygos veins. The six lower intercostal arteries
were also tied and the vertebral veins occluded by injecting hot wax or
exothermic setting plastic cement (- expands on setting) via a lumbar puncture
technique in order to completely abolish collateral flow.
The abdomen was perfused at constant flow through a femoral artery
with blood taken from the carotid artery. In order to reduce the work load
of the Watson Marlow (MHRE) pump we tied, off the kidneys, common iliac vessels
and removed the spleen.
Venous blood was removed from a femoral vein and returned to a
jugular vein either:-
a) At the inflow rate giving an isovolumetric situation in which changes in
venous pressure were taken as an index of changes in capacitance.
b) At constant pressure using our servo-control amplifier system (see p. 89)
to control the Watson Marlow pump. The pump drive electrical output (i.e. the
flow signal) was integrated and.this was our index of the volume (i.e. capac¬
itance) changes.
A cannula was passed through the splenic vein into the portal vien
and enabled us to:-
a) Measure portal venous pressure.
b) Shunt blood to and from the femoral vein and thus bypass the liver. We
help
considered using our servo-control system to/keep portal vein pressure at
the same level as that in the systemic capacitance vessels (i.e. inferior
vena cava - see p. 91)
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P.esul i;s
For each drug we performed, paired tests by comparing the responses
to equal doses given intra - arterially , i.e. into the femoral arterial
inflow line, when the bypass was open and when it was closed. The order
was alternated. Our preliminary experiments on six dogs support our view
that there is an interaction between portal pooling and venous return.
1) Noradrenaline (10-200 pg) (Levophed - Winthrop) - In twelve out of
sixteen paired tests we found that, when the bypass was open, there was a
larger increase in venous return which was accompanied by a smaller rise
in portal venous pressure. '
2) Angiotensin (10 ug) - In five paired tests we observed a similar pattern
of responses to those obtained with noradrenaline.
J
On several occasions, 'when the bypass was closed, both these
drugs have produced an actual fall in venous return when very large rises
in portal pressure occurred.
3) Prostaglandin (50-^1-00 ug) - This resulted in a fall in venous return
combined with a rise in portal venous pressure and in six out of eight
paired tests we recorded a smaller fall in venous return when the bypass
was open.
In one case an actual rise in venous return, associated with a smaller
rise in portal venous pressure was noted.
4-) Prostaglandins and F„w (100-300 ug) - These increased venous return
and portal venous pressure but tachyphylaxis prevented an investigation
of the interaction phenomena.
5) Vasopressin (4-10 I.U.) - Using the capacitance method (a), this led to
a rise in venous return with a rise in portal venous pressure but no change
occurred using the method (b). However, with the bypass open, method (a)
showed the larger rise in venous return and method (b) showed a rise in
venous return combined with a fall in portal venous pressure.
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Discussion
Our results indicate that there is an interaction between the
systemic (i.e. parietal) and splanchnic capacitance beds. Consequently
we felt that the phenomenon of hepatic portal pooling should be considered
when interpreting the action of vasoactive drugs on venous return.
We suggest that the following mechanisms may be involved in
hepatic portal pooling with an accompanying reduction in venous return to
the heart.
A) That associated with a fall in portal venous pressure:-
i
-Portal and splanchnic vein dilatation.
B) Those associated with a rise in portal venous pressure:-
V
i) Constriction of hepatic and portal venule sphincters or dilat¬
ation of hepatic arterioles resulting in an apparent increase in
hepatic resistance.
ii) Dilatation of splanchnic arterioles resulting in increased
flow through the splanchnic bed at the expense of parietal blood
flow.
We consider that our technique is potentially useful for invest¬
igating the effects of drugs and reflexes on arterial resistance and venous
capacitance. Not only can it assess the interaction between portal and
systemic capacitance but also,by using appropriately placed electromagnetic
flow probes,regional changes in arterial resistance can be studied.
It also has the advantage that the vascular territory under study





I would like to finish by asking a number of questions.
If one assumes that the selective neural and humoral mechanisms are
found in the same spedies, then, how is the evidence for the selective
innervation of adrenaline and noradrenaline cells with different
proportions of muscarinic and nicotinic receptors reconciled with the
phenomenom of the induction of PNMT by corticosteroids? What mixture of
catecholamines would chemoreceptor stimulation release in a hypophysect-
omised cat?
The internal circulation of the adrenal gland is complex.
Does it influence catecholamine release through local changes in the
distribution of gland blood flow? The ungulates are particularly interesting
ir
as the/arteriae medullae supply areas containing solely noradrenaline,
(see p. 68)
d
What is the short term fate of cumulating adrenaline?
Is some taken up by the adrenergic neurones and released with the
noradrenaline? If this is the case, then the adrenaline proportion of
the adrenergic neurotransmitter may rise in conditions of chronic adrenal
activation.
What is the role of adrenal noradrenaline? Vane (1969) claims
that adrenal catecholamines play little part in the haemodynamic responses
to reflexes such as those from the baroreceptors and this view is supported
by the work of Celander (195*0 • One possible role is that of "topping up"
peripheral adrenergic neurone stores under conditions of prolonged stress
in which synthesis and reuptake may not be able to keep pace with the
loss to extraneuronal uptake sites.
APPENDIX VI. TABLES OF RESULTS
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Individual Whole Animal Experiments DRi -5 291- 2.95
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Chemoreceptor releases J 332
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Methacholine 3% - 342
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Carbochol C4 - 7 3h-7




Carotid Sinus Pressure (CSP) - mmHg
Systemic Blood Pressure (SBP) - ramHg
Arterial Blood Gas Tensions - torr
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0.59 0.00 5.19 0.74
5-53 7.74 25-9 3.48
6.12 7.74 31.0 4.21
9.6 0.0 16.7 17.4
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TEST DOSE OUTPUT % NA IN TNC^MEOT % M IN
No. (jig/ml) TOTAL CA CONTROL , 4" ? / f RELEASE
(ng/min) (ng/isxn) (ng/mxn)
GLAND A2
3 30 xg/ml 339 14 57 4r 16
k 30 , 293 15 110 83- k7
1 50 530 16 253 173 12
2 50 327 16 236 206 36
5 100 310 21 567 424 28
6 100 293 21 383 259 29
10 150 388 26 537 371 3k
GLAND A3
14 25jjg/ml 33*+ 19 111 90 27
A 30 780 15 139 92 25
1 50 (T\ O -P~ 19 297 269 8
12 50 379 20 397 256 5
11 75 431 15 321 222 5
7 100 516 16 613 548 19
13 100 359 19 1158 787 15
10 150 505 13 1905 1548 11
GLAND A4
1 25pg/inl no release
2 50 707 27 656 553 26
3 100 A73 21 756 684 23
GLAND A5
6 25pg/ml 930 2k 129 85 34
3 50 1055 22 30k 459 8
12 50 520 20 115 77 25
10 75 723 24 246 203 27
7 100 976 20 1305 1194 12





























613 20 134 87
370 24 529 469















3 30;ug/ml 152 23 79 56
1 50 204 21 270 197
2 100 174 24 413 325
3 30^/01! no release
1 50 258 22 84 60
2 100 270 28 198 126
4 100 176 22 160 99

















1 IQQug/ral 28^ 25 . kk$ 37^
2 150 ^37 11 1528 1112
3 200 ^90 -]k 1^75 1179
GLAND A12
1 100jng/ml 113 22 2kk 207 19
2 150 158 2k k89 397 15
























3 30 HC no release
1 50 HC 258 22 85 60 38
2 100 HC 270 28 198 126 3
4 100 HC 176 22 160 100 1T
5 130 HC 172 25 b03 269 6
6 5 Aldosterone no release
7 6 Aldosterone no release
8 10 Aldosterone no release
GLAND A10
5 50 HC no release
3 100 HC 175 21 219 17b 18
6 150 HC 150 38 272 237 28
1 5 Aldosterone no release
2 7-5 Aldosterone no release
h 10 Aldosterone no release
GLAND A11
3 50 HC no release
1 100 HC 28 A- 25 Mf5 37^ 15
2 150 HC ^37 11 1528 1112 12
5 200 HC T90 1 k 1A75 1179 11
h 7-5 Aldosterone no release
6 10 Aldosterone no release








































1) Anaesthetic infusion pumps - Palmer Injection Infusion Pump Apparatus,
G.F. Palmer, Lane End Road, High Wycombe,
Buckinghamshire, England.
2) Watson-Marlow pump - W.M. MERE 200, Falmouth, Cornwall.
3) Blood Pressure Transducer - Physiological Pressure Measurement System,
Electronic Instrumentation Group,
Bell and Howell, Ltd.,
Basingstoke, England.
k) Ultraviolet Recorder - Visicorder 2206 - AC
Honeywell ,
5) Servo - control system -
a) Operational amplifiers - Ancon Ltd.,
Cheltenham, England.
b) Power supply - Fenlow Electronics Ltd. ,
VJeybridge, Surrey.
6) Blood Micro System - Acid - Base Analyser, PHM 71
Radiometer, Copenhagen, Denmark.




8) Chemical Processing Unit - Unicam AC 60,
Pye Unicara Ltd.,
Cambridge, England.
9) "Evapomix" - Evapo - Mix,
Buckler Instruments,
Fort Lee, New Jersey, U.S.A.
10) "Whirlymix" - Rotamixer,
Hook and Tucker, Ltd., U.K.
Reagents - suppliers
1) B.D.H. Chemicals Ltd, Poole, Dorset.
2) Koch - Light Laboratories Ltd., Colnbrook, Buckinghamshire, England.
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GLOSSARY
CATECHOLAMINES - refers only to noradrenaline and adrenaline* (see p 17)
\
BAROREGEPTORS - refers to the carotid sinus stretch receptors- (see p 15)
BARORECEPTOR TEST - reduction of perfusion pressure in the carotid bifurcation
resulting in withdrawal of stretch receptor inhibitory tone, (see p 92)
CHEMOREGEPTORS - refers to the arterial chemoreceptors of the carotid
body. (see p 10)
CHEMOREGEPTOR TEST - perfusion of the carotid bifurcations with hypoxic
blood resulting in stimulation of the arterial chemoreceptors.(see p 92)
SODIUM DITHIONITE - reducing agent used for lowering the oxygen tension of
the blood perfusing the carotid bifurcations. (see p 109)
TEC / Trihydroxyindole reaction - used for producing the characteristic
fluorophors in our catecholamine assay. (see p 12.1 X
BAL / British anti-lewisite - dimercaptopropanol - reagent we used to
stabilise the fluorophors in the TEC reaction. (see p 1^2)
METHACHOLINE - Acetyl B Methyl Choline - muscarinic agonist drug, (see p 152)
hppTMA - rneta-hydroxyphenylpropyl trirnethylammonium - nicotinic agonist
drug. (see p 152)
SYNAGTHEN - synthetic analogue of corticotrophin / adrenocorticotrophic
hormone, ACTH. (see p 10.5)
CYCLOHEXIMIDE - inhibitor of protein synthesis which rapidly blocks the
secretion of corticosteroids from the adrenal cortex. (see p 10^)
Whole Animal Experiments D = Dog
DR 1-5 - alternate baroreceptor and chemoreceptor tests.
DN 1&2 - serial periods of electrical stimulation of the splanchnic nerve
to the adrenal gland. 1
DN 3 - effect of Synacthen administration on serial periods of splanchnic
nerve stimulation.
DA 1-3 - effect of Synacthen administration on serial baroreceptor tests.
DC 1 - effect of prolonged chemoreceptor stimulation on serial baroreceptor
tests.
DG 2-7 - effect of cycloheximide on the response to prolonged chemoreceptor
stimulation.
DG 8 - effect of prolonged chemoreceptor stimulation on serial baroreceptor
tests with the other gland denervated.
CAT 1-8 - alternate baroreceptor and chemoreceptor tests.
*The other catecholamines such as dopamine are only found in small amounts
in the mammalian adrenal gland. However, it has recently been appreciated
that dopamine reaches concentrations an order greater than does noradrenaline
in peripheral plasma but this would not be detected by the TEE assay, (see
"'The Adrenal Gland", Handbook of Physiology series, 1975)-
